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Abstract
In the late 1980s Carver Mead introduced Neuromorphic engineering in which various
aspects of the neural systems of the body were modelled using VLSI1 circuits. As a result
most bio-inspired systems to date concentrate on modelling the electrical behaviour of neural
systems such as the eyes, ears and brain. The reality is however that biological systems rely
on chemical as well as electrical principles in order to function.
This thesis introduces chemical bionics in which the chemically-dependent physiology
of speciﬁc cells in the body is implemented for the development of novel bio-inspired ther-
apeutic devices. The glucose dependent pancreatic beta cell is shown to be one such cell,
that is designed and fabricated to form the ﬁrst silicon metabolic cell. By replicating the
bursting behaviour of biological beta cells, which respond to changes in blood glucose, a
bio-inspired prosthetic for glucose homeostasis of Type I diabetes is demonstrated.
To compliment this, research to further develop the Ion Sensitive Field Eﬀect Transistor
(ISFET) on unmodiﬁed CMOS is also presented for use as a monolithic sensor for chemical
bionic systems. Problems arising by using the native passivation of CMOS as a sensing
surface are described and methods of compensation are presented. A model for the operation
of the device in weak inversion is also proposed for exploitation of its physical primitives
to make novel monolithic solutions. Functional implementations in various technologies is
also detailed to allow future implementations chemical bionic circuits.
Finally the ISFET integrate and ﬁre neuron, which is the ﬁrst of its kind, is presented to
be used as a chemical based building block for many existing neuromorphic circuits. As an
example of this a chemical imager is described for spatio-temporal monitoring of chemical
species and an acid base discriminator for monitoring changes in concentration around a
ﬁxed threshold is also proposed.
1Very Large Scale Integrated
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Introduction
1.1 Motivation for Chemical Bionics
In this decade of digital information, we have seen a convergence of semiconductor based
technologies into the world of healthcare, providing foundations for a new technology plat-
form which provides solutions for diagnosis, monitoring and treatment of disease. Biomedi-
cal devices used for this are getting smaller and cheaper due to the decreasing feature size of
the transistor and the economies of scale of silicon. However, applications are now demand-
ing low power consumption, intelligent information processing and realtime monitoring.
Such constraints has resulted in the information moving back to continuous analogue
quantities which allow implementations of intelligent systems using minimal amounts of
power [1]. In addition to this, the human body processes information in analogue, using
the electrical and chemical behaviours of its neurons to transmit and process information
and inﬂuence various metabolic actions. This equivalence has contributed to the creation of
biologically inspired electronics (Bionics) in which a number of electronic systems designed
in VLSI have been inspired by the functionality of various biological organs.
The motivation which has seen engineers create bionic systems has initially been spawned
by the functionality of the brain in which, unlike machines, is capable of performing 1016
complex operations/sec with just a few watts in power [2]. This tremendous processing in
conjunction with various local neuronal processing at the body’s ‘sensor front ends’ (eyes,
ears, nose, tongue, skin) allows us to see, hear, smell, taste and feel suﬃciently, even though
our sensing receptors are of low precision. Overall, biology has made eﬃcient use of the
resources it has to derive optimal solutions.
1
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Figure 1.1: Chemical relevance of excitable cells. Shown is the neuron of the neural system,
the alpha and beta cells of the pancreas and the myocyte cells of the heart.
As a result, when trying to create a biomedical device aimed at replacing a biological
function, it is advantageous to try and mimic what biology itself has developed. This was
the vision of Carver Mead who in the late 80’s introduced ‘Neuromorphic Engineering’,
in which the electrical neural behaviours of organs such as the brain, eyes and ears, were
modelled in VLSI to create computational systems which replicate various biological traits.
Redundancy, recognition and adaptation are a few to name, which were achieved using
minimal amounts of power [1]. It should be noted however that the organs in the human
body rely on chemical as well as electrical interactions to carry out speciﬁc functions.
Fig. 1.1 depicts several examples of such biological functions whereby the biochemi-
cal physiology of each of the excitable cells1 listed plays an important part in the organs
functionality. The neuron for example, which has thus far only had its electrical behaviour
modelled in VLSI, generates its action potential as a result of initial stimulation from neuro-
transmitters which provoke the inﬂux and outﬂux of the chemical ions shown, which results
in transmission of nerve signals. The alpha and beta cells of the pancreas, rely on glucose
as an input to initiate action potentials leading to exocytosis, which causes secretion of
insulin and glucagon responsible for regulation of blood glucose. Lastly, the myocyte cells
of the heart, rely on calcium intake and outﬂow to generate action potentials which cause
contraction of cardiac muscles. By considering these chemical behaviours, further insight
into the development of new chemically based bionic systems is possible.
Chemical Bionics introduces a new paradigm in which we create such bio-inspired sys-
tems to additionally utilise chemical as well as electrical inputs. With these we aim to
replicate speciﬁc functionality of our organs to make novel bionic prosthetic devices for
healthcare. By mimicking the biochemical physiology of the beta cells, it will be shown
1Excitable cells are a class of cells that generate action potentials as a result of excitation
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that organs such as the pancreas can be modelled to form closed loop systems, which be-
have similarly to their biological counterparts. This ultimately oﬀers a more natural form
of control when dealing with the unpredictability of the human body, reducing secondary
complications of such disease. However, for such a Chemical Bionic system to be monolithic
to form a single VLSI solution, an integrated CMOS chemical sensor is required. The IS-
FET (Ion-Sensitive Field Eﬀect Transistor), which allows for implementation of Biochemical
VLSI [3], is such a sensor and will also be explored in a lot more detail this thesis.
1.2 Research Objectives
This research is aimed at developing the ﬁeld of Chemical Bionics by exploring the paradigms
which may emerge in the ﬁeld of bio-inspired electronics by being able to have a chemical
input to the system as well as an electrical one. In doing so we initiate future research
in this ﬁeld, which will inevitably lead to a completely new breed of prosthetic devices.
Subsequently for this to become a reality, two main topics need to be explored in this
thesis:
1. Given a chemical input to the silicon and observing functionality of various organs
in our bodies, is there any aspect of biology which can be modelled in the framework of
bio-inspired electronics ? Would this make a better therapeutic device, a more eﬃcient
system or give us a better understanding of the physiology by modelling it down to its
physical primitives ?
2. Is it possible to have a chemical sensor made in an unmodiﬁed CMOS process which
could be used as this chemical input to the electronics ?
1.3 Overview
With Chemical Bionics the functionality of excitable cells is replicated to provide novel
solutions to applications of healthcare as well as chemical sensing. This functionality has
been broken down into three main categories, sensing, processing and communication which
are all interrelated by biological feed-forward and feed-back mechanisms in the body. These
categories are shown in Fig. 1.2, along with the relevant associations with each of the
technical chapters in this Thesis. Silicon metabolic cells are described in Chapter 3, in
which the sensing and processing of the beta cell of the pancreas is mimicked to make an
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Figure 1.2: Chemical Bionics overview. Illustrated above are the main functional blocks in
biological cells and how they have inspired the work for each chapter in this Thesis
artiﬁcial prosthetic for glucose homeostasis. Chemical electronics is presented in Chapter 4
whereby the ISFET sensor is developed to be used as the sensing for chemical bionic systems.
Lastly, neurally inspired chemical bionic systems are designed in Chapter 5, combining the
sensing and communication of these cells to make an ISFET based chemical imager which
utilises action potentials to encode and transmit information.
We proceed by providing a succinct, single paragraph synopsis of the material to be
presented in each of the following chapters of this Thesis.
1.3.1 Biologically inspired electronics
This chapter introduces the concept of biologically inspired electronics along with Neuro-
morphic electronics to explain how mimicking biology can lead to eﬃcient solutions. Two
main groups of bionic systems are described, those which mimic biological operation to
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make a more ‘realistic’ prosthetic, and those which are inspired by biology to make more
eﬃcient electronic systems. While most Neuromorphic VLSI concentrates on the neural
behaviour of the body, it is shown with the example of the gated ion channels of cells and
the physiology of the neuron, that the biochemistry of cells is also a factor to consider when
modelling biology. Finally, by using a Hodgkin and Huxley model of a neuron, an example
of a ‘chemical neuron’ is shown which generates action potentials by exploiting its chemical
characteristics.
1.3.2 Silicon Metabolic Cells
This chapter presents a novel chemical bionic system to be used for the development of an
artiﬁcial pancreas for the treatment of Type I diabetes. The problems involved with diabetes
are discussed along with current methodologies used to make an artiﬁcial pancreas. The
biological pancreas as an organ is analysed and the beta cell within it is identiﬁed as the
key cell for sensing and regulating blood glucose levels. The bursting behaviour of the beta
cell in response to glucose is then modelled using a Hodgkin and Huxley formalism and
implemented using an integrated silicon solution. The fabricated beta cell is presented as
the ﬁrst Silicon Metabolic Cell and is shown in a simple demonstrator as a Bio-inspired
Artiﬁcial Pancreas.
1.3.3 Chemical electronics
This chapter presents research in developing the Ion Sensitive Field Eﬀect Transistor (IS-
FET) in an unmodiﬁed CMOS process for use in chemical bionic systems. This begins with
a review of chemical sensors in CMOS along with the introduction to the ISFET, which
details its operation and the physical phenomena that cause its pH sensitivity. Operation of
this device in the weak inversion region is shown along with equations describing its physical
primitives. The current state of research on ISFETs in unmodiﬁed CMOS is then reviewed.
Subsequently the design, characterisation, pH sensitivity and modelling of an ISFET in
three diﬀerent technologies is presented. The challenges which exist with implementing IS-
FETs in unmodiﬁed CMOS are described and shown and methods to compensate for these
are presented. The chapter concludes with design recommendations for implementing these
sensors in an unmodiﬁed CMOS process.
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1.3.4 Neurally inspired chemical bionic systems
This chapter presents the concept of neurally-inspired chemical bionic systems in which an
ISFET sensor is combined with a typical silicon Integrate and Fire (I&F) neuron to produce
a chemically sensitive neuron to allow adaptation of ideas which have thus far been used in
neuromorphic engineering to produce large-scale array-based systems. A chemical imager is
presented as an example. This uses a 3x11 array of chemical I&F neurons using an address
event readout to acquire a spatial image of the pH concentration above a silicon die in
addition to exploiting the leakage properties of the neuron, to provide adaptive buﬀer pH
cancellation. A pH discriminator is also described which uses two neurons to encode acidity
and alkalinity to detect transitions around a known pH.
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Chapter 2
Biologically Inspired Electronics
2.1 Introduction
Since the creation of life, the human body has been forced to evolve, through continual
optimisation, in order to survive. As a result of this, we have become eﬃcient biological
systems made up of billions of unprecise, energy eﬃcient, living cells powered by metabolic
biochemistry.
The brain is the most outstanding example of a cluster of cells which have evolved.
Though made up of slow, noisy and imprecise components, it is able to execute some of the
most computationally demanding tasks such as perception, balance, navigation, recognition
and segmentation. It is able to process the equivalent of 3× 1014 operations using a single
joule of energy, seven orders of magnitude more eﬃcient than what is achievable by any
modern electronic processing system [1].
Our eyes and ears are other ﬁne examples. Though made of millions of poorly deﬁned
sensing receptors, they are able to provide our brains with well conditioned neural signals
which represent accurate images and sounds to allow us to see and hear, even under great
interference. Biological systems have not been optimised with the best technology and
highest digital precision, and yet through this evolutionary process have become eﬃcient,
robust, adaptable, real-time, eﬀective, scalable, redundant and reliable.
Given the inherit merits of biological systems, electronic engineers have begun to explore
ways in which they could create bio-inspired systems that would beneﬁt from these, either by
having the same functionality as biology, or using similar principles to replicate its eﬃciency.
8
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This ﬁeld is termed ‘Bio-inspired electronics’. Bio-inspired electronics was a very general
ﬁeld in the VLSI community until the early 80’s when Carver Mead began the foundations
of what today is called Neuromorphic VLSI [2].
By modelling biology, Neuromorphic circuits have been able to outperform similar dig-
ital implementations for a given power and precision [3]. Until recently however, these
neuromorphic VLSI implementations have mainly been limited to modelling just the elec-
trical behaviours of biology. The body though has many biological functions which rely on
biochemical inputs as well as electrical inputs. Furthermore, technology has now evolved to
the point where we can start to think about having chemical inputs to silicon-based circuits,
using CMOS sensors such as the ISFET [4]. With this in mind, Chemical Bionics aims to
exploit the physical primitives of such devices to promote a new breed of bio-inspired cir-
cuits, interacting with chemical signals in addition to electrical. By using such circuits
implementation of prosthetics may be possible, either to control metabolic diseases such
as diabetes in a more physiological manner or to control neural stimulation based on the
chemical fundamental agents responsible for the action potential.
This chapter provides an introduction to Neuromorphic VLSI which shares the same
design principles with chemical bionic systems proposed in this thesis. Examples of the
kind of neuromorphic systems which have appeared so far are then shown to give an under-
standing of the advantages which may be gained by mimicking nature. An explanation of
the physiology of the neuron is then given, as an example of a cell whose electrical character-
istics are a consequence of the chemical ions surrounding it. This is followed by examining
the chemical interactions of the ion channels of other cells. In doing so, other organs which
could potentially be used as models for chemical bionic systems are shown. The Hodgkin
and Huxley formalism is then presented as a method of modelling the electrophysiology due
to these chemical interactions, which allows for VLSI implementations. Finally a chemical
bionic neuron is shown, which is designed to take advantage of the chemical behaviours of
biological neurons described to produce action potentials.
2.2 Neuromorphic VLSI
Realising the brain’s capability as an energy eﬃcient processor, Carver Mead began investi-
gating the neural organisation and function of the brain in order to see if he could produce
systems of similar representation. The idea was that if electronic circuits could be made
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using the same physical structure and organisation as the neural architecture of the brain,
then in principle, brain-like computers could be made which would be more powerful and
energy eﬃcient than any of the current digital computers of the time [5]. The name given
to such circuits would be Neuromorphic.
The high energy eﬃciency of the brain can be ascribed to the fact that it processes its
information in analogue. It uses the physical primitives of its devices (neurons) to derive
representations which are used to convey information. Contrary to this, digital uses energy
to force the physical primitive of transistors to give a boolean representation of a ‘1’ or
‘0’ which in turn is used to build logic gates which process information. Therefore, Mead
realised that in order ‘to minimse energy you shouldn’t turn the medium into something it
is not, instead invent a representation which uses the physical primitives of the device’ [5].
However, a problem which exists by working in the analogue domain is that the data
processing and communication is vulnerable to noise and mismatch, unlike in the digital
domain where discrete levels in which data is represented are relatively immune to noise.
The brain however, through an optimal wiring strategy which has been over-engineered
by evolution to be redundant and wasteful, and its ability to adapt, is able to process
information reliably in analogue, to provide itself with a well-deﬁned neural representation
of the information it is being given. This adaptation is key as it keeps all the neurons
working in harmony, providing reliability, redundancy and the ability to learn and optimise
for speciﬁc tasks, ultimately increasing dynamic range and reducing noise.
Considering the potential beneﬁts of exploring a new processing paradigm by exploiting
the physical primitives of devices, Mead drew parallels between the primitives of neurons and
those of MOS transistors in semiconductors to build neuromorphic circuits. Using these he
was able to achieve complex operations using very low power, which was ﬁrst demonstrated
by an adaptive retinal chip which performed spatial and temporal gain control similar to that
of a biological retina, in an extremely energy eﬃcient way [5]. Since then, mimicking neural
architectures has served as the basis for implementation of several bio-inspired systems
which try and achieve similar traits, and ultimately produce better prosthetic devices.
Examples of such systems shall be described in the next section.
2.3 Bio-inspired Technology
Bio-inspired technologies to date can be classed into three categories:
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• Systems which are inspired by biology to replace biology. This can be applied to
making prosthetics which are inspired by the biological function of the organ which
they will replace. As a result, they will have some of the traits that come with
modelling biology, such as high dynamic range through adaptivity, low power through
analogue computation and robustness through redundancy.
• Systems which are modelled after biology to help understand biology. Building bio-
inspired blocks which mimic biological function allows creation of systems to under-
stand various complex behaviours about biological systems which cannot be measured
or studied thoroughly.
• Systems which are inspired by biology to make more eﬃcient electronic systems.
Learning about some of the eﬃcient processing architectures of biology, and imple-
menting them in standard technologies, can be used to overcome some of the techno-
logical limitations imposed in today’s analogue and digital design methodologies.
We proceed by describing several examples of these.
2.3.1 Systems inspired by biology
Neural
Modelling fundamental aspects of the neural architecture of the brain in hardware has been
pursued in an attempt to understand its functionality [6] as well as to build highly parallel
brain like processors which can potentially surpass current digital implementations [7]. By
using networks of silicon integrate and ﬁre (I&F ) neurons [8, 9], traits such as adaptation
and plasticity can be implemented on chip to provide novel brain like solutions, to problems
which require classiﬁcation and recognition. Furthermore, technological trends such as the
decreasing feature size of the silicon transistor is favouring the development of this area, as
an increasing number of neurons appearing on chip, may one day see the full implementation
of a silicon brain.
Vision
Countless vision chips have emerged in the neuromorphic community which try to implement
the processing that occurs in the retina [10, 11, 12]. These potentially can be used to make
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epi-retinal implants to stimulate ganglion cells of the blind. ‘Retinomorphic’ cameras as they
are sometimes called are able to process visual information in a parallel, low-power fashion
and achieve high dynamic range by having an adaptive gain control mechanism similar to
the biological retina [13]. Furthermore the parallel processing due to the implementation of a
neural architecture allows for local intelligence which allows tasks such as feature extraction
and contour discrimination to occur in real time [3]. These techniques have also contributed
to making more low power, intelligent and eﬃcient CMOS imagers.
Audition
Cochlear prosthetic chips are used for restoring sound to the deaf. This is achieved by
stimulation of the neurons beneath the hair cells along the basilar membrane in the ear.
Processing is therefore required to adaptively map a high dynamic range audio signal, into
a set of pulses for the stimulation electrodes, of limited eﬀective dynamic range. Therefore
many of the silicon cochleas produced try and achieve this by adopting bio-inspired models
[14, 15, 16, 17]. The artiﬁcial cochlea splits the incoming signal into subsequent frequency
bands and performs automatic gain control to subsequently compress or enhance strong
and weak sounds respectively, thus emulating the operation of the outer hair cells. Such
processors are also used in conjunction with neural networks to perform tasks such as speech
classiﬁcation and spatial localisation [18].
Rhythm Generation
Neuromorphic solutions which mimic the locomotion control circuits of the nervous system
are being developed [19, 20]. These are based on the Central Pattern Generator (CPG)
of the nervous system which controls functions such as walking, running and swimming.
This are mainly aimed towards building better solutions for robot locomotion which could
potentially be used for treatment of paralysis. Using an autonomous system of silicon
neurons, generation of a rhythmic pattern of neuronal discharge that can drive muscles in
a similar fashion to that seen during normal human locomotion is possible [21].
Olfactory
Silicon Olfactory chips are being used for the creation of artiﬁcial noses which are able to
distinguish smells. By using an array of composite polymer chemiresistors or chemicapac-
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itors with limited chemical selectivity [22], it is possible using neuromorphic techniques,
to implement these artiﬁcial noses in a similar fashion to the human olfactory system.
By providing the neural architecture on-chip and allowing for adaption, these can provide
discrimination, identiﬁcation and separation of odours in a low power, realtime fashion [23].
2.3.2 Systems to understand biology
Inner hair cell interactions
Work on reproducing inner hair cell interactions of the active cochlear in VLSI has lead
to a more thorough understanding of the auditory encoding which takes place in the ear
[24]. This has allowed for an understanding of the spatial perception of sound, down to the
neural level.
Visual speed perception
Modelling and implementing the human retina in VLSI has allowed for a more in-depth
analysis of the mechanisms responsible for visual speed perception [25]. Speciﬁcally the
work in [26] has allowed for an understanding of prior expectations which is responsible for
the variability in subject responses for speed discrimination in the human retina.
2.3.3 Bio-inspired tools for more eﬃcient electronic systems
By learning from the way in which the brain encodes and transmits information, several
concepts have been adapted to create more eﬃcient methods of encoding, processing and
communicating data both on- and oﬀ-chip.
Spike domain coding [27]
Spike domain coding is a method of encoding sensory information continuously in time but
discretely in amplitude using spikes. Encoding sensory data in this way has the advantages
of improved versatility in dynamic range, robustness in signal integrity and inherent com-
patibility event driven processing and current digital technologies. Rate coding is one of
the most popular method of spike coding where the amplitude of information is encoded
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encoded temporally as a frequency of spikes. Other derivatives of this include population
average coding, time of arrival, phase coding and synchrony [3].
Event driven communication [10]
Event driven communication is a method of communicating information only when an event
occurs. This leads to better utilisation of communication bandwidth, especially in neural
type applications which have many outputs. The most popular method used is the Ad-
dress Event Representation (AER) in which each pixel in an array has a unique identiﬁer
(i.e. its coordinate) and when a pixel registers an event, this identiﬁer is asserted onto a
digital bus. The data is then communicated oﬀ-chip through means of an asynchronous
handshake. On the receiving end, these address-events can be decoded to reconstruct the
original spatiotemporal pattern.
The systems described all rely on the neuron as the element for sensory information
transduction, coding and processing. We proceed by describing the neuron, identifying its
chemical as well as its electrical characteristics.
2.4 The Neuron
The basic anatomical unit of the nervous system is the neuron. It is responsible for relaying
information using action potentials which are generated as a result of inputs from our senses
or from outputs from the brain for motor function and control.
The ability to model and simulate neurons has become essential to be able to mimic
neural organisation to make brain-like and neural-like computations. With the emergence of
Neuromorphic VLSI, silicon based neurons were created which could allow implementation
of neural architectures on single chips. Their main uses include:
• A tool for understanding neural physiology. Conductance-based silicon neurons be-
have physically as biological ones and allow for observation of the behaviour of channel
conductances and ionic currents of single neurons or neural ensembles. These tend
to be highly non-linear and therefore computationally demanding for software imple-
mentations.
Biologically Inspired Electronics 15
.UCLEUS$ENTRITES -YELIN
3HEATH
3OMA
BODY	
"UTTON
&EET	
!XON
4ERMINALS
.ODE OF
2ANVIER
3CHWANN
#ELL
3YNAPSES!XON
(ILLOCK
!XON UNDER
MYELIN	
$!4! ).
$!4! /54
Figure 2.1: The structure of a neuron [3]
• A building block for Neuromorphic circuits. They are used as a processing element
for modelling neural behaviour in the bio-inspired systems described. These tend to
be ‘integrate and ﬁre’-based as well as conductance based, which accurately mimic
the temporal behaviour of neurons.
Most of the applications which have resulted since the creation of the silicon neuron have
been mainly focused on modelling and using the electrical behaviour of the neuron. How-
ever, the electrical signals observed from biological neurons are a consequence of chemical
ionic interactions around the cell. Using these, a chemically based silicon neuron could be
possible, which utilises the chemical as well as electrical information for applications such as
neuronal sensing and bridging for stimulation. In order to be able to exploit these chemical
characteristics, a more in depth look at the neuron physiology and the chemical processes
responsible for action potential generation is needed. These shall now be described.
2.4.1 Neuron physiology [28]
The basic anatomical structure of the neuron which is responsible for action potential
initiation and propagation is shown in Fig. 2.1. Action potential generation originates
in the soma, as a result of an aggregation of signals from other neurons via its dendrites.
Once initiated, it propagates down the neuron through the axon, where it is constantly
regenerated at the nodes of ranvier (openings in the myelin sheath encapsulating it). This
allows for eﬃcient transmission of the signal. The axons are terminated by synapses which
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Table 2.1: Ion concentrations measured from a cat motoneuron [28]
Concentration Reversal
(mM/l) potential
Ion Inside Outside (mV)
K+ 150 5.5 -88
Na+ 15 150 61
Cl− 9 125 -70
are responsible for releasing neurotransmitter molecules when the action potential arrives.
These then stimulate the dendrites of other neurons and propagate the signal through the
network. These synapses can be excitatory or inhibitory by changing the constitution of the
neurotransmitters, thus being able to adaptively set the synaptic strength at the connecting
node which results in plasticity.
The neuron is surrounded by sodium (Na+), potassium (K+) and chloride ions (Cl−),
in the extracellular ﬂuid, which set up an equilibrium potential with intracellular ions, in
its cytoplasm. Through metabolically-driven pumps, it is able to expel sodium ions and
import potassium ions. As a result when the cell is at rest, there is an abundance of sodium
ions outside the cell and the inside of the cell is enriched with potassium ions. Because of
this, a potential exists across the cell membrane which may be expressed by the Goldman
equation :
Vmem = 58mV log
PK [K+]out + PNa[Na+]out + PCl[Cl−]in
PK [K+]in + PNa[Na+]on + PCl[Cl−]out
(2.1)
where PK , PNa and PCl are the relative permeabilities and [K+],[Na+], and [Cl−] are the
concentrations of ions inside and outside of the cell. Typical concentrations for the various
ions in a mammalian neuron are shown in Table 2.1 whereby the reversal potential given
is when there is no net ﬂow of ions from one side of the membrane to the other. When the
cell is at rest the membrane potential is typically at -70mV.
Action potential generation and propagation is a result of these chemical ions ﬂowing
inside and outside of the cell through special voltage-gated ion channels. Neurotransmitters
coming from synapses of other neurons linked to the dendrites slowly depolarise the cell
membrane. When a certain threshold is reached the voltage-dependent sodium channels
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Figure 2.2: Action potential generation due to sodium inﬂux and potassium outﬂux
of the cell open up and there is a sudden inﬂux of sodium ions causing the membrane
potential to rapidly increase. When this peaks, time-dependent inactivation closes the
sodium channels, and the voltage-gated potassium channels open. Potassium ions then
diﬀuse out of the cell reducing the membrane potential. The membrane voltage undershoots
as the potassium approaches its Nernst potential 1 but then slowly returns to its resting
state. This action is illustrated in Fig. 2.2 whereby the inﬂux of sodium ions is described in
Hodgkin and Huxley (H&H) formalism [29] as an increase in sodium conductance and the
outﬂux of potassium as a negative increase in potassium conductance.
Therefore we can summarise action potential generation as the combination of two
chemical eﬀects:
1. Neurotransmitter molecules, acting to depolarising the cell until it reaches its thresh-
old.
2. Sodium and potassium ions ﬂowing in and out of the cell changing the membrane
potential.
Monitoring of this chemical activity has been shown to be important for detection of
1The potential at which there is no net movement of an ionic species across the cell membrane, because
the free energy decrease resulting from the ion moving down its concentration gradient is balanced by the
free energy increase needed to move the ionic charge through the membrane’s electric ﬁeld.
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pathological states such as epilepsy, pain syndromes, movement disorders and certain psy-
chiatric diseases [30]. In these conditions the ionic homeostasis is often disturbed due to the
defective function of certain ion channels. Excessive and/or insuﬃcient ionic concentrations
in the extracellular space lead to profound changes in the driving force of ionic movements
across the neural cell membrane causing functional deﬁciencies [31]. Therefore, both global
and local ionic variations taking place during brain activity and abnormal variation in
extracellular ionic levels can trigger these diseases.
Being able to monitor these chemical quantities, adds an extra modality to the imple-
mentation of a silicon neuron. Using this will allow implementations of chemically based
silicon neurons which will sense and regenerate action potentials in silicon due to the chem-
ical activity around nerve bundles. Regeneration of these action potentials can be used for
classiﬁcation of the diseases mentioned as well as chemical neural bridging. For the latter,
this will enable closed loop stimulation whereby the stimulation waveforms will be based on
ionic proﬁles observed prior to the onset of the disease allowing more specialised treatment
[32].
It should be noted however that Chemical bionic systems are not limited to just neurons.
By understanding the various ionic eﬀects of the cells in our bodies, and being able to
mimic them, we can eﬀectively replicate the behaviour of other organs down to the cellular
level, which shall be shown in Chapter 3 for the case of the pancreas. However, to do
so, an understanding of the chemical ionic channels and their association to various organ
functionality is required. Some of these shall now be described in the next section.
2.5 Gated ion channels
Cells in our bodies have been engineered by nature to react to diﬀerent stimuli so they can
act as transducers to the physical and biochemical world. Using these, stimuli such as light,
sound and glucose can be sensed and processed. Collections of such cells form tissues which
are grouped together to make up vital organs, which help the human body carry out its
functions. When functioning, these cells undergo a sequence of complex chemical and/or
electrical interactions to carry out speciﬁc tasks. For example, an axon of a neuron uses
chemical ﬂow of sodium and potassium ions to generate an action potential [29]. Similarly, a
beta cell of the pancreas senses glucose to induce action potentials and release insulin [33].
Therefore, in order for the above processes to occur, stimuli must interact with speciﬁc
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Table 2.2: Organ receptor inputs
Organ Cell Type Stimulus Stimulus Form
Brain neuron chemical/electrical neurotransmitters/
gap junction potential
Cochlea inner and outer hair mechanical acoustic
Vestibular type I and II hair mechanical inertia
Retina rods, cones optical photons
Pancreas alpha, beta chemical glucose
Heart myocyte electrical gap junction potential
Nose olfactory chemical various odours
Tongue gustatory chemical salt, sweet, sour, bitter, umami
receptors or ion channels which allow ions to ﬂow in and out of the cell.
Ion channels are membrane proteins which exist on the surface of every cell. They are
responsible for transmission of ions across the cell membrane lipid bi-layer. It is the process
of opening and closing of ion channels in certain electrically active cells, that leads to de-
polarisation and action potential initiation. Movement of ions within the cell may also lead
to secondary biochemical eﬀects internal to the cell, such as exocytosis of chemical granules
[34]. There is a wide range of cells which possess ion channels that can be distinguished
according to their mechanisms of activation. These include:
1. Changes in membrane voltage - The ion channels open and close due to changes in
membrane potential.
2. Binding of ligands - The ion channels activate and inactivate due to binding of ligands
(atoms, ions or molecules) to specialised ionotropic receptors on the cell.
3. Metabotropic receptors - These receptors inﬂuence the ion channels through intra-
cellular messenger proteins which bind to it.
4. Mechanical motion - These ion channels open and close due to movement of certain
cells.
The ion channels mentioned play a crucial role in coupling various stimuli to the cell.
Table 2.2 summarises several key organs of our body, with their associated cell types and
their relevant receptors. This illustrates that several processes in our bodies rely on chemical
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Table 2.3: Several chemical outputs of excitable cells
Cell Excreted Chemical Eﬀects
Neurons neurotransmitters neural communication
Beta cells insulin glucose uptake
Myocyte cells calcium contraction
inputs as well as electrical. Furthermore, some of these cells have chemical outputs, as shown
in Table 2.3.
Therefore, with the understanding that cellular biochemistry is equally important to
the functioning of cells, we may raise the following research question: Given a device which
allows a chemical input to VLSI circuits, and/or can be used with a chemical output reser-
voir, what kind of systems can be developed that take advantage of the chemical behaviour
of biology to form chemical bionic systems for better prosthetic devices? Chapter 3 will
provide a possible answer to this.
We proceed by showing how comparing the physics of semiconductors with that of
gated ion channels can lead to silicon implementations for such systems and how such an
implementation can also be achieved for the chemically gated ion channels mentioned.
2.5.1 Silicon gated ion channels
What is interesting about ionic channels is that they obey a Boltzmann distribution [2].
Such a distribution results in a voltage conductance characteristic seen in Fig. 2.3a. This was
based on experimental data measured from the Sodium ion channel of the giant squid axon
[35]. The ionic current which is generated as a result of this distribution is exponentially
related to the gating voltage.
This is incredibly similar to the current to voltage relation of a silicon ﬁeld eﬀect tran-
sistor (MOSFET) operating in weak inversion, Fig. 2.3b. This similarity comes as a result
of the current in this region of operation being governed entirely by the diﬀusion of elec-
trons which also has a Boltzmann distribution. Having similar physical characteristics, the
MOSFET therefore could be used as a voltage-gated silicon ion channel, whereby the ﬂow
of ions through the channel can be modelled using electrons.
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Figure 2.4: A chemical silicon gated ion channel based on a pH sensitive ISFET
Biologically Inspired Electronics 22
This initial discovery was pivotal by Mead as it spawned new academic research into
the analogies between biology and semiconductors to make new bio-inspired circuits which
actually mimicked the underlying physical primitives of biology. A very ﬁne example of
this is the bio-physical silicon neuron, [36], whereby action potentials are generated a result
of directly mapping the physical primitives of the biological ion channels to those of weak
inversion MOSFET devices.
As discussed previously however, ion channels are not only aﬀected electrically but also
chemically. Therefore the range of biological organs, Table 2.2, which require a chemical
input could have their cell behaviours emulated in silicon if a sensing device existed which
had an ionic input and generated an exponential electron current output as in Fig. 2.4. As
shall be shown in Chapter 4 the ISFET sensor is one such device, which allows for mimicking
of such organs, to create a new type of bio-inspired prosthetic.
2.6 Hodgkin and Huxley model [29, 37]
Having established that electrical activity in cells is a result of various biochemical activity
around it, we now proceed in presenting the Hodgkin and Huxley (H&H) formalism, which
captures this behaviour. Using this we later show it possible to induce action potentials
using the chemical proﬁle which can allow an implementation of a chemical bionic neuron.
Hodgkin and Huxley were the ﬁrst to demonstrate the mechanisms responsible for gener-
ation of action potentials in 1952. With experiments on a giant squid axon the responses of
the sodium and potassium channels were characterised. The result was the development of
an electrical conductance based model of an axon shown in Fig. 2.5. The equivalent circuit
is comprised of a sodium conductance, gNa, a potassium conductance, gK , each described
by a set of diﬀerential equations, characterised to match the voltage and time dependance
of the gated ion channels. The leakage conductance, gL, is constant and is mainly due to
the chlorine ions. VNa and VK are the Nernst potentials of the ions as in Table 2.1. Cm is
the cell membrane capacitance and Vmem is the voltage across it.
Cm
dvmem
dt
= −INa − IK − IL + Istim (2.2)
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Figure 2.5: Electrical circuit representing the membrane of an axon
INa = gNa(vmem − vNa)
IK = gK(vmem − vK)
IL = gL(vmem − vL) (2.3)
The membrane potential, Vmem is deﬁned by the sum of ionic currents into the membrane
capacitance Cm, (2.2), where each ionic current is given by (2.3). When a stimulation
current, Istim is applied, this begins to charge up a capacitance, Cm, which models the
eﬀects of depolarisation. Once it reaches a certain voltage, the temporal and voltage eﬀects
of the sodium and potassium conductances come into play creating the action potential as
was shown in Fig. 2.2.
Sodium and Potassium Conductance
The sodium and potassium conductances are described by expressions (2.4) and (2.5),
whereby the gating terms, (m,h, n), are used to describe the temporal and membrane
voltage dependence of the conductances, gNa and gK .
gNa = gNam(t)
3h(t) (2.4)
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Figure 2.6: Activation variables m,h,n, and their dependance on membrane voltage
gK = gKn(t)
4 (2.5)
The gating terms range from 0 to 1 eﬀectively emulating the eﬀects of opening and
closing the ionic channels in the neuron, as is shown in Fig. 2.6. The sodium channel initially
opens and is then closed by a time dependent inactivation, after which the potassium channel
opens due to a time-dependant activation. Expression (2.6) describes this behaviour in time,
whereby x∞, (2.7) is used to represent the degree to which the channel is open and τx, (2.8),
is the voltage dependant time constant which determines the temporal response. The eﬀect
of each gating term is dependent on membrane voltage, described by a set of rate constants,
αx(vmem) and βx(vmem), whose equations are shown in Table. 2.4.
dx
dt
=
x∞ − x
τx
, x ∈ [m,h, n] (2.6)
x∞ =
αx(vmem)
αx(vmem) + βx(vmem)
(2.7)
τx =
1
αx(vmem) + βx(vmem)
(2.8)
Biologically Inspired Electronics 25
Table 2.4: Sodium and Potassium gating parameters
x αx(vmem) βx(vmem)
m 0.1(v+25)
exp( v+25
10
)−1 4exp(
v
18)
h 0.07exp( v20)
1
exp( v+30
10
)+1
n 0.01(v+10)
exp( v+10
10
)−1 0.125exp(
v
80)
Table 2.5: Hodgkin and Huxley model parameters
x vx gx
Na 55 mV 120 mS
K -72 mV 36 mS
L -49 mV 0.3 mS
The signiﬁcance of the rate constants comes from the original proposition for the dy-
namics of x, (2.9). This was described as the sum of the fraction of gates in the closed state,
(1 − x), with a rate constant of αx(vmem), and the fraction of gates in the open state, x,
with a rate constant of βx(vmem). Both expressions 2.6 and 2.9 result in the same solution
but (2.6) shall be used for the remainder of this thesis as it is more familiar to engineers,
as it describes the eﬀects of a ﬁrst order low pass ﬁlter.
dx
dt
= αx(vmem)(1− x)− βx(vmem)x, x ∈ [m,h, n] (2.9)
The Hodgkin and Huxley neural model simulation in Matlab is shown in Fig. 2.7 ac-
cording to the constants of Table 2.5. The initial depolarisation due to neurotransmitters
is modelled using a stimulus current, Istim. The conductances depicted show an increase
in sodium conductance, gNa, followed by an increase in potassium conductance, gK , sim-
ulating the biological eﬀects. The shape of the ionic currents generated are bell shaped,
shown by the currents INa and IK , and of the same time scale as the neuron. The bell
shaped proﬁles of the the sodium and potassium currents show the inﬂow and outﬂow of
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Figure 2.7: Action potential generation using the Hodgkin and Huxley model. Shown are :
(a) The stimulation current used. (b)The action potential generation. (c) The directions of
the Sodium and Potassium currents. (d) The changes in conductance which generate the
ionic currents. (e) The gating variables which cause the conductance proﬁles of (d)
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sodium and potassium ions respectively. These eﬀectively describe the changes in chemical
concentrations which would need to be sensed for a chemical bionic implementation.
The Hodgin and Huxley neuronal model describes very well the interactions of speciﬁc
ion channels to generate action potentials. The system being described as an electronic
circuit has opened the way for many implementations using MOS transistors [6, 8, 38].
These implementations have been based on an ‘integrate and ﬁre’ method of transmission
where an electric current, used as an input, is integrated on a capacitor mimicking the eﬀect
of synaptic inputs. What shall be shown hereafter is that action potentials can be generated
by observing the chemicals surrounding neurons in a nerve bundle.
2.7 Towards a Chemical Silicon Neuron
As has been described previously, action potential generation and propagation in the neuron
is the result of a inﬂow of sodium ions, and outﬂow of potassium ions which occur as a result
of initial depolarisation due to neurotransmitters. If the concentration of these ions was
to be observed using chemical sensors around a nerve bundle, changes in the outside ionic
concentrations, given in Table. 2.1, could be seen as soon as an action potential propagates.
Since sodium is in abundance outside the cell, this would result in a dip in sodium ion
concentration, followed by an increase in potassium concentration, returning to normal
when the cell returns to its resting potential. These eﬀects were observed in the simulation
of the neuron, Fig. 2.7c.
Observing these chemical concentrations is interesting for both medical diagnosis and
modelling physiology. In the former, generating or reconstructing action potentials based on
monitoring sodium or potassium ions from the axon can be used to bridge to silicon neurons
for further processing. This opens the possibility of creating stimulation waveforms based
on ionic as well as electrical proﬁles, which may provide a new form of stimulation therapy
for neurogenic diseases such as epilepsy. Furthermore, it can be used for classiﬁcation and
prediction of such diseases, which have been known to show chemical imbalances prior to
their occurrence. In the latter, this can be used as a tool to understand the physiological
nature of speciﬁc neurons and their ion channels.
Having established the chemical behaviour around the neuron, we can now consider two
forms of a Hodgkin and Huxley implementation, whereby a chemical input can be used to
induce action potentials. These two implementations are shown in Fig. 2.8. The ﬁrst is the
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Figure 2.8: Chemical Bionic Neuron implementations. (a) Action potential generation is
due to stimulation with an electrical current. This could be provided by a neurotransmitter
sensor. (b) Generation is due to stimulation using Sodium pulses as would be sensed from
an axon
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Figure 2.9: Concept of the chemical bionic neuron sensing ions around a nerve bundle with
sensory and motor neurons
classical neuron which uses a stimulation current to induce action potentials. This current
could be provided from a neurotransmitter sensor [39] located near the dendrites.
The second form uses the sodium ion concentration proﬁle which is seen when an action
potential is propagating down an axon. By using this proﬁle as a stimulus it is possible
to regenerate action potential behaviour as seen in Fig. 2.8. In nerve resting conditions
the extraneural concentration of sodium is roughly 150 mM, which decreases every time
an action potential passes. Therefore by replacing the sodium current branch in a silicon
H&H neuron with a sodium sensor, which would provide this current by monitoring the
concentrations around the axon, a chemical silicon neuron implementation is possible.
Fig. 2.9 gives an illustration of how such a technology could be used to regenerate action
potentials ﬂowing down an axon by sensing sodium or potassium currents from a nerve bun-
dle. The parameters of the model would have to be adapted to match the physiology of the
speciﬁc neuron and the input to the neuron would come from a chemically modiﬁed ISFET
(ChemFET), sensing the transitions in either sodium or potassium concentration. The out-
puts of the silicon chemical neurons could then be processed using standard neuromorphic
techniques, implementing a chemical bionic system.
2.8 Summary
In this chapter we have discussed biology as being a very good example of a system which
accomplishes its tasks eﬃciently using poorly deﬁned primitives. We have shown recent
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trends in the VLSI community have been to model the neural behaviours of such systems, in
what are known as Neuromorphic circuits. It has been established however that much of the
functionality of biological systems depends on the chemical as well as the electrical behaviour
of these systems. With this is mind we propose the potential for bio-inspired systems which
could emerge if we had a chemical as well as an electrical input. As a ﬁrst example, it
was shown that it is possible to exploit the chemical concentrations around an axon to
induce action potential behaviour. In future work, this will lead to the implementation of
a chemical silicon neuron.
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Chapter 3
Silicon Metabolic Cells
3.1 Introduction
In the ﬁeld of Neuromorphic electronics, circuits utilising action potentials are popular for
the implementation of biologically-inspired electronic systems. As a result, spike based
computations similar to those observed in our brains can be modelled, which has spawned
new parallels in circuit design especially in the areas of the artiﬁcial retina, cochlea and
locomotion systems. Therefore it is no surprise that great eﬀort has gone into implementing
neurons in silicon. As described in Chapter 2 however, the electrical nature of neurons is the
outcome of a series of biochemical interactions. Similarly, the beta cell of the pancreas is also
electrically excitable, and its biochemical physiology is directly linked to the maintenance
of speciﬁc metabolic processes, namely glucose homeostasis.
The electrical behaviour observed across the cell membrane of the beta cell is shown in
Fig. 3.1. The membrane potential occurs in slow wave bursts with action potentials super-
imposed on the active phase [1]. These bursts do not appear unless blood glucose levels rise
above the nominal value of 5mM and they increase in burst width as glucose concentration
rises. During every action potential insulin is released through the process of exocytosis,
resulting in the regulation of plasma blood glucose. Herein we utilise the chemical behaviour
of these electrically active biological cells to form circuit based implementations which we
have termed silicon metabolic cells. In doing so we aim to motivate new ideas in bio-inspired
circuit design.
The development of a Chemical Bionic system for use in the creation of an artiﬁcial
pancreas for the treatment of Type I diabetes is presented based upon the design of a
35
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Figure 3.1: The beta cell electrical behaviour, the voltage shown is across the cell membrane
[1]
silicon metabolic cell. This illness is an auto-immune disease in which the hormone insulin
is no longer produced by pancreatic beta cells. Treatment requires a control system that
will sense blood glucose and secrete appropriate concentrations of insulin using a pump.
The aim is to maintain the blood glucose levels in the range of 4-8mM to avoid prolonged
hypoglycemia (low glucose levels) and hyperglycemia (high glucose levels) which are linked
to short, medium and long term complications.
This work focuses on understanding the actual biological mechanisms that occur during
the glucose-insulin feedback cycle and implementing a bio-inspired silicon model of the
pancreas which may be used for treatment of diabetes. A conceptual diagram of this is
shown in Fig. 3.2, whereby the bionic pancreas substitutes the biological one. In this
chapter we present a signiﬁcant step towards achieving this by electrically modelling the
behaviour of the pancreatic beta cells using low power integrated circuits to fabricate a novel
silicon beta cell as an example of a silicon metabolic cell. Utilising a chemical sensor such as
an ISFET (Ion Sensitive Field Eﬀect Transistor) at the input, the silicon beta cell mimics
the behavioural electrical dynamics of their biological counterparts. Having achieved this, a
bio-inspired controller can be developed which could lead to a more physiologically relevant
regulation of blood glucose.
This chapter proceeds with an overview of diabetes and its related problems. The
concept of an artiﬁcial pancreas is introduced with a brief review of relevant systems tested
in a clinical setting. This is followed by a description of the biology and physiology of
the pancreas for a better understanding of the requirements needed to build a bio-inspired
model. The pancreatic beta cell is then modelled using a Hodgkin and Huxley formalism
and implemented in silicon using a conductance based model. Finally, the fabricated silicon
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Figure 3.2: Concept of the bionic artiﬁcial pancreas using silicon alpha and beta cells and
various chemical sensors relevant to diabetes
beta cell is extended to demonstrate a simple closed loop artiﬁcial pancreas.
3.2 Diabetes
Diabetes is a disease described as the inability to maintain blood glucose levels at physio-
logical values (typically 4-8 mM [2]). The main hormone responsible for the regulation of
glucose in the blood is insulin, which is produced by the beta cells of the Islets of Langherans
of the pancreas. Diabetes is characterised as Type I or Type II according to the nature of
the illness. Type I diabetes, also known as insulin-dependent diabetes, is an auto-immune
disease which results in loss of the beta cells, that ultimately leads to a deﬁciency of insulin.
This occurs mainly during childhood and current treatment is by insulin injection before
meals. Type II diabetes, also known as non-insulin dependant diabetes, usually occurs at
an older age and is due to the body’s resistance of insulin that the pancreas produces. This
causes a need for abnormally high amounts of insulin and diabetes develops when the beta
cells cannot meet this demand. This insulin resistance has been linked to obesity but can
also be hereditary. Treatment consists of a carefully managed diet and medication. In
extreme cases injections may be required.
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Control of blood glucose levels is required to avoid prolonged episodes of hyper and
hypo-glycemia that can cause various complications. Hyper-glycemia occurs when glucose
levels rise above the nominal value leading to a harmfully high blood glucose concentration.
This can lead to renal failure, loss of eyesight or damage to the nerves and blood vessels.
Hypo-glycemia on the contrary occurs when the glucose concentration in blood is too low,
usually due to an excess of insulin. This can result in fainting, coma or even death if the
glucose levels are not restored.
Current methods of control of Type I diabetes involve manual injection of insulin into
the blood before a meal. Blood glucose concentration is measured using a drop of blood,
acquired from a ﬁnger-prick, which is placed on a disposable strip and read using an external
reader. Although this method reaches the objective of lowering blood glucose levels, it is
susceptible to human error and fairly ‘open-loop’, therefore having no way of controlling
the time spent outside the healthy glucose range, increasing the risks of hyper and hypo-
gycemia. The result is that Type I diabetic patients suﬀer from many secondary eﬀects
such as blindness, renal failure, heart disease and proprioceptive disorders.
A trial conducted by the Diabetes Control and Trial (DCCT) Research group demon-
strated that intensive management of Type I diabetes reduced these complications by 50-
76% compared with conventional therapy [3]. The intensive management was designed to
maintain blood glucose levels as close to the non-diabetic range as possible. The results
conﬁrmed the need for a closed-loop system to lower the HbA1c 1 levels of diabetic patients
as well as to improve the quality of life of suﬀerers. Glycated hemoglobin, fasting and non-
fasting glucose levels and glycemic instability could also be signiﬁcantly lowered [4]. Such
a closed-loop system is usually referred to as an artiﬁcial pancreas.
3.3 The Artiﬁcial Pancreas
The creation of an artiﬁcial pancreas for the treatment of insulin-dependent diabetes has
been desired since artiﬁcial insulin was discovered. Such a system could bring signiﬁcant
improvements in the disease and quality of life of suﬀerers. Principally an artiﬁcial pancreas
based on beta cell function, is closed-loop system requiring a glucose sensor to determine
the blood sugar levels, a control algorithm to calculate the required insulin dose and an
1HbA1c (Haemoglobin A1c) is a form of hemoglobin used primarily to identify the average plasma glucose
concentration over prolonged periods of time. It is used as a FOM to determine the improvement of Type I
diabetes treatment.
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Figure 3.3: Key elements required to restore closed-loop blood glucose control in type 1
diabetic subjects [4]
infusion pump to deliver insulin to the blood, Fig. 3.3.
Ideally it should perform the same function as the biological pancreas. This maintains
glucose homeostasis by the sensing of blood glucose causing the release of the hormone
insulin and the counteracting hormone glucagon. The regulation proﬁles of these are shown
in Fig. 3.4 and are described as follows: When a meal is eaten and broken down into glucose,
elevation of blood glucose occurs to levels of hyperglycaemia. This stimulates insulin release,
which causes the uptake of glucose in peripheral tissue, consuming it. In the event of too
much insulin release, glucose levels undershoot below the nominal range to hypoglycaemia.
Glucagon is then released which promotes glucose release from stores in the liver, bringing
blood glucose levels back to there nominal range.
We proceed by describing glucose sensors and insulin pumps which are currently being
used to create such a sensing and infusion system. This followed by a description of models
to simulate glucose uptake and a review of algorithms which exist to control blood glucose
which are used to create the artiﬁcial pancreas.
3.3.1 Glucose sensors and Insulin pumps
Current blood-glucose sensors for body-worn devices are divided between optical and elec-
trochemical methods [5]. Though optical methods are the most promising for non-invasive
sensing, ﬁnding the infrared absorption patterns for glucose has been diﬃcult due to the
interference from other molecules such as water and haemoglobin. Thus no reliable continu-
ous optical sensor is yet available. As a result amperometric glucose oxidase (GOx) sensors
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Figure 3.4: Insulin and glucagon release to prevent hyperglycaemia and hypoglycaemia
during an increase in glucose
are the proven technology and form the basis of available systems. There are already sev-
eral commercially available continuous glucose sensors which include the CGMS [6] and
the Freestyle Navigator [7]. Most however require frequent calibration and have a short
lifespan, about 5 days, when implanted subcutaneously, due to sensor fouling by cellular
and protein components. Attempts to overcome these problems using micro-dialysis have
resulted in prolonged dialysis-induced lag times [8].
There are already several commercially available and validated insulin infusion pumps.
Most rely on step-wise pump movement at intervals of 10 to 15 minutes. Examples include
the Medtronic 722, the Animas 2020 and the Roche Accu-Check Spirit. In addition to these
existing pumps, novel technologies are in development such as Micro-Electro-Mechanical
systems (MEMS) and nano-pumps [9] which attempt to miniaturise the device.
3.3.2 Control of blood glucose
Fig. 3.5 depicts the system level diagram of a typical closed-loop system, whereby the goal
of the control algorithm is to maintain the blood glucose levels at the same level as the
reference input during a meal disturbance.
For the development of such algorithms patient models are required which simulate
the eﬀects of glucose uptake in the body. Two speciﬁc models are distinguished in the
literature, the Bergman minimal model [10] and the Sorensen departmental model [11]. The
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Figure 3.6: The Minimal Model of Glucose Disappearance
Bergman model, shown in Fig. 3.6, describes insulin release as a function of current glucose
measurement using minimal parameters. It consists of two ﬁrst order diﬀerential equations,
(3.1),(3.2) and is used in many control algorithms due to its simplicity in predicting glucose
disappearance. Plasma insulin I(t) enters a remote compartment where it is active in
accelerating glucose disappearance into peripheral cells and the liver, and inhibiting hepatic
glucose production, using X(t). GB is the basal glucose rates and P is for the rate constants.
dG(t)
dt
= (P1 −X)G(t)− P1GB (3.1)
dX(t)
dt
= P2X(t) + P3I(t) (3.2)
The Sorensen compartmental model may be considered as a more accurate model as it
describes the uptake of glucose in various vital organs or compartments [11]. The result is a
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19th order model where each diﬀerential equation performs mass balancing around organs
important to glucose or insulin dynamics. There has been a trend to use this model in
recent literature due to the increase in computational power which is now available.
We proceed by describing several control algorithms which are currently being used for
the development of the artiﬁcial pancreas.
Proportional-Integral-Derivative Control
Proportional-Integral-Derivative (PID) control is a generic feed-back loop mechanism which
has been widely adopted in industrial systems due to its simplicity and ease of tunability.
For the application of glucose homeostasis, it can continually adjust insulin infusion rates
according to Eq.3.3, by assessing glucose excursions from three view points, the departure
from the target glucose (the proportional component), the area-under the curve between
ambient and target glucose (the integral component) and the change in ambient glucose (the
derivative component). The inﬂuence of these may be set by adjusting tuning parameters
KP , KI and KD.
I(t) = KP (G−GB) + KI
∫
(G−GB)dt + KD dG
dt
(3.3)
The BIOSTATOR, developed in 1977, was one of the very ﬁrst closed loop systems to
control blood glucose in this fashion [12]. It was demonstrated using an intravenous sensor
and two pump system to infuse glucose and dextrose but was originally bulky and thus
only suited for bed side treatment. Later, many algorithms were developed [13, 14, 15],
which were modiﬁcations of the original to improve performance by reducing postprandial
hyperglycaemia and hypoglycaemia. However, algorithms of this sort are not immune to
patient variability and thus require individual tuning each time a new patient uses the
device. In addition to this, the control is not pro-active, having a high associated risk
and does not take into consideration constraints such as the bounds of hyperglycaemia and
hypoglycaemia.
In recent years however, the PID approach has been favoured by the Medtronic Min-
imed group who are one of the leading protagonists in the ﬁeld due to their Continuous
Glucose Monitoring System (CGMS) [6, 16]. This became the ﬁrst commercially available
subcutaneous glucose sensor. The paradigm they have developed uses PID to emulate the
characteristic ﬁrst and second phases of insulin release, providing a more physiological form
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of regulation [17, 18].
Optimal Control
In optimal control theory the insulin infusion rate, U, is optimised based on a cost function
deﬁned by J(U). A simple form is shown in Eq. 3.4, whereby a square cost function is
adopted [19]. U can be a function based on blood glucose and other important parameters
and constraints, such as insulin release, which can be speciﬁc for each patient. The idea
being that minimisation of J(U), based on the function deﬁned by U, will lead to optimal
control of the problem. This allows some control over the minimum amount of insulin that
should be infused, unlike PID which will just infuse until it reaches its target glucose level.
min{J(U) =
∫ T
0
G2(t)dt} (3.4)
Work on optimal control was initiated by Swan in 1982 [20], whereby a linear combina-
tion of the insulin and glucose concentrations was used to determine the minimum amount
of insulin that should be infused continuously to people with diabetes. Since then various
formulations have been proposed [19, 21, 22, 23] which have been optimised to the compart-
mental models mentioned. These however are not robust to patient variability and therefore
a new control algorithm was required which could adaptively change the constants in both
PID and optimal control but also predict for future values of glucose to be more pro-active.
This was achieved by Model Predictive Control (MPC)
Model Predictive Control
Model-Based Predictive control is a very powerful control method as it continually computes
the optimal solution after each sample of glucose taken [24]. It has the ability to estimate
present and future insulin delivery rates and glucose behaviour. This is signiﬁcant as the
control can be pro-active instead of reactive which is an important feature for patient safety.
The optimisation problem solved at each time step is given by [25]:
min
U(k)
{‖Γy[Ψr(k)−Ψ(k)]‖+ ‖ΓuΔU(k)‖} (3.5)
where Ψr represents a ﬁltered value of the reference trajectory, Ψ is the vector of the
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predicted future measurements, with Γy and Γu being weighting matrices for the input value
U.
Prediction of future values which are included in the objective function, (3.5), require an
accurate compartmental model. Although the Bergman and Sorenson models used capture
the glucose-insulin behaviour to some degree, they do not account for patient variability
over time which can lead to signiﬁcant performance degradation. In Parkers introductory
paper in 1999 [24], this is achieved by adding a state estimation that updates the internal
model parameters by comparing the variability between the forecasted and actual glucose
measurement. This is also known as MPCSE (Model Predictive Control with State Esti-
mation). Several other approaches have been developed which also adaptively change the
internal model to ﬁt the actual patient data. These include neural network approaches
[26] which adaptively trains a network to keep the model accurate, and parametric control
methods [27] which have pre-determined solutions to the optimisation problem, selecting
the most appropriate at any given time. A clear disadvantage of such control methods to
conventional PID, is that they tend to be complex to design, with many parameters, and
require high computational power to compute an optimisation for each time step.
Clinical Evaluation
Although many controllers have been developed in literature none have been established as
a superior algorithm when it comes to controlling diabetes and only a few have been tested
in a clinical setting [8].
The characteristics of the current artiﬁcial pancreas systems, are deﬁned by their lo-
cation. They are either implanted, with direct access to blood, or worn on the body with
subcutaneous sensing and delivery. Implantation of the device allows for a continuous closed
loop model whereas subcutaneous routes introduce delay, both in sensing (10 min) and in
insulin delivery (50 min) [8]. However the body-worn device has been the preferred option
in recent clinical trials because of complications which exist due to implantation of the
pump and the need for a reliable long-term glucose sensor [8].
The systems available can be separated according to the way they handle mealtime
delivery. The ﬁrst types are termed fully closed-loop, (f-cl), which are able to deliver
insulin without information about when and what the patient eats. The other types are
the closed-loop with meal announcement, (cl-ma), or semi-closed loop. In this modality,
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meal information is given in order to infuse an insulin bolus in an attempt to counteract
the delays in subcutaneous insulin infusion.
Table. 3.1 summarises research to date by various groups on artiﬁcial pancreas devel-
opments, described in a review by Hovorka [8]. In his study he found that the glucose
sensor was an important limiting factor for most of these systems and that hypoglycemia
was a major concern when moving to an autonomous system. In the patients which didn’t
experience hypoglycaemia, a postprandial increase in glucose of 3 mM or more was found
which is undesirable as it kept the patient in hyperglycaemia. For healthy regulation these
irregularities need to be avoided, which can be achieved by having more accurate and re-
liable sensing and infusion mechanisms, or a more eﬃcient algorithm to deal with changes
outside a physiological glucose range.
3.3.3 Bio-inspired control
Physiological regulation is important because insulin has both metabolic and mitogenic
eﬀects. Therefore delivery algorithms that are designed to minimise glucose excursions
without regard for how much insulin is delivered may cause excessive weight gain, hyper-
tension or arteriosclerosis [17]. The ePID (external Physiological Insulin Delivery) controller
developed by Medtronic [17] does this to some degree but only considers insulin release from
beta cells at a top level. A more novel approach, which is the work initiated in this thesis,
is to take a bottom up approach and implement the fundamental interactions of glucagon
secreting alpha cells and insulin secreting beta cells of the pancreas.
With silicon implementations of these a bionic artiﬁcial pancreas may be developed
as is shown in Fig. 3.2, which can use a two reservoir insulin-glucagon system to achieve
biological proﬁles as is shown in Fig. 3.4.
In the work presented herein, an integrated circuit capable of mimicking the physiology
of the pancreatic beta cell is developed as a ﬁrst step to building a such a system. In
doing so, we propose an alternative implementation to current classical control methods
described. The development of the system in a bio-inspired manner allows us to gain a
more thorough understanding of the operation of the pancreas during the regulation of
glucose. Furthermore, with future development of a continuous, more robust glucose-based
ISFET sensor, this system can serve as a fully monolithic chemical bionic system. To
develop such a system, the biology and physiology of the pancreas and beta cells within
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Figure 3.7: The Pancreas is located beneath the stomach and consists of clusters of cells
called the Islet of Langherans. These contain the alpha cells responsible for glucagon secre-
tion and the beta cells responsible for insulin release
shall now be described.
3.4 The Pancreas
The pancreas is a glandular organ situated behind the lower stomach. Its main roles in the
body include blood glucose homeostasis and the production of digestive enzymes to break
down the food we eat. The endocrine tissue of the pancreas is made up of clusters of cells
called the Islets of Langherans, Fig. 3.7, which are responsible for producing the enzymes
necessary to control blood glucose. The predominant cells which make up each Islet include:
• Alpha Cells - Responsible for secreting glucagon when blood glucose levels are below
normal. This acts to release glucose stores from the liver, thus preventing hypogly-
caemia.
• Beta Cells - Responsible for producing and secreting insulin when blood glucose levels
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are high. Insulin acts to cause glucose uptake by cells, thus lowering blood glucose
and preventing prolonged hyperglycaemia.
• Delta Cells - Responsible for secreting somatostatin which acts as an inhibitor for the
insulin and glucagon released.
Blood glucose regulation occurs via a number of interconnecting events through both
positive and negative feedback mechanisms [2]. In short, the Islets act to maintain home-
ostasis as follows: A rise in glucose concentration is sensed by the beta cells. This rise
stimulates release of insulin granules from the beta cells by the process of exocytosis. This
acts to cause uptake of glucose into surrounding muscle and adipose tissue and triggers the
synthesis of fatty acids and glycogen in the liver, which reduces blood glucose. Conversely,
a fall in blood glucose below the nominal level is sensed by the alpha cells. These release
glucagon granules in a similar fashion. The glucagon releases glycogen stores in the liver
which can then bring the blood glucose back to its nominal level preventing further hypo-
glycemia. During these events, delta cells release somatostatin which blocks further release
of insulin and glucagon, thus preventing the detrimental eﬀects that would arise from the
uncontrolled secretion of these two hormones.
The beta cell has been identiﬁed as the main cell responsible for reducing the blood
glucose levels during occurrences of hyperglycaemia. The insulin released from these cells
is a direct consequence of the electrophysiological mechanisms which occur within the cell.
These shall now be described.
3.4.1 Electrophysiology of the beta cell [1]
In order to envisage what happens in the cell we have to consider that its’ cytoplasm (cellular
material within the cell) contains various ions, as does the extracellular ﬂuid in which the
cell rests in. The ions which play an important role in the glucose-insulin mechanism are
potassium, K+, and calcium, Ca2+. Diﬀerent concentrations of ions inside and outside
the cell set up a potential diﬀerence across its cell membrane which is about -70mV when
the beta cell is electrically silent at rest. Along the cell membrane there exists gated ion
channels which allow ﬂow of ions in and out of the cell illustrated in Fig. 3.8.
As the glucose concentration increases, special glucose transporter molecules, (GLUT2),
transfer the glucose inside the beta cell. The glucose inside the cell is then broken down
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Figure 3.8: The beta cell ionic channels with superimposed circuit-equivalents
by the process of glycolysis to give Adenosine Triphosphate, (ATP), which is the common
carrier of energy in our bodies. This rise in ATP causes closure of ATP-sensitive K+ ionic
channels, KATP . As a result, depolarisation of the cell membrane is initiated from -70mV
due to the ionic gradient induced. When this voltage reaches -40mV it opens up the voltage
dependant Ca2+ channels and initiates bursting action potential behaviour across the cell
membrane as in Fig. 3.9. An inﬂux of Ca2+ into the cell results in a rise of internal calcium
concentration and triggers exocytosis. This increase then opens up the calcium sensitive
K+ ionic channels which bring the cell back to its original state to restart the bursting
cycle.
What is interesting about this bursting behaviour is how it varies with glucose concen-
tration. At nominal glucose levels, (5mM in a healthy person), the cell remains electrically
silent, with a negative membrane potential of about -70mV. An increase in glucose con-
centration above 7mM however, depolarises the cell membrane and electrical activity is
initiated giving the described bursting behaviour. As the glucose concentration rises, the
pulse width of the bursts increases, Fig. 3.9, until eventually at 20mM there is saturation
and just a train of action potentials remains [1]. The ratio of the duration of the active
phase and the burst period is referred to as the plateau function [42], Eqn. 3.6.
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Figure 3.9: Burst pulse variation with glucose concentration
ρ =
active phase
burst period
(3.6)
A variation in the plateau function results in a change of the concentration of insulin
released. The data from empirical measurements are summarised in Table 3.2. As is shown
an increase in glucose increases the rate of insulin release, I, per islet, but also in plateau
function. The proﬁle is shown in Fig. 3.10.
3.4.2 Insulin Release
In-vivo the beta cell responds to glucose challenges with a characteristic ﬁrst and second
phase insulin response. The ﬁrst phase is a rapid increase in insulin secretion which is then
followed by the second phase which is a more gradual increase over time as is shown in
Fig. 3.111. Typical values of ﬁrst phase response are in the range of 80μU/ml for a period
of about 5-10 minutes [17].
Insulin release at the cellular level
The biphasic response of inulin release can be explained by considering the fact that insulin
granules are stored in the beta cell in two compartments. The ﬁrst is a small ready releasable
pool, (RRP), containing only a small fraction (∼500) of insulin granules that are released
immediately upon stimulation. The second is the reserve pool which contains the remaining
granules (∼13000) and serves to ﬁll up the RRP gradually over time illustrated in Fig. 3.12
[47, 48]. The mechanisms causing this release are related to the bursting behaviour described
1The biphasic response may be observed using the hyperglycemic clamp technique in which beta cells are
subjected to a step input of glucose and the insulin response is observed.
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Figure 3.10: Plateau function variation with glucose concentration.
Table 3.2: Experimental data of burst pulse variation with glucose and insulin release [42]
Ashcroft Meissner Beigelman Rosario
et al [43] and Schmelz [44] et al [45] et al [46]
g(mM) I(ng/hr/islet) ρ ρ ρ
0.0 0.4 0.00
1.8 0.5
2.2 0.00
2.8 0.7
4.3 1.2
5.5 2.4 0.16 0.00
5.6 0.10
6.7 4.5
6.9 0.17
8.3 0.25
8.4 6.2
11.1 7.9 0.54 0.54 0.56
16.6 0.89 0.92
16.8 12.1
20.0 12.0
22.2 1.00
27.7 1.00
27.8 1.00
28.0 13.0 1.00
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Figure 3.11: The biphasic response of insulin secretion [47].
Figure 3.12: Insulin granules are stored in ready releasable pools and reserve pools [47].
previously. An increase in glucose causes an inﬂux of Ca2+ into the cells’ cytoplasm which
promotes fusion of the insulin granules of the RRP to the cell membrane upon which they
are released into the blood. This process is called exocytosis and gives rise to the sharp
ﬁrst phase of biphasic insulin secretion [49]. Throughout this time the reserve pool slowly
reﬁlls the RRP by the process known as mobilisation which gives rise to the second phase.
The dynamics of exocytosis can be described by expression (3.7) [49]. The supply of
granules into RRP from RP is described by the rate k1 and the reversal of the process is
governed by the rate constant k−1. Exocytosis proceeds at the speed vexo(t), which varies
as a function of time after onset of depolarization (t).
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Figure 3.13: Hodgkin and Huxley formalism of beta cell ionic channels.
RP
k1

k−1
RRP
vexo(t)→ exocytosis (3.7)
3.5 Beta Cell modeling
The beta cell electrical activity was ﬁrst modeled by Chay and Keizer [50] in the 1980s and
has been subject to various revisions since then [51, 52]-[55]. The core of these models are
based on the Hodgkin-Huxley equations for neuronal electrical activity which were originally
derived from the measurements of the action potential from a giant squid axon [56]. As
explained previously, cells like these consist of a cell membrane which has various gated
ionic channels. Referring to Figs. 3.8 and 3.13 these characteristics can be modelled with
a capacitor representing the membrane capacitance and variable conductances representing
the gated ionic channels that open or close depending on the membrane voltage. The
mathematical formulation of this model is shown in Eqn. 3.8, where the rate of change
of the membrane voltage, v, is the sum of the ionic currents ﬂowing into the membrane
capacitance, Cmem.
Cmem
dv
dt
= −ICa(v)− IK(v)(v, n)− Islow(v, s) (3.8)
The set of equations shown contains the minimal features needed to generate the simple
bursting behaviour of the beta cells’ membrane potential as described in [57]. The param-
eters used are shown in Table. 3.3. Spiking is the result of the delayed fast varying current
generated by IK , Eqn. 3.10, interacting with voltage dependant current ICa, Eqn. 3.9, and
the bursting is due to the superimposed delayed slow time varying current Is, Eqn. 3.11. As
is shown below these ionic currents are generated by the diﬀerence in membrane potential
from the reversal potentials vk , vCa [58] across the conductances gCa, gK , gs.
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Table 3.3: Beta cell model parameters
y|x gy(ms) vy(mV ) vx(mV ) Xx(m) τx(sec)
Ca|m 360 25 -20 − −
K|n 100 -75 -16 5.6 0.015
s 40 − -40 10 30
ICa(v) = gCam∞(v)(v − vCa) (3.9)
IK(v) = gKn(v − vK) (3.10)
Is(v) = gss(v − vK) (3.11)
dn
dt
=
n∞(v)− n
τn
(3.12)
ds
dt
=
s∞(v)− s
τs
(3.13)
x∞ =
1
1 + exp((vx − v)/xx) , x ∈ [m,n, s] (3.14)
The conductances used to generate the ionic currents are modulated by a set of gating
parameters, m,n, s ∈ [0, 1] which represent the opening and closing of the ionic channels
in the cell. The time dependance of the n and s gating terms is given by the diﬀerential
equations (3.12) and (3.13), where n∞(v) and s∞(v) are the steady state activation functions
and τn and τs are the time constants. Intuitively these diﬀerential equations can be seen as
a delay of the activation functions. Eqn. 3.9 contains m∞ instead of m for the mere fact
that τm is quite small compared to τs and τn.
The activation functions for each gating parameter has the form of a sigmoid shown in
Fig. 3.14 which is derived from the general Eqn. 3.14, where vx is the centre of the sigmoid
and 1/xx is its slope. As can be seen in Fig. 3.14, x∞ ≈ 1 when v >> vx and x∞ ≈ 0 when
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Figure 3.14: A typical activation variable curve.
v << vx , and the slope 1/xx determines how much greater or less the membrane voltage
v has to be to reach these two extremes, deﬁning when the ionic channel is open or closed.
In order to modulate the burst pulse with glucose concentration, a variable kGluc is
introduced on the slow activation variable, Eqn. 3.15 as proposed in [50]. An increase in
kGluc increases bursting in a similar fashion to that observed by the eﬀective closure of KATP
glucose dependant channels in physiology [1]. Thus adopting a glucose sensor to provide
the equivalent values of kGluc allows for accurate modeling of the glucose input stage.
ds
dt
=
s∞(v)− kGlucs
τs
(3.15)
Fig. 3.13 shows how the combination of all these blocks are connected in order to generate
the ionic currents necessary for beta cell bursting behaviour. As can be seen the membrane
voltage, v=Vmem, is fed back to each current to produce its gating term, and the slow
current Is has an additional glucose input which can modulate the plateau function.
3.5.1 Why spiking and bursting occurs
The features contributing to action potentials and bursting may be easily understood ob-
serving the systems phase plane [59, 60]. The described system consists of three state
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Figure 3.15: a) Phase plane showing v− and n−nullclines for variation of s, b) Trajectories
of three set points on v, n phase plane at s=0.10, c) s=0.18 and d) s=0.28
variables, the membrane voltage, v˙ , the fast activation variable, n˙, and the slow activation
variable, s˙. The v, n phase plane which gives rise to spiking is shown in Fig. 3.15a, by plot-
ting the v-nullcline, v˙ = 0 (3.16), against the n-nullcline 2, n˙ = 0 (3.17), with s being used
as a bifurcation parameter. Bifurcation in this case refers to the changing and introduction
of intersect points between the two curves due to the shifting of the v-nullcline generating
new behaviours. The v-nullcline will shift up and down as s changes since Is and IK have
the same reversal potential.
n =
−gCa.m∞(v).(v − vCa)− gs.s.(v − vK)
gK .(v − vK) (3.16)
2Nullclines are simply lines on a x, y phase plot that denote x˙ = 0 and y˙ = 0. Their intersection represents
equilibrium points in the system.
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n =
1
1 + exp((vn − v)/xn) (3.17)
What is interesting about non-linear systems is that their trajectories from an initial
point are determined by the nature of these intersect points. They may form stable equi-
librium points as indicated by the solid intersections of the nullclines in Fig. 3.15a, which
attract surrounding points or unstable equilibrium points indicated by the hollow intersec-
tions, which may repel surrounding points.
Spiking behaviour may occur when trajectories in the phase plane form a closed loop
around an unstable equilibrium point. A periodic trajectory of this sort is referred to as
a stable limit cycle. In order to visualise the dynamics of the system, the trajectories of
three points on the phase plane will be described (their initial positions indicated by black
points) for the three diﬀerent values of s shown in Fig. 3.15a.
s=0.10
Fig. 3.15b. At this point exists only one intersection between the v− and n−nullclines,
which is unstable but forms a stable limit cycle. The three initial trajectories all converge
to this stable limit cycle which is represented by periodic spiking in the time domain.
s=0.18
Fig. 3.15c. Since the lower knee of the v−nullcline intersects with the n−nullcline, two new
points are formed in the process which is known as a saddle node bifurcation [60]. The two
points introduced correspond to a stable node which attracts near by trajectories, and an
unstable node known as a saddle. Two of the initial points are now attracted to this steady
state solution located at v =-65mV whereas the third forms a limit cycle, which can be
seen as oscillations in the time domain from v =-50mV to v =-25mV. These two states are
important as it is those we observe when the beta cell is bursting, v =-65mV being the silent
state and the limit cycle being the active spiking state. The saddle point introduced plays
a signiﬁcant role as it annihilates the limit cycle via a homoclinic bifurcation [60]. One can
imagine that as the v− nullcline moves further down, the saddle point moves closer to the
limit cycle until at certain threshold turns it into an unstable spiral. When this happens
all surrounding points converge to the one stable node on the left and bursting ceases.
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s=0.28
At this point just one stable node exists attracting all surrounding trajectories Fig. 3.15.d.
In this situation the cell always remains electrically silent at -70mV.
What is clear from these three cases is that variation in s could cause the system to
change from a stable equilibrium state to an unstable equilibrium state where spiking occurs.
3.5.2 Fast-Slow Dynamics
Every bursting pattern consists of oscillations with two time scales, the fast time scale
producing spiking and the slow time scale producing the silent phases of a bursting pattern.
The bifurcations shown for the n−, v−nullclines suggest how spiking occurs on the fast time
scale but in order for bursting to occur we introduce the variable, s, with the dynamics of
Eq. 3.13, which is on a slower time scale. The role of s is to modulate the spiking via a slow
negative feedback of the Is current formed. As can be seen in Fig. 3.17 the repetitive spiking
causes a slow build up of s which slowly causes the current Is to activate. At a certain point
the contribution of the Is current will be such that spiking can no longer be sustained. In
this phase space this is seen as shift of the n−nullcline causing the bi-furcations described
previously.
Fig. 3.16 depicts the v−, s− phase portrait of the system during bursting. Starting
with the membrane potential in its resting state of stable equilibrium, s slowly decreases
and the bursting trajectory slides along the bottom half of the parabola. At s = s1 the
stable equilibrium coalesces with an unstable equilibrium (saddle) and they annihilate each
other via saddle-node bifurcation. The trajectory then jumps up to the stable limit cycle
corresponding to repetitive spiking (active phase). While the fast subsystem spikes (due to
the v−, n−nullcline interaction) s slowly increases. At s = s2, Is is so large that spiking
cannot be sustained. The limit cycle becomes a homoclinic orbit to a saddle and then
disappears. The trajectory jumps back down to the silent phase and the cycle is repeated
[60].
3.5.3 Varying the burst pulse
We are now ready to describe the eﬀects of glucose on our model. As mentioned at low
glucose concentrations (up to 7mM) the cell is silent whereas at high glucose concentrations
Silicon Metabolic Cells 59
       
  ´
  ´
  ´
  ´
  ´
  ´
  ´V MV	
SS S
ACTIVE PHASE
SILENT PHASE
X
A
B
:CURVE
Figure 3.16: Bursting phase portrait. v− and s−nullcline with n˙ causing spiking.
(20mM) spikes continuously. In between these two states the cell exhibits bursting behaviour
with the fraction of time spent in the active phase increasing as the glucose concentration
rises. This characteristic can be achieved by the shifting of the intersect point between the
s−nullcline and the v−nullcline (Z-curve), point x Fig. 3.16. This point is unstable as a
result it repels all nearby trajectories. One can think about it as a force which repels or slows
down the trajectories which pass nearby it as they are rotating around this point. Assuming
the trajectory is traversing between the two phases, moving x closer to a, Fig. 3.16, causes it
to slow down when it is in the silent phase, increasing the time spent in this phase. Likewise
moving it closer to b causes a similar slow down but in the active phase, shown in time in
Fig. 3.17. Using kgluc, Eqn. 3.15 implements this shifting by changing linearly the slope to
the s−nullcline and thus shifting the intersect point.
3.6 Silicon implementation
Bursting of the beta cells is brought about by physical properties, (diﬀusion of ions through
the cell), which also appears in silicon transistors. The exponential relation of silicon tran-
sistors biased in the weak-inversion region is a direct result of the Boltzmann distribution
which appears in many biological systems, as a result it can serve as the main building
block for bio-inspired systems [58]. Accurate modeling of the individual ionic channels of
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Figure 3.17: Varying the plateau fraction by increasing kGluc.
the Hodgkin and Huxley formalism may be accomplished by substituting the individual
blocks in the system with their transistor circuit equivalents as has been done thus far for
neural implementations [61, 62, 63]
In real beta cells the ionic currents ﬂow in and out through the cell membrane which
is capacitively coupled to the membrane voltage. In electrical circuits, electronic currents
ﬂow in and out of a capacitor to give the same coupling eﬀect. Eqn. 3.18 gives the general
physical equation of a capacitor.
C
dv
dt
= −Iout (3.18)
Comparing this with Eqn. 3.8 it is easy to see that the dynamics will be the same as
long as we can get an accurate representation of the ionic currents of Eqns. 3.9, 3.10 and
3.11 using electronic currents.
Fundamentally the ionic channel may be represented using three blocks, as in Fig. 3.18.
A voltage dependant sigmoid like function will generate the activation variable, a low pass
ﬁlter will generate the ﬁrst order time dependance and a variable linear transconductor to
emulate the required impedance of the channel.
The detailed implementation of these blocks, utilising the physics of transistors, shall
now be described.
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Figure 3.18: Block diagram of the potassium channel.
3.6.1 The steady state activation functions
The diﬀerential pair is a circuit which is well known for its sigmoidal voltage to current
relation [58]. The circuit topology shown in Fig. 3.19 comprises of transistors biased in the
weak-inversion region of operation. Apart from consuming minimal power due to current
ﬂow by diﬀusion, the current is exponentially related to the voltage of the device allowing
for implementations of various hyperbolic functions [64, 65].
Eqn. 3.19 describes the output current generated from the circuit shown in Fig. 3.19,
where A is the gain of the ampliﬁer, n is the sub-threshold slope parameter, Ut the thermal
voltage of the device and IB the tail current of the diﬀerential pair generated by the voltage
vB. The requirement of pre-ampliﬁcation of the signal by A is due to the fact that the
maximum slope of the diﬀerential pair is limited to IBn.Ut [58].
Comparing Eqns. 3.14 and 3.19 reveal that they are of the same form allowing for direct
implementation of the activation functions m∞(v), n∞(v), and s∞(v), Fig. 3.20, using the
parameters as described in Table. 3.4. The slope of each sigmoid may be adjusted by setting
the gain according to A = nUt/sx, with the maximum value to the sigmoid determined by
the tail current IB.
Iout =
IB
1 + exp(A(vs − vmem)/nUt) (3.19)
Iout = IB.s∞ (3.20)
It is important to note that our information will be processed in current mode due to
the activation variable being represented by a current, Eqn. 3.20. This allows for easier
implementation of subsequent blocks since for relatively slow varying signals such as the
ones used here, mathematical operations in current-mode can in principle be implemented
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Figure 3.20: Realisation of the steady state variables using a tail current IB=50nA.
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Figure 3.21: A ﬁrst order log domain ﬁlter circuit used to generate the activation variable.
much easier than their voltage-mode counterparts by direct application of the translinear
principle [66].
3.6.2 Time dependance of activation function
The activation functions of each ionic channel needs to be delayed using ﬁrst order diﬀer-
ential equations, Eqns. 3.12, 3.13, to implement the slow dynamics, bursting, and the fast
dynamics, spiking, of the cell. Equations of this sort are very common in electronic circuit
design as these dynamics exactly replicate a low pass ﬁltering function.
Filtering in the log-domain has gained considerable attention over the past few years
mainly because of the companding nature of the resulting topologies leading to higher
dynamic range and low power of operation [67]. As in the activation variable circuit all
transistors are biased in the weak-inversion region. Fig. 3.21 depicts a typical ﬁrst-order low
pass ﬁlter circuit whose output current is given by Eqn. 3.21, where C is the ﬁlter capacitor,
I0 is a bias current which controls the time constant and ID sets the gain. Comparing with
Eqns. 3.12 and 3.13 we see that the output current of the ﬁlter exactly represents the gating
variables n, for ID=I0, and s for , ID=Igluc, with the magnitude of the variable depending
on the input current IB from the previous stage, Eqn. 3.22. The time constants of the state
variables, τs and τn are now set according to Eqn. 3.23.
dIout
dt
=
I0Iin − IDIout
CnUt
(3.21)
Iout = IB.s (3.22)
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τs =
CnUt
I0
(3.23)
In Eqn. 3.15 we deﬁned the constant kgluc as our glucose modulating term. In our
implementation this is just the ratio of currents Igluc/I0 so we can expect an accurate
variation of the burst period just by a correct mapping of Igluc to any type of glucose sensor
as discussed later in Section 3.6.4.
3.6.3 Implementation of ionic conductance
Circuits described so far allow for accurate implementation of the required gating variables.
What is needed now is to generate the ionic currents of Eqns. 3.9, 3.10 and 3.11 by
implementing a function of the form Iion = gion.(v − vx). Since the activation variable
is represented by a current mode signal, (Eqn. 3.22), a variable linear transconductor, is
required which may be controlled by a current, IB. The diﬀerential pair mentioned earlier
is commonly used as a linear conductance element since its sigmoidal characteristic is linear
around the centre, give by Eqn. 3.24. The only constraint of the basic form of the diﬀerential
pair is that its linear range is limited to approximately ±50mV which is not enough for
bursting oscillations to occur.
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The circuit arrangement shown in Fig. 3.22 increases the linear range of the basic dif-
ferential pair to ±100mV by the introduction of the current IBump. Bump linearisation
[68, 69] as this technique is known is a simple way of increasing the linear range as it re-
quires the introduction of only two transistors which act by stealing tail current in regions
where non-linearity appears.
Comparing Eqn. 3.24 with the expressions of the ionic currents Eqns. 3.9, 3.10, 3.11 and
taking into consideration that the input current from the previous stage is s·IB, giving a tail
current as in Eqn. 3.25, we can see that the ionic conductance may be set using Eqn. 3.26,
where K is just a scaling term due to the tail current mirror and IB is our selected bias
current, Eqn. 3.20.
Iout =
Itail
2nUt
.(vmem − vK) (3.24)
Itail = K.s.IB (3.25)
gion =
K.IB
2nUt
(3.26)
Silicon Metabolic Cells 66
Fig. 3.23 shows the simulated results of the potassium channel, gk = Iout/(v − vk),
using parameters as in Table. 3.4. What is seen is how the conductance varies for diﬀerent
values of the activation variable (deﬁned by Iin = IB.s). A change in the activation variable
current causes a linear change in the slope of the graph which directly relates to the change
in conductance.
3.6.4 Implementation of a chemical input
This circuit has been designed based on the requirement that the glucose input will be a
current Igluc which maps the physiological glucose range, 5mM-20mM, to a current of the
same absolute value, 5nA-20nA (i.e a 1nA/mM ratio). One way of providing this current
is via an amperometric glucose sensor and some conditioning circuit. A more novel method
which allows for monolithic implementation is using a glucose-based ISFET. ISFET-based
chemical sensors, ﬁrst introduced by Bergveld [70], have gained considerable interest due
to their ion sensitivity, fast temporal response, compact size and prospect of monolithic
integration [71]. They shall be studied in detail in Chapter 4, but will be proposed here as
a possible sensor for the silicon beta cell.
The ISFET device can sink an output current which is dependant on the pH of the
solution. This is due to the binding of hydrogen ions to the silicon nitride surface (CMOS
passivation layer) above the gate forming a capacitive coupling with a Ag/AgCl reference
electrode [70]. The ISFET biased in the weak-inversion region of operation by applying
a suitable voltage on the reference electrode, minimises power consumption and exploits
the exponential device characteristic [72]. The output current relation to hydrogen ion
concentration is given by Eqn. 3.27 where Kchem is a pH independent constant, n the
sub-threshold slope factor, Ut is the thermal voltage and a is a dimensionless sensitivity
parameter relating the ISFET’s sensitivity to the Nernstian relationship [73]. This sensor
current can be used in a current mirror conﬁguration [73], which can be scaled according
to the requirements of Igluc and used as a direct input to the log-domain ﬁlter, Fig. 3.21,
to generate Igluc.
IISFET = I0e
Vref
nUt Kchem[H+]
a
n (3.27)
However, in order to provide a physical link between Igluc and the glucose concentra-
tion, an enzyme must be used to generate hydrogen ions which are sensed by the ISFET
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Figure 3.24: Drain current vs glucose relation with the ISFET operating in weak-inversion.
sensor. Glucose oxidase (GoX) is the most common enzyme used for this [74], which can
be immobilised on the bare gate of an ISFET using covalent binding. A one to one relation
between hydrogen ions and glucose ions is given by the reaction of glucose with the enzyme
as follows:
glucose + O2 + H2O
GoX−→ gluco-δ-lactone + H2O2
gluco-δ-lactone + H2O −→ gluconicacid
gluconicacid −→ gluconate + H+
A commercial ISFET provided by Sentron b.v was modiﬁed into a glucose EnFET3
(enzyme fet), according to the protocol described in Appendix C.4. Experimental results
of the biosensor biased in weak-inversion are shown in Fig. 3.24. These are preliminary but
serve to demonstrate the concept of using glucose modulation. Glucose may be sensed up
to 25mM, with a current consumption in the order of nano-amps.
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Figure 3.25: Microphotograph of fabricated silicon beta cell.
Table 3.4: Silicon model parameters
channel A IB(nA) I0(nA) C(uF ) K
Ca 2.8 50 10 − 0.9
K 6.5 50 10 0.005 2.4
s 3.5 50 10 10 0.95
3.7 Design fabrication and testing
The silicon beta cell has been designed and fabricated in a commercial 0.25μm CMOS
process. The circuit design was based on the minimal model for beta cell bursting described
using parameters shown in Table 3.4 and a membrane capacitor, Cmem=2nF. The total chip
area of the three ionic channels is 500μm x 350μm. A photograph of the completed chip
is shown in Fig. 3.25. What you can distinguish in this photo is the three ionic channels,
IS , IK and ICa. In order to preserve real life dynamics of the beta cell, discrete capacitors
have been used to implement the large time constants, τs and τn (Table. 3.3), as well as the
membrane capacitance. Implementing similar sized capacitors on chip would require a large
silicon area, as capacitance scales at approximately 1nF/mm in a standard CMOS process.
The full circuit schematic of the slow ionic channel Is is shown in Fig. 3.26 consisting of
3Prepared by Dr. Anna Radomska using commercial ISFETs supplied by Sentron b.v.
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Figure 3.26: Full schematic of s ionic channel channel. The sigmoid thresholds the mem-
brane voltage which is time delayed through the log domain ﬁlter and converted to an ionic
conductance through the linear transconductor. The log domain ﬁlter has a glucose sensor
input which modulates bursting.
the three blocks described plus an additional glucose sensor block which drives the variable
Igluc. The circuits of ICa and IK are designed in a similar fashion. The device sizes were
chosen to have large areas to reduce low frequency ﬂicker noise and reduce mismatch due
to process variation. The ampliﬁer A is constructed using a two-stage op-amp with a bias
current of 100nA and all the transistors biased in the weak-inversion region for minimal
power. A supply voltage of 2.5V was used and the biasing current of the activation variable
IB and ﬁlter I0 set 50nA for low power operation. Capacitor values were chosen based on
the desired time constants, τs and τn Table. 3.3, using Eqn. 3.23 with the sub-threshold
slope parameter n=1.28 for the given technology.
The simulated steady state current contributions from the three ionic channels are shown
in Fig. 3.27 based on the activation functions shown in Fig. 3.20. The current magnitudes
span to several tens of nA consuming minimal power. What we can distinguish in the region
of bursting (-70mV to -20mV) is that ICa has a region of negative conductance, i.e ˙ICa(v) <
0 which creates positive feedback between the voltage and gating variable whereas IK and
Is are positive in conductance creating negative feedback. This positive feedback is what
causes the initial rapid increase in membrane voltage when the cell becomes depolarised
and then through delayed negative feedback (IK and Is are delayed through Eqns. 3.12
and 3.13) of the other ionic currents the cell is brought back down to its original state.
The AC responses for the log-domain ﬁlters used for the gating variables s and n are
shown in Fig. 3.28. These have relatively low cut oﬀ frequencies due to the large time
Silicon Metabolic Cells 70
´   ´   ´   ´   ´          
´
 






) N!	
V M6	
)#AV	
)SVS	
)KVN	
Figure 3.27: Steady state ionic currents generated from silicon beta cell.
constants required, (τs = 30sec ∴ Cs = 10 μF and τn = 0.015sec ∴ Cn= 5 nF using
Eq. 3.23). Fig. 3.29 shows the variation in the AC response of s for changing values of Igluc
from 5nA to 20nA. This result is a change in the amplitude response of the ﬁlter which is
dependant on I0/IGluc but also shift the corner frequency according to ω0= IGluc/CnUt 4.
The ionic current blocks are connected to a capacitor, Cmem which implements the role
of the cell membrane. The charging and discharging of the capacitor produces the bursting
membrane voltage according to Eqn. 3.18. The measured bursting patterns for the silicon
beta cell are shown in Fig. 3.30. The glucose current for this experiment was supplied from
an oﬀ chip current source and the measured membrane voltage is oﬀset by 820mV due to
the single ended supply. We can clearly distinguish both the bursting and the spiking of
the beta cell which closely matches results from experiments providing real beta cell data
[43]. What is important is the variation of the plateau function mentioned, Eqn. 3.6 with
glucose stimulus. The measured results depicts how the burst width changes with glucose
current stimulus. The period of bursting does not remain constant which is a result of
the simpliﬁed model used. However, as is shown in Fig. 3.31, the full variation of plateau
function still matches biological beta cells, which can be used to determine the amount of
insulin released.
4The ﬁlter AC response may be described as Iout
Iin
= A · ω0
s+ω0
with A=I0/IGluc and ω0= IGluc/CnUt
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Figure 3.31: Plateau function variation for silicon beta cell. The results are compared with
the biological beta cell.
The total power consumption of the fabricated device was measured to be 4.5μW at a
supply voltage of 2.5V. The silicon beta cell consumed 1.9μA during the active phase and
1.7μA during the silent phase. A signiﬁcant amount of the static current consumption was
drawn from the op-amp to provide the gain A though this may be signiﬁcantly reduced by
using speciﬁc op-amp designs for low power applications using supply voltages down to 1V.
Despite this, the power consumption is still considerably small which allows for use in a
portable device.
3.8 Discussion
Thus far we have shown the ﬁrst silicon implementation of the pancreatic beta cell capable
of performing simple bursting with a chemical input. This circuit is the ﬁrst step towards
building an artiﬁcial bionic pancreas which shall be used for blood glucose regulation in
conjunction with an insulin pump. The results are very promising as the silicon beta cell
shows bursting behaviour similar to that of real beta cells as well operating with low power
consumption rendering it ideal for implantation or to be used as a body worn device.
Insulin secretion in the body occurs in a characteristic ﬁrst and second phase as was
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shown in Fig. 3.11. Though this occurs over the course of several minutes, the bursting of
a single beta cell occurs over several seconds. What causes this diﬀerence in time scale is
the fact that bursting of a cluster of beta cells in the Islets has a larger period than that of
individual beta cells, which is referred to as compound bursting [51]. This is a result of the
the gap junction coupling between the cells, which causes them to synchronise and through
certain interactions [47] causes bursting with a very long ﬁrst burst (ﬁrst phase) followed
by shorter bursts (second phase) on the time scale of minutes.
Mathematical models of compound bursting have been developed [52, 75]. The non-
linear equations of these models are still of the same type as those used for the silicon
implementation of the beta cell. In the future these will be implemented to accommodate
for all modes of bursting.
Since this bursting is associated with insulin release, the membrane dynamics of a silicon
implementation may be processed to predict the amount of insulin infusion required to the
patient. Using this data one may either derive an empirical relation for the plasma insulin
required per burst or model the actual exocytocic mechanisms of the cell to give more
physiological levels of insulin requirement.
What shall be now shown is a simple demonstrator implementing a linear algorithm of
insulin release using the silicon beta cell to serve as a bench top proof of principle. Using
this one can then implement the more complex insulin algorithms discussed previously.
3.9 Bio-inspired artiﬁcial pancreas demonstrator
This demonstration presents the ﬁrst bio-inspired approach to glucose management of Type-
I diabetic patients using a real-time semi-closed-loop insulin delivery system. The delivery
system consists of a glucose biosensor, used with the silicon beta-cell to drive a motorized
pump, Fig. 3.32.
3.9.1 Overview of the system
In the non-diabetic pancreatic beta cell, blood glucose is sensed and insulin is released into
the circulation to eﬀect the metabolic changes required to reduce the glucose concentration.
In an artiﬁcial pancreas a glucose sensor is used, providing an output to a control algorithm
which dynamically alters insulin infusion rates. Physiologically, the beta cell releases insulin
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Figure 3.32: Bio-inspired Artiﬁcial Pancreas demonstrator
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Figure 3.33: Bio-inspired Artiﬁcial Pancreas system top level
when the glucose levels rise above approximately 5mM. Insulin exerts it’s metabolic eﬀect
by promoting glucose uptake into cells, particularly liver cells and skeletal muscle where
glucose may be stored as glycogen.
In order to demonstrate our platform we1 model the patients blood glucose using a
glucose buﬀer solution with the eﬀect of insulin being modelled using water to dilute the
solution and thus decrease the glucose concentration. Additions of glucose are used to
simulate the eﬀect of having a meal. The glucose ‘water bath’ experimental setup is shown
in Fig. 3.33. This system works as a semi-closed-loop system as insulin removal is not
possible and therefore is required to be under-damped. The whole system is described in
detail in [76].
A three electrode electrochemical glucose biosensor is used as the sensing element. The
full circuit schematic is shown in Appendix F. A potentiostat ﬁxes the voltage between
the glucose biosensor’s reference (RE) and working electrode (WE) at +700mV. The sensor
responds linearly to the glucose concentration in the water bath via a current ﬂowing from
the working to the counter electrode (CE). The current generated is used as an input to
the silicon beta cell via current mirrors.
The silicon beta cell reacts to the glucose current by bursting in a comparable fashion
to its biological counterpart. Action potentials occur on these slow wave bursts, varying
1This system was designed in collaboration with Dr. Suket Singhal for the design of the glucose biosensor,
Dr. Mel Ho for the design of the potentiostat, motordriver and Dr. Nick Oliver for the clinical insight
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in pulse length with changing glucose concentration [77]. The duty cycle of the bursting is
linearly related to the glucose concentration. The spikes generated are used to control the
insulin delivery.
The insulin delivery mechanism in this demonstration is achieved by using a stepper
motor to actuate the syringe. The spikes from the beta cell turn on the stepper motor
which pushes the syringe at a pre-determined rate. Therefore, ﬂuid will be infused from the
syringe into the water bath.
The control sequence is thus as follows: First a bolus of glucose solution is added to
the water bath to simulate the eﬀect of an increase in blood glucose, for example having a
meal. This bolus will generate a sensor current from the potentiostat which will depolarise
the silicon beta cell and cause it to burst. Every spike on the bursting plateau of will cause
the motor to turn and pump water into the bath, diluting the glucose solution. The eﬀect
of dilution will be a decrease in the glucose concentration which will eventually cease when
the silicon beta cell becomes silent.
3.9.2 Insulin release
In the biological beta cell insulin is released during bursting by the process of exocytosis.
During bursting, each spike contributes to an inﬂux of calcium which contributes to the
docking of insulin granules which are later released. In order to have a bio-inspired insulin
release the dynamics of the granules released need to be modelled as in (3.28) for a popu-
lation of beta cells. This would then be triggered by each spike caused by the bursting of
the beta cell. In this demo each spike from the beta cell is used to infuse a ﬁxed volume of
ﬂuid into the bath.
The spikes in the bursting signal are converted to 3.3V pulses using a comparator which
are then used to step the motor. A Haydon linear actuator is used to push the syringe.
This contains water which is used to dilute the glucose in the beaker. The stepper motor
is controlled by a Rohm BA6845FS stepper motor driver. The linear actuator and the
motor driver are conﬁgured to operate in the bipolar mode. The motor driver chip receives
two square waves that are 90 degrees out of phase. The frequency of the square waves,
determines the speed the linear actuator extends and retracts. The pulses converted from
beta cell spikes then turn on the linear actuator. The actuator pushes the syringe at a ﬁxed
speed while the control signal is high.
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Each square wave of period Tstep causes the motor to move a distance, d, which induces
a unit insulin volume, Vunit=πr2d where r is the radius of the syringe. The motor is active
for the spike length, Tspk. The total insulin infused by N spikes is thus given by:
Vinsulin =
N.Vunit.Tspk
Tstep
(3.28)
This bench top demo served as a proof of principle of the system. The silicon beta cell
depolarised upon sensing glucose which caused release of water into the beaker. Though this
linear spike to volume infusion achieves closed loop control, in order to make the system
fully replicate the biology of the beta cell, the dynamics of (3.28) need to be included.
Adding the patient in the loop will also add further degrees of complication, as the current
system assumes a linear plant response. Lag times due to sensing and infusion need to be
considered to make the patient model more realistic. This is subject to ongoing research.
3.10 Summary
Presented in this chapter was the ﬁrst implementation of a chemical bionic system in silicon.
The beta cell of the pancreas was chosen due to its signiﬁcance in the control and regulation
of glucose in our bodies. The electrophysiological behaviour of the cell to glucose stimulation
was modelled and implemented using silicon integrated circuits. Bursting of the cell was
shown for glucose concentrations above 5mM. Coupled with an on-chip glucose sensor this
can serve as a monolithic implementation of a silicon beta cell whose dynamics replicates
its biological equivalent.
Implementing the beta cell in silicon enables a novel implementation of an artiﬁcial
pancreas. The artiﬁcial pancreas is important for tight glycemic control of Type I diabetic
patients, which reduces secondary complications. A simple control loop using the silicon
beta cell has been presented for use as a bench top demo. The aim is that this bio-inspired
route will tackle some of the problems seen with conventional control methods such as
hypoglycaemia. Though it is recognised that the pancreas itself uses more than just the
beta cell to maintain a normal glucose concentration, these have been identiﬁed, (alpha
cell for preventing hypoglycaemia), and silicon implementations are subject of future work.
What makes this possible is the fact that the circuits used herein for creating the silicon beta
cell are generic to any electrically excitable cell characterised by H&H. Once the silicon Islet
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has been developed it will be used as the core for the artiﬁcial pancreas. This however still
requires clinical trials for validation and a continuous glucose sensor for its full development.
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Chapter 4
Chemical Electronics
4.1 Introduction
We are living in an era where advances in silicon-based technologies are driven by the re-
quirements of computing and mobile communications. In recent years however, the growing
needs of society to improve on healthcare and quality of life have seen integrated circuits
oﬀering novel solutions for various biomedical applications. As a result there is a new drive
for these technologies to be applied in healthcare, to provide cheap, disposable, low power
and intelligent systems to provide diagnosis and treatment of medical conditions.
In Chapter 3, an example of such a system had been presented, whereby a model of a
chemically sensitive biological cell, the beta-cell, could be implemented using microelectronic
technology to make a novel bionic system to control Type I diabetes [1]. The aim being
that such a system could not only provide a physiological control of diabetes, but also
leverage on the advantages of using semiconductors, to make the solution low power, cheap
and therefore disposable. However, if such bionic systems are to take full advantage of
implementation in silicon, integration of the chemical sensing front end with the processing
circuitry is desirable.
An integrated chemical sensing front end as such, could potentially open up new paradigms
in electronic design whereby we no longer need to think of our inputs as electrical but we
can start to formulate systems in which the input is chemical. With this in mind, chemical
bionic systems can be created which mimic the chemical functionality of various biological
systems in the body, to provide more bio-inspired treatment as was shown with our artiﬁcial
pancreas.
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This chapter presents work on the development of a silicon-based electrochemical sensor
called the Ion Sensitive Field Eﬀect Transistor (ISFET) which can be used to develop novel
chemical bionic systems. It is mainly divided into two sections. The ﬁrst section gives a
brief overview of implementation of chemical sensors using CMOS technology, along with an
explanation of low power operation of CMOS using the weak inversion regime. The ISFET
is then presented as a sensor for use in chemical bionic system. An explanation based on
the chemical phenomena that lead to its pH sensitivity and a model which describes its
operation in weak inversion, are then described. This is then supported by experiments
conducted using commercially-available ISFETs.
The second section of this chapter focuses on work undertaken as part of this research to
implement and characterise ISFETs in an unmodiﬁed CMOS technology. Issues of threshold
voltage variation and reduced sensitivity of ISFETs in CMOS are addressed followed by
identiﬁcation of the passivation capacitance of the insulator, as one of the main factors
which contribute to a deviation of the ISFET characteristics from the standard MOSFET
from which it is made. An empirical model which encompasses all these factors is then
derived for modelling and simulation of ISFETs in weak inversion. Design and fabrication
of ISFET devices in several CMOS technologies is shown to conﬁrm the model as well as to
provide the ﬁrst technology wide comparison of ISFET devices. The chapter concludes with
methods of compensating for threshold voltage variation due to trapped charge, and also
a design guide for implementing the devices based on theoretical and experimental work
conducted.
4.2 Chemical sensors in CMOS
In order for any chemical sensor to be monolithically integrated on a single chip to make a
chemical bionic system, it must be implementable within the same technology on which the
circuits are made. CMOS-based integrated circuits are getting smaller and lower in cost as
a result of the decreasing feature size of the MOSFET, and the economies of scale of semi-
conductors. Implementing chemical sensors in CMOS has therefore been an avidly pursued
research area due to the overlapping requirements of modern day chemical microsensing
devices [2]. These include miniaturisation of sensors, batch fabrication and incorporation
of processing and signal conditioning circuitry to improve SNR, implement intelligent algo-
rithms and conserve power.
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Implementing chemical sensors in CMOS requires miniaturisation of the sensing technol-
ogy to a two-dimensional planar form which can be fabricated on the silicon die from which
the chip is made. Microsensors of this sort are usually referred to as solid-state sensors [3].
Of the many solid-state chemical sensing technologies, which include optical, piezoelectric,
magnetic, mass-based, coulometric and frequency-based chemical detection, electrochemical
microsensors have the most widespread utility, for detecting chemical species [4]. This is
because they are based on ion or electron transfer at the interface between the sample and
solid state substrate, giving a direct transduction of the kinetic nature of the analyte being
sampled. This makes it an ideal sensor for real-time detection as well as having minimal
complexity for implementation in CMOS, as it needs no lenses, light sources or ﬂuorescent
labels, which would be required for equivalent well established optical techniques.
Electrochemical sensors in CMOS are principally based on three types of sensing modal-
ities: voltammetric, potentiometric and conductimetric. CMOS implementations of these
are thoroughly reviewed in [4, 5] and shall now be brieﬂy described.
Voltammetric sensors (also known as amperometric when the potential is ﬁxed) require
a counter, a reference and a working electrode to analyse a sample. In amperometry,
a ﬁxed potential is applied to the reference electrode to cause a redox reaction in the
analyte which causes ﬂow of electrons between this electrode and the working electrode.
The amount of current measured through the working electrode is used to determine the
concentration of the species. The counter electrode is used to provide a current path to
prevent current passing through the reference electrode which may alter its potential. In
voltammetry, the potential applied to the reference electrode is time varying, providing
more information about the species. Implementation of the electrodes on a CMOS substrate
requires deposition of an inert metal such as platinum or gold using standard lithographic
methods. Using these planar electrodes leads to successful electrochemical detection of
microlitre samples in CMOS [6, 7].
Potentiometric sensors are based on a voltage measurement at an electrode equilibrium
state in which no current may ﬂow. This is usually between an ion-selective electrode and a
reference electrode which measure this potential as a result of a diﬀerence in concentration
between the sample and a reference solution. FET-based chemical sensors (ISFET, CHEM-
FET, Work function FET) fall into this class whereby the charge in solution, exposed to a
ﬂoating gate, may be sensed via a stable reference electrode [8]. A standard liquid junction
silver/silver chloride (Ag/AgCl) electrode is normally used as reference. Successful imple-
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Table 4.1: CMOS based chemical sensors
Sensor Type Analytes Post processing Ref
ISFET Potentiometric H+ No 1 [8]
CHEMFET Potentiometric K+ Yes [9]
Work function FET Potentiometric Neutral gases, VOCs Yes [10]
Planar electrode Amperometric O2, sugars, alcohols Yes [7]
Chemiresistor Conductiometric CO, inorganic gases Yes [4]
organic volatiles, VOCs
Chemicapacitor Conductiometric humidity, VOCs Yes [11]
1 Assuming an external reference electrode is used
mentations in CMOS have lead to detection of analytes such as hydrogen, potassium and
various neutral gasses and volatile organic compounds (VOCs) [8, 9, 10].
Conductimetric sensors are based on measuring the conductance of the sample to deter-
mine the concentration of charge therein. Chemiresistors and Chemicapacitors fall into this
class in which a measure of the change of resistance or capacitance of selective membranes
between a set of electrodes determines the concentration of species within [11, 4]. Typically,
such sensors exhibit low selectivity, but are ﬁnding their way into applications where large
arrays of sensors are required for pattern recognition such as electronic noses and tongues
[12, 13].
Various implementations of all these sensors in CMOS along with the analytes being
detected are summarised in Table 4.1. With any CMOS-based chemical sensor, it is desirable
to keep to a minimum any non-standard process steps, because these result in an increase
in manufacturing complexity and therefore cost per sensor. All CMOS sensors shown in
Table 4.1 require post-processing to some degree to either deposit electrodes on the die, or
attach membranes to make the sensors selective to speciﬁc analytes. Fabrication of ISFETs
has been achieved using standard MOSFETs and the native passivation of the CMOS
process, which is usually referred to as ISFETs in unmodiﬁed CMOS [14]. For applications
of proton2 sensing this requires no extra processing steps to deposit the membrane and
can be used unmodiﬁed using an external reference electrode. From thereon making the
devices selective to other ions requires deposition of other membranes. This has made the
2Proton in this case refers a single hydrogen ion, H+, which carries a positive charge.
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ISFET an attractive option because it can take full advantage of the merits which come with
implementation in a standard CMOS process which include miniaturisation, repeatability,
minimal process variation, high yield and low cost of large volumes.
Having the same physical primitives as MOSFETs, has allowed for the ISFET to be
monolithically integrated into CMOS circuits to make ISFET/MOSFET combinations [5].
Early monolithic integration concentrated on making more robust sensor interfaces to cancel
out transistor based non-idealities, such as temperature, by operation in a diﬀerential pair
conﬁguration [5]. However, in recent years it has been shown in the work of Shepherd et
al [15], that the ISFET can be utilised as a transistor with a chemical input to make a
new building block for bio-inspired circuits. By exploiting the underlying semiconductor
physics and using the weak-inversion region of operation it was shown that the device could
be operated in low power to linearise chemical phenomena due to Boltzmann distribution.
A new bio-chemical translinear principle was also a result of this work [16], which allows
representation of the chemical concentrations as variables in a translinear circuit to perform
mathematical manipulations using the translinear principle [17].
Following on from this work, ISFET-based sensors are developed in this thesis to be
used for low-power inputs to chemical bionic systems whereby the actual concentration of
the solution can serve as a physical parameter in the circuit design. The focus of the work
is to achieve operational devices in an unmodiﬁed CMOS process which are pH sensitive
and able to operate in weak inversion.
4.3 Weak Inversion Technology
In order to exploit the physical characteristics of any CMOS-based sensor, the operation
and functionality of the device needs to be well understood and characterised. Using FET-
based sensors such as the ISFET has the added advantage that the electrical characteristics
of the device are well described using standard MOSFET models.
The operation of the MOSFET is mainly grouped into three operating regions deﬁned
by the physics of the semiconductor: strong, moderate and weak inversion. For low power
analogue design the MOS transistor is most eﬃciently used in the weak inversion region
[18]. In this region the movement of charge carriers in the channel is governed by diﬀusion
rather than drift due to the extremely low gate voltage, VGS < Vth, which is just enough to
invert the channel. This results in the drain current relation given by (4.1)
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ID = ID0 exp
VG
nUt
(exp
−VS
Ut
− exp −VD
Ut
) (4.1)
where VG is the gate potential, VS the source potential, and VD the drain potential, all
referred to the bulk, ID0 is a characteristic current, n is the sub-threshold slope factor and
UT = kT/q is the thermal voltage [18].
Referring all voltages to the source and grouping constants as I0 we may simplify ex-
pression 4.1 to:
ID = I0 exp
VGS
nUt
(1− exp −VDS
Ut
) (4.2)
whereby the drain current is exponentially related to the gate voltage. The weak in-
version transconductance is given by (4.3). Dividing this by the drain current leads to the
expression of transconductance eﬃciency given by (4.4). Operating in weak inversion gives
the maximum transconductance eﬃciency, allowing best utilisation of the device for a given
current range.
gm =
ID
nUt
(4.3)
gm
ID
=
1
nUt
(4.4)
Fig. 4.1 depicts a typical ID − VGS transistor characteristic of a typical 0.25 μm CMOS
process, emphasising the weak inversion region of operation. On a logarithmic scale the
exponential relation appears linear with a slope of 1/nUt. The span of the weak inversion
region is even more apparent on the transconductance eﬃciency curve on the right, where
by gm/ID is expected to be constant and is shown by the maximally ﬂat part of the curve.
Operating within 90% of the maximum, shown by the mean line, gives a satisfactory region
for weak-inversion operation.
The peak transconductance eﬃciency is determined by the weak inversion slope factor,
n. This is a parameter deﬁned by the capacitive division of the gate voltage, VG to give the
surface potential of the device and is dependant on the ration of the depletion capacitance
CD and the oxide capacitance COX of the device:
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Figure 4.1: UMC 0.25μm MOSFET drain current (left) and transconductance eﬃciency
curves (right).
n = 1 +
CD
COX
(4.5)
The exponential relation of drain current to gate voltage in weak inversion has not only
allowed for design of low power circuits, but also made analogue computation possible,
by exploiting the mathematical properties of the exponential relation using the translinear
principle [17]. This very important computational primitive has served as a building block
for many current mode neuromorphic circuits, allowing mathematical operations to be per-
formed, using less power and fewer transistors than a digital equivalent implementation for
a given precision[19].
4.4 The Ion Sensitive Field Eﬀect Transistor
The ISFET was the ﬁrst FET-based electrochemical sensor developed, proposed by Bergveld
in the 1970s [20]. Its original use was to be for electrophysiological measurements due to the
extremely small dimensions possible. Since the discovery of its chemical sensing capabilities
though, it has been used in numerous biomedical applications where micron size samples
are required to be sensed, such as lab-on-chips. The ISFET operates on similar principles
to its MOSFET counterpart, with the standard gate oxide of the device replaced by an
insulating membrane, Fig. 4.2. The gate bias of the device is now applied using a reference
electrode, typically Ag/AgCl, which also provides a stable phase-boundary potential to the
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solution [2]. The insulating membrane acts to trap protons whose activity is related to
the ions in solution. These protons modulate the charge distribution in the channel of the
ISFET, changing the threshold voltage of the device. A change in ionic concentration can
thus be measured by observing the threshold voltage of the transistor.
B
p +
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p -S i
n + n +
INSULATING 
MEMBRANE
3I/
Figure 4.2: The ISFET.
Traditionally the ISFET is a pH sensing device. The original fabrication of the device
used silicon dioxide as the insulating membrane which is sensitive to hydrogen ions. This
though had been shown to be unstable due to hydration eﬀects causing cracks in the insu-
lating membrane and now insulators such as aluminium oxide, silicon nitride and tantalum
oxide are preferred for better pH sensitivity and stability [20].
Although the ISFET is sensitive to hydrogen ions, various membranes can be added
to the insulating membrane to make it selective to other chemicals of interest. The two
most popular derivations from ISFETs are the CHEMFETs (Chemical -FETs) and the
EnFETs (Enzyme -FETs). CHEMFETs are ISFETs which are made sensitive to other ions
by deposition of ion-selective membranes or ‘ionophores’ on top of the insulating membrane.
As a result the ion-selective membrane traps the ion to which it has speciﬁcity which in
turn modulates the threshold voltage of the device. EnFETs have an enzyme immobilised
on the gate which acts as a catalyst to a reaction which reacts with the analyte of interest to
either produce or consume hydrogen ions which may be sensed as a change in pH. Table. 4.2
summarises the various chemicals which can be sensed by the ISFET families along with
the sensitive membranes used.
The potential of the ISFET to sense numerous chemical compounds, which may be
found in our body, makes it ideal to make chemical bionic systems which replace biological
function. Other potential beneﬁts of using ISFETs to build such systems include:
• Minimal or no post processing - CMOS ISFETs are inherently sensitive to hydrogen
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Table 4.2: Chemical and biochemical analytes sensed by ISFET-based sensors
Analyte Membrane Type Ref
H+ SiO2, Si3N4, Al2O3, Ta2O5 bare insulator [20]
K+ Valinomycin ionophore [21]
Na+ ETH227 ionophore [21]
Ca+ Dioctylphenylphosphate ionophore [21]
Cl− TDMACl ionophore [22]
NH4− Nonactin ionophore [22]
Glucose Glucose Oxidase enzyme [23]
Creatinine Polyvinyl alcohol enzyme [24]
using the native passivation of the die [14]
• Low power processing - Can be operated in weak inversion in which current is governed
by diﬀusion to give low power operation [16]
• Boltzmann relation to ionic current - Obeys a Boltzmann distribution in weak inver-
sion which can be used to implement chemically-gated ion channels [5]
• Monolithic integration - Can be integrated with its MOSFET counterpart to make
diﬀerential readouts as well as to apply well-known circuit techniques which are used
in solid-state integrated circuits.
• Array processing - Can be grouped into arrays to provide redundancy and spatio-
temporal mapping
With these in mind we proceed by describing the operation of the ISFET and the
phenomena which occur when it is sensing to gain more insight of the physical characteristics
of the device.
4.4.1 ISFET operation
The operation of an ISFET can best be described by comparing it with its MOSFET
counterpart. A MOSFET uses an SiO2 insulator, covered by a polysilicon gate, which is
contacted by metal to allow application of a gate voltage to bias the device. In a traditional
ISFET, the polysilicon gate and metal is replaced by an ionic solution and a reference
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Figure 4.3: Measured ID-VGS characteristic for variable pH.
electrode, Fig. 4.2. This results in a dependance of the ISFET threshold voltage to pH
which can be observed as a shift in the ID − Vgs characteristics of the device, as shown in
Fig. 4.31.
This threshold voltage relation to pH can be derived by ﬁrst considering the threshold
of the voltage of a typical MOSFET, described by (4.6). It is made up of three potentials
resulting from, the diﬀerence in work function between the metal contact and the silicon
surface, φm − φsi, the accumulated charge in the oxide, Qox and the oxide-silicon inter-
face, QSS , as well as the depletion charge in silicon, QB, and the Fermi potential of the
semiconductor, φf .
Vth(MOSFET ) =
φm − φSi
q
− Qox + QSS + QB
COX
+ 2φf (4.6)
In the expression for the ISFET threshold voltage, the work function of the metal, φm,
is replaced by a term relating to the hydrogen ion concentration of the solution and the
reference electrode. This is shown in (4.7), where Eref is the potential due to the reference
electrode, xsol is the potential due to the existence of dipole molecules in the solution and
ψ0 is a chemical potential related to pH [25]. Eref is constant and xsol is dependant on
electrolyte composition as opposed to pH, so the only pH-dependant term which concerns
1Acquired using the procedure described in Appendix. D
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us is ψ0.
Vth(ISFET ) = Eref − ψ0 + xsol −
φm
q
+ Vth(MOSFET ) (4.7)
Vchem = Eref − ψ0 + xsol − φm
q
(4.8)
A convention which shall be adopted in this thesis is to group the chemical related terms
in a potential called Vchem, as in (4.8). In the following section the phenomena which lead
to the pH-sensing properties of the ISFET are described and analysed in order to give an
understanding as to why there is a reduction in pH sensitivity from the gold standard glass
pH electrode. The pH-dependance of ψ0 is then derived to give a more useful equation for
Vchem to be used for modelling of the device.
pH sensitivity
When talking about pH sensitivity it is common practice to always compare with the Nern-
stian sensitivity derived from a gold standard pH electrode, (Appendix C). The Nernst
equation (4.9) deﬁnes the potential generated due to ion activity on either side of a semi-
permeable membrane, where ai,sample is the activity of the sample solution, ai,int is the
activity of the reference solution, R is the universal gas constant, T is the temperature in
Kelvin, F is the Faraday constant and n is the charge of ion i.
Emem =
RT
nF
ln
ai,sample
ai,int
(4.9)
For a standard pH electrode where the activity of the reference solution is constant the
following relationship exists which is deﬁned as the nernstian sensitivity for pH sensors:
dEmem
dpH
=
2.303RT
nF
= 2.303Ut = 59mV (4.10)
Electrode potentiometric systems are easily deﬁned in terms of Nernst potentials as they
consist of metal references in contact with ionic solutions giving stable potentials. For a
unit change in pH we expect to get a 59mV change in signal using a glass pH electrode.
However, in the case of an ISFET the mechanisms which occur on the surface to give
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solution.
a potential related to pH are more complex. We have an electrolyte in contact with an
insulator on semiconductor (EIS) 1 [26] which exhibits a pH dependence as a result of two
phenomena: the site binding of ions at the insulator surface [27], and the Gouy-Chapman-
Helmholtz capacitive double layer formed [28]. These shall now be described.
Site-binding of Insulator
When the ISFET surface is immersed in solution, the insulating membrane of the device
interacts with the ions present in the solution according to the site binding model [27].
The principle behind this model is that the insulator contains discrete surface sites which
are neutral, positive or negative allowing binding of ions from the solution. Fig. 4.4 shows
an example of what the surface of an SiO2 membrane would consist of. Amphoteric sites
such as SiOH are present which would either be neutral, accept or donate a hydrogen ion
to the solution. In this case the binding sites which would exist are SiOH, SiOH+2 and
SiO− respectively. An overall surface charge is thus exhibited from the insulator which is
dependent on the number of charged sites available.
These binding sites react with the hydrogen ions present at the surface of the insulator
according to the following set of reactions:
SiOH  SiO− + H+S , with Ka =
[SiO−][H+]s
[SiOH]
(4.11)
1Usually referred to as an Electrolyte-Insulator-Semiconductor boundary or EIS
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SiOH + H+S  SiOH
+
2 , with Kb =
[SiOH+2 ]
[SiOH][H+]s
(4.12)
where Ka and Kb are the equilibrium constants of the binding reaction, deﬁning the
concentration species on both sides of the reaction when it is in equilibrium, and [H+]s is
the concentration of hydrogen ions present at the surface of the insulator. The overall charge
on the surface of the insulator is thus dependent on the surface hydrogen concentration,
which determines the number of charged surface sites available.
The expression for surface charge per unit area, σ0, of the SiO2 can therefore be deﬁned
as the the sum of positive and negative sites available multiplied by the elementary charge,
q:
σ0 = q([SiOH+2 ]− [SiO−]) (4.13)
Including the surface hydrogen dependency, [H+]s, through the equilibrium constants
of (4.11) and (4.12), we can deﬁne the surface charge of an ISFET with an SiO2 membrane
to be [25]:
σ0 = qNs(
[H+]2s −KaKb
KaKb + Kb[H+]s + [H+]2s
) (4.14)
where Ns is the total number of surface sites available.
The amount of hydrogen ions bound to the surface, [H+]s, is related to the bulk concen-
tration of the solution, [H+], by the Boltzmann relation (4.15). The potential ψ0 is the pH
related potential which is now also required to derive the surface hydrogen concentration
[H+]s.
[H+]s = [H+]e−qψ0/kT (4.15)
Substituting (4.15) into (4.14), the surface charge becomes:
σ0 = qNs(
e−(4.6pH+2qψ0/kT ) −KaKb
KaKb + Kbe−(2.3.pH+qψ0/kT ) + e−(4.6pH+2qψ0/kT )
) (4.16)
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which is dependent both on pH and on the electrolyte insulator potential ψ0. This charge
is also coupled to the diﬀuse charge which exists in the solution through the capacitive
double layer.
Capacitive double layer
A double layer capacitor is formed on the surface of the ISFET due to the presence of ions
creating a Helmholz plane and a Gouy-Chapman layer, shown in detail in Fig. 4.5.
The Helmholz plane is subdivided into the inner Helmholz plane (IHP) and the outer
Helmholz plane (OHP). The IHP is deﬁned as the line of charge attracted to the surface
sites of the insulator. The OHP is deﬁned as the line through the centres of hydrated ions
which are at their distance of closest approach to the solid, Fig. 4.5b. This is limited by
the water molecules bound to them not allowing them to get very close. The combination
of these two planes results in an almost linear voltage drop of potential in solution and is
modelled using the Helmholtz capacitor CHelm:
CHelm =
Aε0εr
dOHP
(4.17)
where A is the surface area of the insulator, ε0 is the permittivity of free space, εr is
the relative permittivity of the electrolyte and dOHP is the distance of the OHP from the
insulator surface [29].
The Gouy-Chapman layer consists of a diﬀuse charge extending from the OHP into the
electrolyte bulk. This charge follows a Boltzmann distribution before an even distribution
of charge is reached in the bulk of the solution, Fig. 4.5c. The charge in this region, σdl,
can be described by the Gouy-Champman theory using:
σdl = −
√
8kTεrε0n0sinh(
qψ1
2kT
) (4.18)
where ψ1 is the potential across the diﬀuse layer and n0 is the bulk number concentration
of ions in the electrolyte [28]. The Gouy-Chapman capacitance, CGouy, can thus be deﬁned
as:
Cgouy =
dσdl
dψ1
=
√
2εrε0q2n0
kT
cosh
qψ1
2kT
(4.19)
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The potential ψ1, which sets the level of the diﬀuse charge σdl, (4.18), is coupled to the
surface charge σ0 through the formation of capacitor Chelm, (4.20). Decoupling the chemical
related charges from the electrical one and assuming a charge neutrality of σ0=−σdl as in
[30] we can now deﬁne the pH-related potential, ψ0 as:
ψ0 = ψ1 +
σ0
Chelm
=
2kT
q
sinh−1(
−σ0√
8kTr0n0
) +
σ0
Chelm
(4.20)
In order to have a pH related potential of the form ψ0=f(pH) equations (4.20) and
(4.16) need to be resolved. A unique solution is provided in [25] which deﬁnes the surface
potential as:
ψ0 = 2.3
kT
q
.α(pHpzc − pH) (4.21)
α =
(
2.3kTCdif
q2βint
+ 1
)−1
(4.22)
where pHpzc is the value of pH at which the oxide surface is electrically neutral, derived
in [25], and α states the deviation from the Nernstian response and is in the range of 0 to
1. Determination of α is given by (4.22), where Cdif 1 is the total capacitance in the double
layer and βint is the intrinsic buﬀer capacity of the oxide surface 2. Both are dependent on
the pH of the solution.
Substituting (4.21) back into (4.8) results in a more simplistic equation for Vchem, orig-
inally deﬁned in [16]:
vchem = γ +
2.3αkT
q
pH (4.23)
where γ is a grouping of all the non pH related terms. This is the notation which shall
be used in the remainder of this thesis to be able to model the behaviour of ISFETs in weak
inversion.
1 1
Cdif
= 1
Cgouy
+ 1
Chelm
2The intrinsic buﬀer capacity is deﬁned as βint=
d([SiO−]+[SiOH+2 ])
dpHs
, which is the change in number of
surface sites available for a given change in pH
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4.4.2 Modelling of ISFETs
Modelling the ion sensing characteristics of the ISFET is fundamental for thorough under-
standing of the sensor capabilities as well as exploitation of the device physics for monolithic
integration with MOSFET devices. A behavioural macromodel of the ISFET is shown in
Fig. 4.6, originally shown by Martinoia et al [31], which adapts the chemical related com-
ponents on a standard MOS model. This is useful because it will later allow us to create
ISFET macromodels for diﬀerent MOSFET technologies.
Using a ﬁrst order MOS model operating in weak inversion, we can now combine the
term relating to the solution, Vchem, to that of a MOSFET, giving a drain current relation:
ID = I0 exp
VG′S
nUt
(1− exp −VDS
Ut
) (4.24)
where
VG′ = VG − Vchem. (4.25)
assuming VDS > 4Ut and solving (4.24) for pH we get:
ID = I0 exp
VGS − γ − αSNpH
nUt
(4.26)
where SN=2.3·Ut=59mV is the Nernstian potential. This expression is important as
it deﬁnes the pH characteristics of the device in weak inversion, which fundamentally de-
scribes the operation of the device using extremely low drain currents and hence low power.
Shepherd et al [32] were the ﬁrst to describe the weak inversion ISFET, whose exponential
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Figure 4.7: Commercial Al2O3 ISFET Gate voltage vs drain current (left) and transcon-
ductance eﬃciency (right) for pH buﬀer solutions of 4, 7 and 10.
relation to pH allowed exploitation of the Nernstian relation to hydrogen ions, linearising
the response.
The validity of (4.26) was conﬁrmed by conducting experiments using a commercially
available Al2O3 gate ISFETs by Sentron b.v. The ISFET was biased using a Ag/AgCl
reference electrode with a drain source voltage of 500 mV. ID-VGS characterisation sweeps
were conducted using a semiconductor parameter analyser (Keithley 4200S), at room tem-
perature, using pH buﬀer solutions of pH 4, 7 and 10. The results are shown in Fig. 4.7.
A linearity on the exponential drain current curve spanning approximately 200 mV, can
be seen, conﬁrming the existence of a weak-inversion region, which remains the same for
all pH. A shift in characteristic is also observed with a sensitivity of 47 mV/pH, which
is expected for custom-made Al2O3 ISFETs [20]. These shifts are also reﬂected on the
transconductance eﬃciency curves. These results agree with the formulation of expression
4.26 which predicts a similar curve shift for α=0.796 and n=1.755.
These experiments have conﬁrmed the functionality of the ISFET as a pH sensing device
able to operate in weak inversion as was shown originally in [16]. The aim was to gain insight
into the functionality of the device as well as to validate the equations derived based on
the theory. Having established the behaviour of the ISFET in weak inversion, this chapter
goes on to present work done in achieving similar performance using ISFETs designed in
unmodiﬁed CMOS.
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4.5 ISFETs in unmodiﬁed CMOS
Implementing ISFETs in an unmodiﬁed CMOS process has been avidly pursued in the last
decade in an attempt to combine the advantages of miniaturised solid-state sensors with
those of a CMOS process, as well as allow for monolithic integration of chemical sensors with
CMOS circuits to make smart chemical systems on chip [8, 14, 33, 34]. Having conﬁrmed
the ISFET can be operated in weak inversion, implementation in unmodiﬁed CMOS is the
next step to achieving a true monolithic implementation of a chemical bionic system.
In this section we explore fabrication of ISFETs in unmodiﬁed CMOS and discuss the
issues which exist. Furthermore we quantify the important parameters which allow us
to derive the CMOS ISFET from its MOSFET model and validate this experimentally.
This proceeds with experiments conducted on ISFETs designed in three diﬀerent CMOS
technologies, with identiﬁcation of their weak inversion regions and a technology wide com-
parison of the results.
4.5.1 Fabrication in CMOS
Custom fabrication of the ISFET device involves addition of an insulating layer sensitive
to ions directly in the area where the polysilicon gate of a MOSFET would normally lie
[20]. In the fabrication of the MOSFET in a standard CMOS process, the presence of the
polysilicon is required as part of the process to deﬁne the n+ implantation regions (used as
the source and drain of an NMOS device) of the p-substrate, in which the device is made.
Therefore in the absence of the polysilicon layer, the custom fabrication of the ISFET
involves creating separate n+ implantation for source and drain regions using lithographic
methods so as deposition of a pH sensitive insulator directly on the substrate is possible.
Deposition of the insulating layer is achieved using low pressure chemical vapour deposition
(LPCVD) at high temperature.
Original attempts at making ISFETs in CMOS included custom steps to etch away the
passivation and polysilicon gate, to add the insulating membrane directly on a freshly grown
silicon dioxide layer on the substrate [35, 36]. The metallisation layers also needed to be
made silicon rich with tungsten silicide as aluminium could not withstand the temperatures
required for the LPCVD deposition of the nitride. Even though the process worked to
produce reliable devices with pH sensitivities of about 58mV/pH, the extra post process-
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Figure 4.8: (a) Original ISFET design and (b) extended gate approach for CMOS.
ing required added levels complication, which hindered the advantages of having a fully
unmodiﬁed process.
Implementation in unmodiﬁed CMOS was shown to be possible however, by Cane et
al.[8] and later championed by Bausells et al. [14], by using the ‘extended gate’ approach
shown in Fig. 4.8. It utilises the top passivation material inherent in the standard CMOS
processes, which tends to be silicon nitride or silicon oxynitride (added by plasma enhanced
chemical vapour deposition (PECVD)) and can therefore serve as the insulating layer of
the ISFET. The idea is to extend the polysilicon gate to the nitride passivation using the
metal layers in the process connected through using vias as is seen in Fig. 4.8b. In this
formation the ISFET can be considered as an ion selective electrode with a FET detection,
in which charge binding on the passivation is coupled to the polysilicon through the metal
layers and appears. What changes now from the original ISFET design is the addition of
the passivation capacitance between the solution and the top metal which scales the voltage
established on the insulating membrane from G’ to G”. Keeping the polysilicon gate has
also been shown not to aﬀect the device operation and by adding the metal layers above it
has the advantage of shielding the device from light to which it is normally sensitive [14].
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Table 4.3: ISFETs made in unmodiﬁed CMOS
Year Ref Type Passivation Threshold voltage Sensitivity Technology
thickness range mV/pH
1996 [8] n-type 1.5μm 3.5 V 41 Atmel ES2
1.0μm 1P2M
1999 [14] n-type 1.5μm -7 to 6.5 V 47 Atmel ES2
1.0μm 1P2M
2000 [33] n-type 0.75μm 8.5 V 25 AMS
0.6μm 2P3M
2002 [34] p-type 0.4μm/0.6μm 1 8 to 33 V 42 AMS
0.6μm 2M
2004 [37] n-type 1.0μm direct gate bias 0.22 2 AMI
1.6μm
2004 [38] p-type 0.4μm/0.6μm -5 V 43 AMS
0.6μm 3M
2005 [39] n-type - - 40-45 3 AMI
1.5μm
2008 [40] p-type 1μm/0.9μm -4 to -1 V 46 AMS
0.35μm 3M
1 Si3N4/SiOxNy.
2 Al2O3 gate used by oxidation of bond pad.
3 Data was vague.
Table. 4.3 summarises the work done thus far to fabricate ISFETs using the extended
gate method in unmodiﬁed CMOS. One of the main issues encountered by using the na-
tive passivation of an unmodiﬁed process is extremely high threshold voltages. A higher
threshold voltage is expected from the standard ISFET due to the extra thick passivation
layer forming a solution - passivation - top metal capacitance. In CMOS this can range
from 0.7μm to 2μm whereas the nominal value for ISFET passivation thickness is normally
about 750 A˚ [36]. This though is not enough to account for the extremely high threshold
voltages seen.
Trapped charge, left by fabrication, has been proposed as the main reason for a large
deviation in the threshold voltage. In the ISFET this can exist either in the passivation
layer or on the ﬂoating gate [40]. As the polysilicon gate is only connected to metal which is
ﬂoating, any charge in the polysilicon has no path to ground and remains trapped, similar
to memory storing mechanisms of EEPROM [41]. The Si3N4/SiO2 passivation forms a
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Figure 4.9: Removal of trapped charge using UV radiation
stack in which charge can also remain trapped for long periods, similar to the mechanisms
used in metal-nitride-oxide-silicon (MNOS) transistors to make non-volatile memory [42].
Attempts to remove the trapped charge using UV radiation have given satisfactory results
[38]. UV radiation gives the charge enough energy to either tunnel out of the polysilicon
into the ﬂoating metal, where it may discharge through the metal insulator ohmic contact,
or tunnel out of the passivation reducing the threshold voltage. This is illustrated in Fig. 4.9
Other expected issues in CMOS ISFETs are reduction in sensitivity from near Nernsitian
(59mV/pH) and increased drift. This is due to the quality of the silicon nitride used as
the insulator in CMOS. Silicon nitride as an ISFET-sensing layer is usually obtained by
LPCVD, whereas PECVD is used to create the CMOS passivation layer 1. PECVD tends
to have a lower oxy-nitride content and therefore fewer available binding sites for hydrogen
ions resulting in a reduced sensitivity [44]. The drift is thought to be caused by the slow
conversion of the Si surface to a hydrated SiO or oxynitride layer during contact with
the solution [38]. The growth of this surface layer aﬀects the overall capacitance of the
passivation and thus changes changes the threshold voltage.
1LPCVD has a higher deposition rate and excellent purity and uniformity but is unsuitable for deposition
on metals due to the high temperatures required, which is why PECVD is preferred [43]
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4.6 Design of ISFETs in CMOS
This section will report ISFETs designed and fabricated in a standard 0.25μm CMOS
process, based on the extended gate approach described. The additional capacitance of the
passivation layer is presented as a cause of deviation in characteristics from the standard
MOSFET from which it is made. Characterisation experiments were conducted on the
device, to show this eﬀect as well as to identify any other non-ideal parameters which may
inﬂuence the device. Weak inversion operation is also conﬁrmed. Finally these parameters
are quantiﬁed and a new ISFET macromodel is derived for unmodiﬁed CMOS.
Fig. 4.10 shows the cross section of a standard 0.25 μm 1P5M CMOS technology. The
top passivation consists of 0.6μm silicon nitride / 0.7μm silicon dioxide double layer which
acts as the sensing surface. Each layer in the stack is planarised with intermetal dielectric,
(IMD), which is silicon dioxide. The top metal layer, metal 5 is not planarised and is covered
with passivation resulting in a non planar surface. Each metal layer is connected using vias.
The ISFET used for this work is designed using a standard triple well NMOS device to
eliminate the body eﬀect. The ﬂoor plan of the device in addition to the microphotograph
are shown in Fig. 4.11. Gate dimensions of (W/L)elec=200/0.34 are chosen to ensure a
large transconductance as well as a large weak inversion exponential operating range and
reduced low frequency ﬂicker noise [45]. Two ﬁngers are chosen in the layout to make the
device compact. The gate is electrically connected using vias to a metal stack of active area
(W/L)chem=103.1/32.1 which reaches the top passivation layer.
(W/L)chem is important as it deﬁnes the active area of the device which is seen by
the solution charge. It can be modelled as a capacitor by assuming the two passivation
dielectrics (SiO2, Si3N4) form a series capacitive network. The passivation capacitance
for a speciﬁc technology can be calculated using (4.27) where ε0, εSi3N4 and εSiO2 are the
permittivities of free space, silicon nitride and silicon dioxide respectively, and tSi3N4 , tSiO2
are the respective passivation thicknesses. This assumes that the parasitic capacitance
introduced by the metal stack to the substrate and fringing eﬀects are negligible, and is
only an approximation as a detailed analysis of multiple substrates of this type is beyond
the scope of this thesis.
Cpass = (W.L)chemε0
εSi3N4εSiO2
εSi3N4 .tSiO2 + εSiO2 .tSi3N4
(4.27)
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Figure 4.10: Technology stack for a typical 0.25μm CMOS process showing 1 poly and 5
metal layers
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Figure 4.11: Microphotograph of the fabricated ISFET with illustrations of surface view
and cross section.
The eﬀect that passivation capacitance has on the overall ISFET structure is a division
of the surface potential. Considering the capacitances now available in the CMOS ISFET,
shown in Fig. 4.12, the eﬀective gate voltage now seen by the fabricated MOSFET can be
calculated as follows:
V ′′G = V
′
G.A = V
′
G
Cpass
Cpass + CoxCdCox+Cd
(4.28)
where Cpass, Cox and Cd are the passiviation, oxide and depletion capacitances respec-
tively and A is the eﬀective division of the surface potential due to these capacitances.
What we can see from (4.28) is that the ISFET characteristic will tend to converge to that
of its underlying MOSFET for increasing Cpass. This is important when designing and
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Figure 4.12: Capacitances of a CMOS ISFET
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Figure 4.13: ID-VGS characteristics for varying divisions of the gate voltage. A diﬀerence
of slope can be associated with the extra passivation capacitance
fabricating ISFETs as it determines their intrinsic characteristics.
Fig. 4.13 shows how the ID − VGS characteristic of a MOSFET in the same process
is expected to change for a division of its surface potential.. This division reﬂects the
eﬀects of voltage division due to a decreasing passivation capacitance shown in expression
4.28. The eﬀective slope of the weak inversion region will increase for decreasing passivation
capacitance, expanding the linear voltage operating range. Higher voltages are thus required
to achieve the same amount of current, as in the unmodiﬁed MOSFET.
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4.6.1 Testing of CMOS ISFETs
The device shown in Fig. 4.11 was fabricated in UMC 0.25μm CMOS 1. Experiments were
conducted to conﬁrm the weak inversion operation, verify the eﬀects of passivation capaci-
tance and show the non-ideal behaviours which exist in unmodiﬁed CMOS ISFETs as well
conﬁrm its pH sensitivity.
Three dies, each with one test device, were encapsulated for testing by spin coating
SU8-2100 while the active ISFET area was deﬁned by photolithography. The procedure
is described in Appendix E. An Ag/AgCl reference electrode was used to apply a sta-
ble potential to the solution. All measurements where carried out using a Keithley 4200
semiconductor characterisation system.
The testing procedure involved two stages:
• Device characterisation using a standard pH 7 buﬀer. This test is to determine the op-
erating range, linearity of the weak inversion region, transconductance and passivation
capacitance.
• Sensing characteristics using variations in pH. This is to determine the device sensi-
tivity compared to the ideal Nernstian sensitivity.
In each test, the ISFET was biased with a drain source voltage of 500 mV 1 with the
bulk and source connected to eliminate body eﬀects. Fig. 4.14 shows the results of ID-VGS
sweeps performed using a droplet of pH 7 buﬀer solution of on the gate. Independent tests
where carried out on diﬀerent days. The results are summarised in Table. 4.4.
The results show a the large variation in threshold voltage between the dies tested. This
variation of up to 10V can be seen in Table. 4.4 for an ID=100nA.
One possible explanation for this is that it is due to the trapped charge as other authors
have reported [38], but its location is not in the polysilicon as was claimed. Any trapped
charge in the polysilicon is assumed to have been removed during fabrication by placement
of vias on the polysilicon to metal, which leads to its discharge through the ohmic contact
of the silicon dioxide inter-metal dielectric. Therefore, the charge seen here is trapped
1Initially designed in a collaborative project with Dr. Kostis Michaelakis, Dr Tim Constandinou, and Dr
Leila Shepherd
1VDS > 4Ut for Weak Inversion saturation
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Figure 4.14: ID-VGS sweeps of device for three separate packages on separate days.
Table 4.4: CMOS ISFET initial ID-VGS sweeps
DIE Day Vgs (100nA) ID(min)
1 1 -1.4 V 956 pA
2 1 <-10 V -
3 1 -575 mV 1.17 nA
1 30 -55 mV 7 pA
2 3 -9.1 V 367 pA
3 2 -30 mV 1.4 nA
between the silicon nitride/silicon dioxide passivation stack. This shall be conﬁrmed later
in the chapter. A change in threshold voltage is also seen during reuse of the device which
is the result of some charge being removed every time an experiment is conducted. This
causes the threshold voltage to slowly shift back up to a normal operating range (towards
0V).
Another issue is a variation of the oﬀ-current of the device from die to die. This is
believed to be mainly due to the encapsulation integrity of the device, as any electrons
allowed to ﬂow out through the substrate to the solution will cause an increase in leakage
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Figure 4.15: Measured ISFET ID-VGS sweep compared to the plain MOS device. A diﬀer-
ence of slope is due to the extra passivation capacitance
current of the device. This is veriﬁed by experiments in [5] whereby independent tests on
other devices on the same die have shown similar leakage currents for a given encapsula-
tion . ‘Oﬀ’-currents 1 under 1nA are satisfactory as they still allow large operation range
in weak inversion. Die 1’s oﬀ-current was reduced dramatically after several experiments,
approaching expected leakage currents. This is possible due to the SU-8 encapsulant begin-
ning to fail, dissolving and ﬂowing closer to the device contributing to a tighter coverage of
vulnerable area.
4.6.2 Derivation of a Macromodel for ISFETs in unmodiﬁed CMOS
This section compares the CMOS ISFET fabricated with the MOSFET model from which
it was derived to conﬁrm the eﬀects of extra capacitance on the gate and trapped charge.
Empirical methods to determine these are presented along with a new formulation for the
weak inversion slope factor based on the capacitances present in the device. Furthermore
the device is tested for pH sensitivity and ﬁnally a macromodel is presented which includes
all the phenomena observed.
Fig. 4.15 shows a comparison of the ID-VGS sweeps of the fabricated ISFET from Die 1
1Deﬁned as the minimum current in the ISFET which under perfect encapsulation should approach the
leakage current of the device
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Figure 4.16: Comparison of ISFET and MOSFET transconductances
and the simulated model of a MOSFET in with (W/L)elec=200/0.34 in the same technology.
The diﬀerence in transconductance is also shown in Fig. 4.16
The deviations shown from the standard MOSFET model conﬁrm the hypothesis of
Sections 4.6 and 4.6.1 which may be summarised as:
1. Trapped charge in the passivation. This has the eﬀect of biasing the ISFET (even
at Vgs=0), such as a ﬂoating gate device, which results in an eﬀective shift of the threshold
voltage of the device.
2. Capacitive division of the gate voltage by the passivation capacitance. This has the
eﬀect of slewing the ID-VGS characteristic as any voltage applied to the gate is divided
down through the passivation.
Attempts to quantify these two phenomena are now presented, so that an empirical
model of an unmodiﬁed CMOS ISFET can be derived.
Determination of Trapped charge
A good reference point to determine the presence of trapped charge in the ISFET is the
drain current given, of the MOSFET from which it is made, when the gate bias is at zero.
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Figure 4.17: Comparison of the eﬀective weak inversion slope factor.
The MOS device designed gives a drain current of 80 pA when VGS=0 1. We can therefore
assume that when the drain current of the ISFET is at 80 pA, the amount of voltage on
the reference electrode is to counteract the trapped charge, as well as to bias the solution.
The ISFET of Die 1 gives 80 pA of current at -770 mV. Consequently a 770 mV shift to
the left in the ID-VGS characteristic is observed in Fig. 4.15 conﬁrming this. Assuming that
Vchem≈ -550mV, (derived in Appendix C), that gives a V ′g=1.32 V needed to counteract
this charge.
Determination of Passivation Capacitance
The top passivation Silicon Nitride, used as a sensing surface for the ISFET, contributes to
the overall skewing of the ID-VGS characteristic as shown in Fig. 4.15. This is due to the
additional passivation capacitor connected to the gate oxide of the device.
In weak inversion the transconductance eﬃciency of a MOSFET device, given by (4.29),
is constant over the region in which the characteristic is exponential as was shown in Section
4.3. This is a clear indication of the boundaries of weak inversion and remains constant
1Modern day CMOS devices have extra doping of the channels which allow diﬀusion currents to ﬂow even
at 0V [46].
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because the weak inversion slope factor, n, is constant in that region of operation.
gm
ID
=
1
nUt
(4.29)
An intuitive way to verify the additional capacitance, by observation of the ID-VGS
curves, is to compare the weak inversion slope factor, n, of the two devices. The slope
factor is deﬁned as the inverse of the change in surface of potential, ψs, of the MOSFET
with respect to the gate bulk voltage, VGB, shown in (4.30). This is can be calculated
by considering the capacitive stack represented by the oxide capacitance, Cox and the bias
dependent depletion capacitance, Cd. Changes in VGB get divided down in the capacitive
stack to give changes in ψs. As a result n can be calculated using the values of these
capacitors using expression 4.30 [45].
n =
(
dψs
dVGB
)−1
= 1 +
Cd
Cox
(4.30)
What changes in the ISFET model is the presence of three more capacitors interfaced to
the oxide capacitance shown in Fig. 4.17. The eﬀective combination of the oxide capacitance,
Cox, passivation capacitance, Cpass, Gouy and Helmholz capacitor, Cgouy and Chelm now
contribute to the division of VGB to give ψs. We can now formulate an eﬀective weak
inversion slope factor of the ISFET, n′, (4.31), whereby the depletion capacitance is now
divided by the series combination of all the capacitors above it, (4.32).
n′ = 1 +
Cd
Ceff
(4.31)
1
Ceff
=
1
Cox
+
1
Cpass
+
1
Chelm
+
1
Cgouy
(4.32)
What is important to note is the that the passivation and oxide capacitances are several
orders of magnitude smaller that the Helmholz and Gouy Chapman capacitances 2 [28]
making them eﬀectively dominant in the calculation of Ceff . With this in mind, only
considering the passivation capacitance, Cpass, gives us a fair indication of what the devices
characteristics will be.
2Typical values of Cgouy and Chelm are 0.14pF/μm
2 [29] giving a maximum double layer capacitance of
0.14×(32.1× 103.1)= 463 pF for our ISFET
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Figure 4.18: ID-VGS sweeps of device for three separate packages on separate days. gm/ID-
ID curves of devices compared to the MOSFET
Table 4.5: MOSFET weak inversion parameters for (W/L)elec=200/0.34 triple well nmos
device and CMOS ISFET equivalent weak inversion parameters.
MOSFET CMOS ISFET
gm
ID
n Cox gmID n’ Ceff
28.58 S/A 1.35 0.427 pF 1 9.6 S/A 4.02 49.6 fF 2
1 Using Cox = 627.8 × 10−5pF/μm2 and (W
×L)elec=200x0.34 μm2.
2 Using equation 4.31.
Fig. 4.18 shows the transconductance eﬃciency curves for the native MOSFET and all
the measured UMC 0.25 CMOS μm ISFET devices, with the peak values of gm/ID shown.
What is clear is the reduction in transconductance eﬃciency by the introduction of Ceff ,
but also the matching of all ISFETs, in terms of peak gm/ID, indicating the introduced
capacitances are standard for all ISFETs in this technology. Using a value of Ut=25.9 mV
(thermal voltage), the weak inversion slope factors of the MOSFET, n, and the ISFET, n′,
can be deduced using (4.29) as well as the relevant capacitances. These are all summarised
in Table 4.5.
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Figure 4.19: pH sensitivity of UMC 0.25μm CMOS ISFET.
4.6.3 pH sensitivity
All pH sensitivity tests were carried out using the ISFET in a ﬁxed current, ﬁxed gate
voltage, source-drain follower conﬁguration described in Appendix D. A change in pH
is indicated by a change in VGS for diﬀerent concentrations. Fig. 4.19 shows the derived
calibration curve of using the ISFET of Die 1 in pH buﬀer solutions of 4, 7 and 10. The
result shows a linear response with a sensitivity of 36.6 mV/pH. The reduced sensitivity is
as expected for PECVD deposited silicon nitride.
4.6.4 A Uniﬁed Model
By addition of the passivation capacitance and the oﬀset voltage due to the trapped charge
a more accurate model for the CMOS ISFET can be created to be used for circuit design.
Fig. 4.21 shows the proposed schematic which is an adaptation of the Shepherd [16] model.
The eﬀective gate voltage, V ′G, seen by the device is a combination of the voltage applied
to the reference electrode, VG, the input referred trapped charge 1, Vtc, and the chemically
dependant potential, Vchem, (4.33).
V ′G = VG − Vtc − Vchem (4.33)
1Vtc models the measured trapped charge in the passivation, referred to the input and is seen as a constant
DC oﬀset.
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Figure 4.20: Modiﬁed ISFET model.
Considering that the voltage seen by the MOSFET beneath the passivation is scaled
down by the passivation capacitance, we introduce a scaling term, A in the range of 0 to 1,
which results in:
V ′′G = A.V
′
G (4.34)
whereby A3 can be calculated based on the capacitances present in the device or deter-
mined empirically for diﬀerent technologies using the eﬀective weak inversion slope factor,
n′:
A =
Cpass
Cpass + CoxCdCox+Cd
≈ n
n′
(4.35)
Including all these terms we can formulate a weak inversion drain current expression
4.36 (assuming VBS=0), which describes a CMOS based ISFET.
ID = I0 exp
A.v′G − vs
nUt
(4.36)
Substituting expression 4.33 and grouping all the non-pH dependant terms in K, the
ID-pH relation for the weak inversion CMOS ISFET is:
ID = I0.K. exp
−A.a.SN .pH
nUt
(4.37)
3Expression valid for large values of Cgouy and Chelm, which are typically 0.14pF/μm
2 [29] giving a
maximum double layer capacitance of 0.14×(32.1× 103.1)= 463 pF for our ISFET
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Figure 4.21: Comparison between simulated (based on model) and measured data.
Table 4.6: UMC 0.25μm CMOS ISFET parameters
CMOS ISFET Parameters
(W×L)elec 200μm × 0.34 μm
(W×L)chem 103.1μm × 32.1 μm
Cpass 56.11 fF
Cox 427 fF
Cd 150 fF
gm/ID 9.6 S/A
n 1.35
n’ 4.02
A 0.336
Sensitivity 36.6 mV/pH
α 0.620
γ -550 mV
vtc 1.32 V
What we see in (4.37) is that the pH to drain current sensitivity is eﬀectively reduced
by A. However, this results in an eﬀective extension of the weak inversion linear range by
1/A, which allows biochemical translinear processing [16] to occur over a wider pH range.
Fig. 4.21 shows a comparison of simulated ISFET with the actual measured results of
the ISFET of Die 1 summarised in Table 4.6. The results show the model is well matched
for weak inversion operation and transconductance eﬃciency, with a slightly higher oﬀ
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current due to actual device having slight leakage through the encapsulation and the higher
saturation current is due to the fact the eﬀective oxide capacitance is not constant in strong
inversion and therefore n is no longer constant. For weak inversion however, the model
allows simulation and design for monolithic integration with other circuits.
In this section an ISFET in umodiﬁed CMOS was designed and tested. The eﬀects of
trapped charge and passivation capacitance were discussed and measured and a new ISFET
speciﬁc weak inversion slope factor, n′ was derived along with a macromodel which deﬁnes
the drain current behaviour of the ISFET. Furthermore, this macromodel is adaptable on
a standard MOSFET model which will aid development of spice based models. This will
ultimately lead to a simulation environment in which monolithic CMOS ISFET/MOSFET
based circuits can be designed and fabricated.
4.7 Study of Technology variation of ISFET devices
This section presents the ﬁrst technology wide comparison of ISFETs in unmodiﬁed CMOS.
ISFETs of similar size and geometry to the UMC 0.25μm ISFET were designed and fabri-
cated in two more technologies, UMC 0.18μm and AMS 0.35μm. The scope was to conﬁrm
functionality of the device in these technologies as well as evaluate their performance in
terms of pH sensitivity, threshold voltage variation and dynamic range of the linear weak
inversion region. Determination of n′ was also conducted, with an observation of the eﬀects
of the diﬀerent passivation thicknesses in each technology.
Table 4.7 highlights key diﬀerences in the three technologies. The most notable one
which will cause a deviation in the ISFETs characteristic is the passivation type and thick-
ness. Although both foundries (UMC & AMS) use PECVD to deposit their silicon nitride,
it is expected that the conditions which the deposition is made may vary slightly. Vari-
ation in characteristics is also expected due to the AMS technology having a very thick
passivation (2μm) relative to the UMC ones.
We proceed by describing the fabrication and testing of the ISFET in the two technolo-
gies. Results are presented at the end of each section. This follows with a comparison of
the key ﬁndings of the experiments for the three diﬀerent ISFETS.
All dies in these experiments have been packaged on dipstick PCBs to which they are
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Table 4.7: CMOS technology comparison
0.18μm 0.25μm 0.35μm
Poly/Metal 1P6M 1P5M 2P4M
Passivation PSG/PE-Si3N4 1 HDP2/PE-Si3N4 TPROT1/TPROT2 3
Thickness (nm) 500/700 600/700 1000/1030
Permittivity, ε 3.9/7.5 4.1/7.5 3.9/7.9
Gate Oxide Thickness 4 70 A˚ 70 A˚ 76 A˚
Top metal thickness 8.6 kA˚ 8.8 kA˚ 9.25 kA˚
1 Phosphosilicate Glass/Plasma enhanced Si3N4
2 High Density Plasma SiO2
3 SiO2/Si3N4
4 3.3V devices used
wire-bonded and encapsulated using an epoxy 1 rather than the SU-8 which was used in
for the UMC 0.25μm dies. This is due to the deterioration of the encapsulation which was
observed after constant use in the UMC 0.25μm devices. Furthermore, epoxy is known
for its robustness as a sealant, which is required for proper isolation of bond pads and die
substrate from the solution. The procedure is detailed in Appendix E.
UMC 0.18μm device experiments
Five identical ISFETs were designed and fabricated on a single die to be used as a multi-
sensing platform in conjunction with ﬁve microﬂuidic chambers. The chip microphotograph
is shown in Fig. 4.22 with the ISFETs numbered 1-5 for reference. The ISFETs were triple
well 3.3V NMOS devices as in the UMC 0.25μm chip using same dimensions for comparison.
Two dies were encapsulated and tested with only ISFET 2, 3 and 4 wire-bonded due to pin
limitation on the PCB.
)3&%4 )3&%4 )3&%4 )3&%4 )3&%4
Figure 4.22: Microphotograph of test devices implemented in UMC 0.18 μm
1Glob-Topping epoxy by EPO-TEK, type: T7139
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Table 4.8: UMC 0.18μm CMOS ISFET gate voltage at ID=1μA
Die 1 VG(1μA)
ISFET 2 354 mV
ISFET 3 -1.03 V
ISFET 4 4.17 V
Die 2
ISFET 2 -247 mV
ISFET 3 760 mV
ISFET 4 2.11 V
Fig. 4.23 shows ID−V gs sweeps and the gm/ID curves of the six ISFETs for a pH 7 buﬀer
solution, biased with an Ag/AgCl reference electrode. Each sweep was performed twice. As
in the sister UMC 0.25 μm technology, the threshold voltages are distributed randomly, from
-1.03 V to 4.17 V, due to the presence of trapped charge in the passivation. These variations
are summarised in Table. 4.8 for a ﬁxed drain current of 1 μA. The transconductance
eﬃciency curves peak at 6.2 S/A which is slightly lower than UMC 0.25 μm. A weak
inversion dynamic range of over 90 dB is achieved which is good for low power operation
and translinear processing. The pH sensitivity of the devices was evaluated and are shown
Appendix D. The ISFETs were tested in buﬀer solutions of pH 6, 7 and 8 giving an average
sensitivity of 33.16 mV/pH. The response to diﬀerent pH is shown in Fig. 4.25.
AMS 0.35μm device experiments
A similar ISFET to the one designed in the UMC technology was fabricated in an AMS
0.35μm process, but with a transistor gate dimensions length of 200μm × 0.35 μm due to
the minimum feature size limitation of that technology. The device was a single-well NMOS
as triple well devices are not available in this technology. As a result the source needed to
be grounded to overcome body eﬀects. Two ISFET dies were wire-bonded and encapsulated
using epoxy.
The ID − Vgs characteristics of the devices for a pH 7 buﬀer solution and Ag/AgCl
reference electrode bias are shown in Fig. 4.24. Tests were carried out on two separate
days. Die 1 shows a variation in threshold voltage in consecutive runs over the ﬁrst day
which settles down to a repeatable trace on the second day, summarised in Table. 4.9. This
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Table 4.9: AMS 0.35μm CMOS ISFET gate voltage at ID=1μA
Die 1 day 1 VG(1μA)
Run 1 967 mV
Run 2 1.022 V
Run 3 1.144 V
Run 4 1.388 V
Die 1 day 2
Run 1 1.688 V
Run 2 1.731 V
Die 2 day 2
Run 1 1.104 V
Run 2 1.193 V
is due to the initial drift of the device which is caused by hydration of the silicon nitride.
Once it saturates the drift is minimised. Both ISFETs show a good linear weak inversion
range of about 90dB with a maximum transconductance eﬃciency of 7 S/A. The average
pH sensitivity of these devices was found to be 31.7 mV/pH, which is described in Appendix
D. The response to diﬀerent pH is shown in Fig. 4.26.
Summary of ISFET technologies
The results of the experiments conducted on the three ISFET technologies are shown and
compared in Table 4.10. All ISFET devices tested were shown to be responsive to pH
changes with an average sensitivity of about 30 mV/pH. The similar sensitivity across
technology indicates that the PE-CVD Silicon Nitride insulator surface quality is similar in
both technologies. Though pH sensitivity is low, as is expected with the low nitride content,
the sensitivities observed in this work are still lower than what has been presented in the
literature, which is about 40 mV/pH as summarised in Table 4.3. This is due to the fact
that all pH tests were conducted on ISFETs which hadn’t been given enough time to ‘burn
in’. Normally, the ISFETs should be allowed to soak in solution to allow the insulator
to solvate. This so-called ‘burn in’ time causes the insulator to establish an equilibrium
with the solution, considerably reducing drift and increasing sensitivity [47]. The ISFETs
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Figure 4.23: UMC 0.18μm ISFET ID-VGS characteristics (left) and transconductance ef-
ﬁciency cures (right) for the three ISFETs on two seperate dies, with MOSFET model
comparison
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Figure 4.24: AMS 0.35μm CMOS ISFET drain current (left) and transconductance eﬃ-
ciency curve (right)
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Figure 4.25: pH response of UMC 0.18μm ISFET
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Figure 4.26: pH response of AMS 0.35μm ISFET
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Table 4.10: CMOS ISFET technology comparison
UMC 0.18μm UMC 0.25μm AMS 0.35μm
(W×L)elec 200μm × 0.34 μm 200μm × 0.34 μm 200μm × 0.35 μm
(W×L)chem 103.1μm × 32.1 μm 103.1μm × 32.1 μm 103.1μm × 32.1 μm
Cox 335 fF 335 fF 317.8 fF
Cpass 132 fF 122 fF 75 fF
gm/ID 6.3 S/A 9.6 S/A 7.04 S/A
n 1.28 1.35 1.28
n’ 6.128 4.02 5.43
A 0.21 0.336 0.23
Avg Sensitivity 1 33.16 mV/pH 36.6 mV/pH 31.7 mV/pH
Vth spread 1 -1.03 V to 4.17 V -10 V to -30 mV 0.967 V to 1.73 V
1 Average values estimated in Appendix D.
in this work were tested from dry, as would be the case if they were used in a disposable
point of care device, which requires an immediate result. However this resulted in large
drift variations and reduced sensitivity as shown from the ﬁgures in Appendix. D. A higher
sensitivity of about 45 mV/pH can be obtained by compensating for this drift, as it was
shown for the UMC 0.25μm ISFETs in [5].
Due to the limited amount of devices available for test, no conclusive statistical data
may be derived for the variation of the threshold voltage of the ISFETs for each technology.
However variations in threshold voltage are observed in each technology which conﬁrms the
existence of trapped charge. As mentioned previously, this is due to the two layer stack
which is common in all technologies, making up the passivation. The UMC 0.25μm ISFET
had the most spread of threshold voltage, which is mainly contributed to the one device
having a threshold voltage of -10V. It is a possibility that this ISFET became compromised
due to the handling during encapsulation or wirebonding.
Reduction in transconductance eﬃciency is observed in all ISFETs due to the extra
eﬀective capacitance on the gate, dominated by the passivation capacitance. This is seen
by the measured values of n′ which are considerably higher than the original values of n, of
the MOSFETs from which they were made.
The parameters of Table. 4.10 can now be used to make macro-models for ISFETs
according to equation 4.36, which can allow simulation in the three diﬀerent technologies
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and ultimately design of monolithic circuits.
4.8 Modiﬁcation of threshold voltage
As we have seen in Table 4.3 and from experiments conducted in Section. 4.6.1, ISFETs
in unmodiﬁed CMOS suﬀer from large threshold voltage variations. This is mainly due to
charge trapped somewhere between the polysilicon gate of the device and the top passivation
surface, causing a constant voltage shift in the devices characteristics. This section presents
work done in dealing with the issues of trapped charge. Tests are performed to conﬁrm the
existence of trapped charge on a bare die when it comes from the CMOS foundry. This
proceeds with experiments to remove the charge by UV radiation. The section concludes
with the development of a programmable gate ISFET which can be used to cancel out the
eﬀects of trapped charge and drift.
Origin of trapped charge
A test was carried out on a bare UMC 0.25μm CMOS die, (Appendix B), to determine
whether any trapped charge exists in the native die passivation when it arrives from the
foundry. ESD protection was used to prevent minimal charge from entering the passivation
during handling. The die was placed on a probe station with the device contacts probed
with needles and a miniature Ag/AgCl reference used as a bias. A tiny drop of pH solution
was placed on the die centre to make contact with the reference electrode.
Fig. 4.27 shows the ID-VGS characteristic of the bare die. The threshold voltage was
found to be in the range of -3 to -4 V. This conﬁrms that the trapped charge is present
before encapsulation of the die. Is it either added during fabrication, or during dicing
and handling of the dies. Batch removal of trapped charge from all dies could thus be a
possible solution with a UV source, ensuring that they are charge free when they are later
encapsulated and tested.
Trapped charge removal
One device with an extremely high threshold voltage was chosen for UV exposure using
a laser1 which radiates at wavelength of 355nm with an energy of 0.2 mJ per burst. By
1EzLaze II UV3 (355nM)
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Figure 4.27: Bare die test of CMOS ISFET
using a wavelength of 355nM, the radiation emitted is not short enough to penetrate the
nitride, allowing all the energy to be absorbed by the trapped electrons in the passivation.
Once they have enough energy, they are able to to escape and discharge, thus reducing the
eﬀective threshold voltage.
Fig. 4.28 shows the ID-Vgs characteristics of a CMOS ISFET at pH 7 which has under-
gone UV radiation. The initial threshold voltage was at 8 V. The UV laser was applied ﬁrst
for 3 minutes and then for a further 10. The UV energy used was low so as not to cause any
damage or thinning of the passivation. The integrity of the passivation was checked using a
surface proﬁler 2 which conﬁrmed no thinning. The results of the sweeps show a reduction
of 800mV in the ﬁrst 3 minutes followed by a further 4 V in the second test. This conﬁrms
a reduction in threshold voltage by gradual removal of trapped charge from the passivation.
4.8.1 A Programmable Gate ISFET device
As was shown in the previous section one can physically remove any trapped charge by
UV radiation, bringing the threshold voltages to their nominal values. The drawback of
this method however is the extra processing steps required, potentially increasing costs of
development. A less laborious way of dealing with this variation is to make the threshold
2Dek Tak Surface proﬁler
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Figure 4.28: UV radiation of CMOS die. Laser treatment brings the threshold voltages
back to normal.
voltage programmable either by applying voltage to the back gate of the device or to have
a programmable ﬂoating gate attached to the polysilicon. This section presents the design
and fabrication of Programmable Gate ISFET (PG-ISFET) which utilises the programmable
ﬂoating gate to reduce the problem of large threshold voltages as well as threshold voltage
variation between devices.
Floating gate devices are an attractive solution to make reconﬁgurable devices as has
been demonstrated for the neuron νMOS transistors for neural networks [48] and the
chemoreceptive neuron MOS (CνMOS) to be used in silicon olfactory and gustatory systems
[49]. The ﬂoating gate voltage of the device is established by a weighted sum of voltages
applied to the control gates of the device. The weight of each control gate is proportional to
the capacitance of the control gate normalised by the total capacitance of the ﬂoating gate.
Using this method, a ﬁxed control gate can be used to counteract the eﬀects of trapped
charge and drift on the polysilicon ﬂoating gate of the ISFET.
The PG-ISFET schematic is shown in Fig. 4.29 whereby a second control gate, VCG
is capacitively coupled to the ﬂoating gate, VFG through the capacitor CCG. The drain
current of the ISFET is now deﬁned as:
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Figure 4.29: PG-ISFET schematic
ID = I0 exp
VFG − VS
nUt
(1− exp −VDS
Ut
) (4.38)
where VFG is the voltage seen by the polysilicon gate and is the weighted sum of the
input voltages to the device given by:
VFG =
V ′G.Cpass + VCG.CCG + VS .CGS + VD.CGD
CT
(4.39)
CT = (Cox//Cd) + Cb + Cgs + Cgd + Cpass + CCG (4.40)
V ′G = VG − Vtc − Vchem (4.41)
where CCG is the control gate capacitance, Cpass is the passivation capacitance and
Cox, Cd, Cgs and Cgd follow the same deﬁnition as a conventional MOSFET [18]. Equation
4.39 is important in setting the operating point of our transistor in a controlled fashion by
adjusting the voltage VCG.
Using (4.39) and (4.41) we can see that the eﬀect of trapped charge maybe cancelled if
the following relation holds:
CpassVtc = −CCGVCG (4.42)
Additionally, by making VCG programmable, we can cancel out drift and mismatch of
the ISFET. In the ﬁrst case, given an array of ISFETs, information of mismatch of each
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Figure 4.30: Microphotograph and ﬂoor plan of PG-ISFET
device may be stored in memory and used to set the control gate voltages of the devices
such that their drain currents are made equal. To cancel out sensor drift, given a signal
d(t), which describes the drift, superimposed on our chemical signal as V ′G + d(t), we apply
a time varying control gate voltage given by expression 4.44. If the trend of d(t) is thus
known then it will be cancelled out.
VCG(t) =
−Cpass.d(t)
CCG
(4.43)
Design and Fabrication of a PG-ISFET
A PG-ISFET device was designed and fabricated in AMS 0.35μm. The ﬂoorplan and mi-
crophotograph of the device are shown in Fig. 4.30. A 5V thick oxide NMOS device was used
for extra tolerance of the ﬂoating gate. The device dimensions are W/Lelec =200μm/0.5μm
and W/Lchem = 103.1μm/32.1μm. A control gate of 500fF was used, which is split into two
Chemical Electronics 136
´ ´ ´     
´
´
´
´
´
´
'ATE 6OLTAGE 6	
$
RA
IN
 #
UR
RE
NT
 !
	
6 #'

 6
6 #'

 
6
6 #'

 6
6 #'

 
6
6 #'

 6
Figure 4.31: ISFET ﬂoating gate voltage variation
Table 4.11: AMS 0.35 FG ISFET gate voltage at ID=1μA
VCG VG(1μA)
0 V 5.820 V
0.5 V 3.658 V
1 V 1.498 V
1.5 V -0.665 V
2 V -2.847 V
250fF capacitors added on either side of the polysilicon to maintain symmetry.
The PG-ISFET has been tested in a pH 7 buﬀer solution with an Ag/AgCl reference
electrode used as the reference gate. Fig. 4.31 shows the PG-ISFET ID-VGS curves for
a VCG of 0 to 2V in steps of 500mV. Constant shifts in the characteristic are observed,
demonstrating the programmability of the device. Table. 4.11 summarises the eﬀective gate
voltage needed to be applied to the reference electrode to achieve a 1μA drain current at pH
7, which without the control gate would be at 5.82V. A 500mV increase on the the control
gate leads to an eﬀective 2.16 V decrease of the ISFET threshold voltage.
By observation of the results in Table. 4.11 we can formulate an empirical deﬁnition of
the ﬂoating gate voltage, expression 4.44, in which α=0.406, β=0.094 and VFG(1μA)=545mV.
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VFG = αVCG + βVG (4.44)
This section presented an ISFET with a programmable threshold voltage. The PG-
ISFET has potential in compensating for threshold voltage mismatch as well as adaptively
compensating for drift, rendering it an attractive solution where array based adaptive chem-
ical bionic sensing systems are required.
4.9 Longevity of ISFET sensors
Longevity of ISFET sensors is important for applications where long term monitoring is
required such as implantable chemical sensors and growth of cell cultures. The lifetime
is often limited by a break down of the encapsulation epoxy resin, corrosion of outgoing
wires and the pollution and degradation of ion-sensitive membranes, all of which cause loss
of sensitivity or malfunctioning of the sensor [50]. Although longevity is limited by the
encapsulation, robust encapsulants have been shown reporting lifetimes of up to 250 days
[51]. Commercially available devices also exist with lifetimes greater than eight months [52].
Table 4.12 summarises various reports on the length of time experiments were conducted
with ISFET based devices, giving an indication of the longevity.
Using the native passivation of a CMOS process for cell culture capacitance measure-
ments has been shown in [56, 57], reporting cell monitoring for up to four days. Similar
performance can be expected for CMOS ISFET measurements as the only diﬀerence will be
the underlying electronics. SU-8 photoresist encapsulation of CMOS ISFETs for pH sensing
has been shown with a working life time of up to a week [38]. The same group has used
this to make a lab-in-a-pill sensor to measure, in vivo, the pH of the gastrointestinal system
Table 4.12: Longevity of ISFET based sensors
Analyte Duration of use Ref
pH 1 week [38]
Na+ 2 months [53]
Urea 35 days [54]
Glucose 1 month [55]
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[58] for up to 42 hours. Provided the encapsulation is robust, ISFETs made in unmodiﬁed
CMOS can be used for long term monitoring.
4.10 Design considerations for CMOS ISFETs - A summary
This section summarises some key factors which need to be considered when designing IS-
FETs on unmodiﬁed CMOS based on the knowledge gained and the experiments conducted
and presented in this chapter:
• pH Sensitivity - ISFETs, unlike potentiometric pH sensors, will generally show a lower
sensitivity than the Nernstian one due to the existence of the Helmholz and Gouy-
Chapman layers as well as the quality of the insulating layer. Insulating layers, such
as Silicon Nitride, added by LPCVD at high temperature give the best results in
terms of sensitivity. When designing in CMOS though the Silicon Nitride passivation
is added by PECVD leading to a lower quality Nitride which will tend to lower the
pH sensitivity of the device, making it nonlinear to changes in pH and introducing
drift. This makes is diﬃcult to characterise as a stand alone pH sensor but it still
can be used for applications which require monitoring of changes in pH rather than
absolute value. If CMOS ISFETs are to perform as stand alone pH sensors then the
device must be created with a window in the passivation above the gate for addition
of an insulating layer by LPCVD.
• Device Characteristics in CMOS - ISFETs have a gate oxide deﬁned by W×Lelec and
a chemical gate deﬁned by W×Lchem which deﬁnes the area of the stack connected
to the passivation. W×Lelec can be chosen as in a normal MOSFET, to give the
required operating range and transconductance of the device. However, it must be
noted that the eﬀective gate voltage on the device is scaled down due to the presence
of the capacitor formed by W×Lchem and the passivation. This acts to skew the device
characteristic, making it need more gate voltage to achieve the same drain current.
Theory suggests that W×Lchem should be made as large as possible to increase the
voltage coupling between the passivation and the gate oxide.
• Linear Weak Inversion Dynamic Range - ISFETs in CMOS have been shown to exhibit
weak inversion characteristics as those of the MOSFET from which they were designed.
The skewing eﬀect due to W×Lchem will tend to extend the weak inversion region
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over a large gate source voltage. This is advantageous if a large exponential operating
region is required in applications which utilise translinear circuits. The oﬀ-current of
the device is determined by how well the encapsulation is as leakage from the substrate
to the solution tends to raise this.
• Encapsulation - In order for proper operation of the device to occur the encapsulation
must completely isolate the solution from the substrate of the die. If not, leakage
will occur which can be monitored by observing the current through the reference
electrode. High reference electrode currents is a sign of package degradation [50].
The encapsulation must also not act as a trap for solution after it has been washed
as this will cause cross contamination and give inaccurate results. Two types of
encapsulation were tried, spin coated SU-8 photoresist and epoxy. The SU-8 was
easier to encapsulate due to standard lithographic methods but seemed to degrade
on reuse, and dissolve under more acidic conditions. The epoxy was the more robust
of the two as it showed no signs of degradation on reuse and gave extremely low
reference electrode currents, though it had to be applied manually by hand. For
batch processing and microﬂuidics standard lithographic methods must be used and
therefore a more robust photoresist is required.
• Threshold Voltage Variation - Variations in threshold voltage are expected when fab-
ricating ISFETs in unmodiﬁed CMOS due to the presence of trapped charge in the
passivation stack or in the polysilicon. From the passivation this can either be removed
by UV radiation at a low wavelength or compensated for by a change in architecture
such as the PG-ISFET. In the polysilicon, this can be eliminating during fabrication
by placement of vias to connect it to the metal stack.
• Drift - Drift is always an issue observed with sensors which have an insulator-solution
interface. The hydration eﬀects of the insulating layer usually lead to an increase in
capacitance which manifests itself as drift [59]. The drift rate is usually a function
of how long it takes for the insulator to equilibrate with the solution. ISFETs in
CMOS with the low quality insulator passivation will be more susceptible to this.
Solutions to counteract drift involve brieﬂy washing with hydroﬂuoric acid before
use or use a much better insulator. CMOS ISFETs though can be integrated with
MOSFETs to perform clever processing which could potentially cancel out drift. A
lot of work has been done on reference FETs (REFETs) [20], which use a special
membrane insensitive to hydrogen ions, and cancel out the drift using a diﬀerential
arrangement. A more simplistic way is to use the PG-ISFET, assuming we have a
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predictable drift pattern. With the emergence of specialised microﬂuidic techniques,
a solution whereby an accessible reference solution for auto-calibration can also be a
potential solution.
• Technology Selection - In order for ISFETs to be maximally sensitive in an unmodiﬁed
CMOS process the passivation layer covering the die must contain amphoteric sites
to trap protons, as is the case with Si3N4. However, as was shown, CMOS based
passivation is usually a stack of Si3N4/SiO2 or Si3N4/PSG, which can trap charge.
This results in extremely high and variable threshold voltages. If available, single
layer passivation will yield better results. The thickness of the passivation is also
important in determining the passivation capacitance, which acts to change the device
characteristics.
4.11 Summary
This chapter has examined the ISFET as a sensing device for the front-end of a chemical
bionic system. Its ability to be customised to sense multiple biological analytes along
with the fact that it can be integrated with standard CMOS circuits make it ideal for
implementing monolithic systems which imitate biological functions. The mechanisms which
occur for an ISFET to sense pH were analysed to provide a more thorough understanding
of the chemical behaviour of the device, as well as to justify a reduction in sensitivity from
the ideal Nernstian response. The existence of the weak-inversion region of the ISFET has
been conﬁrmed and explored which gives scope for implementation of low power systems as
well as for potential exploitation of the mathematical properties which exist.
ISFETs in unmodiﬁed CMOS have been chosen due to the advantages of monolithic
integration with MOSFETs, miniaturisation of the sensors, as well as minimum cost of
fabrication. Several ISFETs were fabricated in three separate technologies in standard
submicron CMOS and have shown to be functional with initial pH sensitivities of about 30
mV/pH. Weak inversion regions have also been identiﬁed allowing for low power operation.
Key issues addressed for ISFETs in unmodiﬁed CMOS were threshold voltage variations
due to trapped charge in the passivation, introduction of a passivation capacitance which
divides down the eﬀective gate voltage, and reduction in sensitivity and drift due to the
low quality nitride content of the passivation. A uniﬁed model has been proposed which
includes reduced sensitivity, trapped charge and passivation capacitance scaling, allowing for
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simulation of the devices in SPICE simulators using the MOSFET models from which they
were created. Modiﬁcation of threshold voltages was accomplished by removing trapped
charge using UV laser trimming. An ISFET utilising a ﬂoating gate was also presented as
a solution to programming the threshold voltages as well as counteracting for drift. Finally,
design considerations have been described, for implementing ISFETs in unmodiﬁed CMOS
which allows for better implementations of the devices in future.
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Chapter 5
Neurally inspired chemical bionic
systems
5.1 Introduction
Neuromorphic systems are becoming increasingly popular in applications where large array
based, parallel processed, low power systems are needed for implementation in CMOS. In
these systems sensor information is conveyed using action potentials, which are generated
using on chip integrate and ﬁre neurons. In doing so they are able to interact with pop-
ulations of neurons to perform clever processing such as learning and adaptation as well
as transmit information extremely eﬃciently using event driven protocols such as Address-
Event-Representation (AER).
Successful implementation of ISFETs in unmodiﬁed CMOS has made realisation of large
chemical sensor arrays possible. Array processing of ISFETs would be useful for sensor
redundancy as well applications such as compensating in sensor mismatch by averaging,
performing spatio-temporal ﬁltering to remove drift and temperature dependance, or as
will be demonstrated in this work, producing a chemical imager capable of taking a spatio-
temporal snap shot of the chemical activity above it. For an increasing number of ISFET
sensors per die, neuromorphic techniques can be applied which will increase the usable
dynamic range of the sensor, allow adaptability of the array pixel, transmit information
more eﬃciently as well as conserve power. All these techniques have thus far been used for
neuromorphic imagers and will be adapted herein to use an ISFET as the input to allow
other forms of spatial array processsing.
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Figure 5.1: ISFET bias and readout
This chapter assesses the potential of the ISFET as a chemical input to a neuromorphic
system. A simplistic ISFET readout is presented with minimal component count to be
used in large scale arrays such as populations of neurons. Then a low power ISFET based
integrate and ﬁre neuron is designed which conveys the chemical sensor amplitude as a spike
frequency proportional to proton concentration. This ISFET based neuron is then used to
produce a 3 x 11 array to act as a chemical imager with adaptive biasing of the pixels and
using standard a AER protocol to transmit the data. This concludes with simulations of a
circuit acting as a pH discriminator, to detect transitions around a known pH.
5.2 An ISFET readout circuit
ISFET readout circuits require that the chemical information seen by the insulator on the
gate, Vchem, be successful transduced into a form which can be further processed. This is
achieved by biasing two of the three variable parameters of the ISFET (VG, VDS or ID) with a
constant source and reading the third to follow changes in Vchem. Common ISFET readouts
[1] such as the one used so far in Appendix D for pH tests, achieve successful transduction by
ﬁxing VGS , VDS 1 and ID and having the circuit operating in a source follower conﬁguration
with feedback through operational transconductance ampliﬁers (OTAs) so that Vchem can
be monitored by observing the source voltage of the device.
Interface circuits such as the one in Appendix D are not the most eﬃcient implemen-
1When in strong inversion, operating the ISFET in the triode region is desired to get a linear relation of
Vchem with the output. Therefore a ﬁxed VDS is usually required to ensure operation in this region
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tations when it considering transistor count and power consumption for implementation in
large scale arrays. The regulated cascode circuit shown in Fig. 5.1 is simple but eﬀective
circuit used for imaging pixels as it uses only three transistors in feedback conﬁguration to
ﬁx a voltage and readout a current. It has been shown how it can be adapted to be used
with an ISFET in [2].
Iout(SI) = μ0Cox
W
L
[(VGS − Vchem − VT )VDS − V
2
DS
2
] (5.1)
Iout(WI) = I0e
VG′S
nUt = I0e
VGS
nUt e
−Vchem
nUt (5.2)
Vchem = γ + 2.3UtapH (5.3)
A constant potential is applied to the reference electrode of the ISFET with the source
grounded. The drain of the ISFET, X1, is held at a constant potential due to the voltage
clamping action of transistors M1 and M2. The voltage regulation is the result of the high
gain single stage ampliﬁer formed by M1 and its load, which is connected in a negative
feedback loop the drain of X1 via the source follower M2.
With the drain clamped and the ISFET source grounded, any change in ion concentra-
tion in solution changes the output current of the ISFET for a given reference electrode
bias. Expressions 5.1 and 5.2 gives the output current of the ISFET in this conﬁguration
when it is biased in strong inversion for a linear readout and in weak-inversion.
In weak inversion output current is exponential related to the change in Vchem. By using
the logarithmic relation of pH =-log[H+] we can eﬀectively use the expansive properties of
the exponential to linearise this result as was shown in [3]. Rearranging this equation to
the form of expression 5.4 gives us a direct relation to hydrogen ions.
Iout(WI) = I0e
VGS
nUt e
−γ
nUt [H+]
a
n (5.4)
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5.3 An ISFET based leaky integrate and ﬁre neuron
An integrate and ﬁre circuit as its name suggests, integrates a small current on to a capacitor
until a threshold is reached, and then generates (ﬁres) a fast discrete pulse known as spike,
resetting the capacitor [4]. Analogue information is thus portrayed as a series of spike trains
whereby the information is carried in the temporal structure of the inter-pulse intervals.
This method of encoding is usually referred to as rate coding. A/D conversion of the
information can be direct by counting the number of spikes in a ﬁxed time frame or by
measuring the inter-spike intervals.
Encoding sensor information in the spike domain has the advantages of :
• Improved versatility in dynamic range - As the sensory information is encoded in the
time domain we are no longer constrained to voltage headroom issues to deﬁne the
dynamic range. A pulse frequency output can usually vary to 5-6 orders of magnitude
[5] which gives plenty of resolution for ﬁne chemical sensor information.
• Robustness in signal integrity - As the spikes are discrete in amplitude the information
transmission has all the beneﬁts which come with encoding information in the digital
domain. Furthermore, the signal to noise ratio of any particular pulse frequency
output is relatively constant over the entire dynamic range [5].
• Inherent compatibility to address-event encoding - This utilises the available band-
width of communication to the most active events, relaying information only where it
occurs and thus conserving power [6].
• Technology scalable - Lends itself to modern sub micron processes as it allows opera-
tion below 1V, and becomes faster with decreasing transistor sizes.
The original VLSI based integrate and ﬁre circuit described by Mead [4], referred to
as the ‘Axon-Hillock’ circuit because it mimicked the behaviour of the Axon Hillock in the
neuron, consisted of a capacitor to perform the integration with an inverter to perform
the thresholding and reset though a transistor which discharges the capacitor. The major
issues of this original neuron were that it dissipated non-negligible amounts of power due
to the slow switching of the neuron allowing for short circuit currents of the inverter 1 to
1Short circuit currents in an inverter are a result of the region in which both the transistors in the inverter
are on and conducting
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Figure 5.2: ISFET based integrate and ﬁre neuron
become signiﬁcant, as well as the fact the the threshold voltage and refractory period of the
neuron were determined by CMOS process parameters. Since then many I&F models have
appeared which signiﬁcantly increase the neurons switching time to conserve power as well
as to allow programmability of the neurons parameters [6][7].
In this work we adapt the integrate and ﬁre neuron circuit, based on the design by
Indiveri in [7], to encode ISFET sensory information as a series of spikes. Fig. 5.2 shows the
circuit schematic of the neuron interfaced to the ISFET readout described. All device sizes
have been chosen to optimise for low power. This neuron has been selected over alternative
implementations because it achieves reduced power consumption by use of the feedback
current, Ifb, which signiﬁcantly reduces the short circuit current through the inverter made
up of transistors M10 and M11, allows tunability of the neurons refractory period by the
voltage Vrfr, setting a limit on the maximum spike frequency and hence the maximum
power consumption, has a programmable threshold voltage given set by Vsf and has an
explicit leakage current, Ileak, set by Vthr, which will be shown to act as a threshold for the
chemical sensor.
Neurally inspired chemical bionic systems 153
5.3.1 Circuit operation
Since the neuron is leaky, the capacitor, Cmem, will only start charging when the sensory
current, Isensor, exceeds the leakage current, Ileak. Assuming that during the time the
capacitor is charging the feedback current in negligible, the membrane voltage Vmem will
rise according to:
Cmem
dVmem
dt
= Isensor − Ileak (5.5)
Once the capacitor charges Vmem above a threshold set by Vsf using the source follower
M7 - M8, the voltage Vin will begin to rise according to:
Vin = k(Vmem − Vsf ) (5.6)
where k is the sub-threshold slope coeﬃcient [7]. Once Vin approaches the switching
threshold of the inverter M10-M11, the feedback current, Ifb begins to increase, adding pos-
itive feedback and making Vin rise faster and causing the inverter to switch instantaneously.
In doing so it reduces the time that both M10-M11 are on and reduces power. Vin high sets
Vreset hight which turns on the bleed transistor M21 which instantaneously discharges Cmem
and produces a spike at Vspk, Fig 5.3. Cmem can only begin to charge again once Vreset
goes low by discharging through the channel resistance of transistor M18. This is tunable
through the voltage Vrfr which sets the refractory period of the neuron and ultimately the
maximum spiking frequency.
The spike-rate dependence on the the sensor current can therefore be approximated as:
fspike ≈ Icap.frfr
Icap + Cmem.V0.frfr
(5.7)
Icap = Isensor − Ileak (5.8)
where Icap is the diﬀerence between the sensor and leakage current, frfr=1/trfr is the
neurons refractory period and V0 is the threshold of the inverter M10-M11.
Using the ISFET, this sensor current can now be dependant on the pH change of a
solution. Assuming the pH change is small, this will provide a linear proton to spike
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Figure 5.3: Spike generation determined by Vmem and Vreset
conversion. Furthermore, the neuron itself can provide a form of adaptation to counteract
for buﬀer pH which shall now be described.
5.3.2 Chemical Sensing
In many biomedical applications, the reaction to be measured is usually contained in a
buﬀer solution of some form. The role of the buﬀer solution is to resist any changes in
pH so as the reaction can occur. This is required because some reactions only occur at
a speciﬁc pH. For example, enzymatic reactions such as glucose oxidase with glucose and
nucleic acids produced by of DNA/RNA complexes usually favour a pH of about 7 for
optimum sensitivity [8].
In such situations the change in pH sensed due to a reaction is given by the protons,[H+],
produced during that reaction divided by the buﬀer capacity, β, which is speciﬁc to the
solution, expression 5.9.
ΔpH =
[H+] produced
β
(5.9)
When considering reactions such as these taking place in buﬀered mediums, the infor-
mation contained in Isensor is a combination of a ﬁxed DC current, Ibuffer, due to the
buﬀer concentration of the solution and a smaller current due to the generation of protons,
Δ I[H+]:
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Isensor = Ibuffer +ΔI[H+] (5.10)
Using the neuron in Fig. 5.2, the leakage current which is deﬁned by Vthr, can now serve
as a threshold current, below which no spiking activity will occur. For a reaction whereby
we expect proton generation, setting Ibuffer=Ileak will allow full utilisation of the neurons
dynamic range by the reaction occurring, reduce power by removing spiking due to the
buﬀer pH and allow potential adaptation for any buﬀered medium. The spike frequency
dependance on the reaction will thus be as in (5.12) assuming small currents and grouping
all the non-pH dependant constants of expression 5.2 as Kchem.
fspike ≈
ΔI[H+]
Cmem.V0
(5.11)
fspike ≈ KchemΔ[H
+]
a
n
Cmem.V0
(5.12)
Compensating with the leakage current also reduces the dynamic power consumption of
each pixel, which for very small currents are approximated by Eq. 5.13 where Espike is the
energy contained in each spike.
Pdynamic =
Espike.Icap
Cmem.V0
(5.13)
5.3.3 Circuit simulation
The circuit of Fig. 5.2 has been designed and simulated in AMS 0.35μm (Hitkit 3.70
C35B4C3 technology). For all simulations the ISFET is implemented using a Spectre HDL
model implementing Vchem, attached onto a standard BSIM model for a MOSFET. The
parameters used were α=0.9 and γ=-324mV and the ISFET is biased at 920mV to give
10nA in a pH 7 buﬀer solution. The membrane capacitor of the neuron, Cmem is 1pF with
vsf set to 500mV to give a neuron ﬁring voltage, V0 of 1V with a 3.3 V supply. vrfr is also
set to 500mV to give a refractory period of 1.65μs limiting the maximum ﬁring frequency
to conserve power.
Simulation of the ISFET integrate and ﬁre circuit is shown in Fig. 5.4 for a pH 7 stimulus.
This achieves good power eﬃciency as expected from [7]. The minimum spike frequency
Neurally inspired chemical bionic systems 156
esnopseR tneisnarT
0 0.001 0.002 0.003 0.004 0.005
)su( emit
5.3
5.1
5.−
V
 (V
)
V
 (V
)
5.1
0.1
5.
0
V
 (V
)
V
 (V
)
0.03
0.5−
Y
2 
(u
A
)
Y
2 
(u
A
)
0.521
0.001
0.57
0.05
0.52
0
Y3
 (E
−1
2)
Y3
 (E
−1
2)
 kpsV/ 
 0V/ memV/  
 tnerruCylppuS/ 
 ygreneekipS 
M 01x589.2 ,su3.211(0 11− )01x589.2 ,su3.211(0 11− ). ,.( ). ,.( ). ,. )
)Au60.52 ,su1.601(1M )u60.52 ,su1.601(1 ). ,.( . ,. . ,.
M )Vm9.254 ,su47.54(2 )9.254 ,su47.54(2 ). ,.( . ,.( . ,.
Figure 5.4: Response of the ISFET I&F neuron to a pH 7 (10nA) stimulus.
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Figure 5.5: ISFET sub-threshold current mode readout
due to leakage was found to be 2 Hz with a maximum linear frequency of 121.7 kHz giving
about 95.6 dB linear range for pH sensing.
Fig. 5.5 shows how well the output current of the readout circuit tracks the change
in pH in the range of 1-14. The voltage clamp circuit works well to give and exponential
current to pH variation with a current sensitivity of -7.73dB/pH in the sub-threshold region
of operation. Fig. 5.6 shows the frequency response of the I&F neuron to an increase in
proton concentration by one pH (7-6). What we can see is that by setting the explicit
leakage current of the neuron to be that of the background pH of the buﬀer results in no
spiking at buﬀer pH.
The designed ISFET I&F neuron can now be used as a building block for various neu-
romorphic type circuits as shall be shown in the following sections.
5.4 An ISFET based Chemical Imager
In this section we present initial research in combining an ISFET based biosensor with the
backbone of a neuromorphic imager to make a chemical imager. Neuromorphic imagers
have well matured since their introduction by Mead [4] allowing for further experimenta-
tion in terms of algorithms. We believe that as CMOS ISFET sensors are becoming well
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Figure 5.6: Spike frequency dependance on proton concentration, with and without buﬀer
compensation
characterised and understood, as is the case with photodiodes, implementation of intelli-
gent circuits with the ISFET as part of the actual analogue building blocks will be feasible.
As a result we can start to envisage applications for various neuromorphic algorithms on
chemical samples, such as tracking, recognition, edge detection and adaptation.
Chemical imaging allows for a spatio-temporal proﬁle of the chemical concentration of
the sample to be acquired. Like with an optical imager, one will be able to visualise the
chemical activity occurring on the surface of the die, whereby the output of each pixel will
contain information on the local concentration. Therefore by having an array of ISFET
pixels it is possible to monitor various chemical compounds as was described in Chapter 4.
Some applications which could utilise a chemical imager include:
• Monitoring reaction diﬀusions - With the increasing integration of microﬂuidics on
CMOS, one can monitor the actual diﬀusion occurring when reagents combine in this
chamber. This could be an indication of how favourable a reaction is depending on
the combination rate.
• Monitoring of action potentials - Action potentials change the local concentrations
of sodium and potassium when they propagate down nerve bundles. Using an array
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of potassium sensitive ISFETs one can monitor this activity spatio-temporally and
deduce whether the signal is sensory or motor as was described in Chapter 2.
• Monitoring growth of cell cultures - It has been shown [9], that monitoring of the
acidiﬁcation of cells (i.e. increase in pH) gives an indication for their metabolic activ-
ity, which is important for healthy growth in stem cell cultures. A simpliﬁed equation
to evaluate the pH variation depending on metabolic activity is shown in Eq. 5.14
[10] where Cden is the number of cells per unit area, [H+] is the protons generated,
D is the cell population sensor distance and β is the buﬀer capacity of the medium.
By using an array of ISFET sensors acquisition of the pH proﬁle of the cells above is
possible.
dpH
dt
∼= Cden.[H
+]
D.β
(5.14)
Given that the data in many biochemical processes is slow and thus sparsely encoded,
an Address Event readout is well suited for retrieving the data without the need for a
traditional analogue to digital converter. In this modality the available output bandwidth
is allocated only when there is information to be sent rather than scanning each pixel
individually [6]. Encoding the data in this way gives better utilisation of communication
bandwidth, reducing power consumption and also allows for potential processing using pulse
stream arithmetic [11].
This section proceeds with the design of a 3x11 Chemical Imager in a standard 0.35μm
CMOS process. The ISFET based I&F neuron described previously is used and the trans-
duction element with an event driven readout. A novel on-chip adaptation mechanism is
also proposed to allow the sensors to work in any buﬀer pH without the need of recalibration.
5.4.1 ISFET design
The ISFET used for this work was designed using the same methodology as the AMS 0.35μm
device described in Chapter 4. The ISFET is electrically equivalent to the one presented in
Fig. 4.24 but with a square chemical gate of W/Lchem = 57.5μm/ 57.5μm to accommodate
the pixel design. The physical length of the device was also reduced by designing the gate
with 10 ﬁngers of 20μm to give an equivalent electrical length of 200μm. The new device
ﬂoor plan and microphotograph are shown in Fig. 5.7.
Neurally inspired chemical bionic systems 160
,
XSTACK
TOX
0OLYSILICON /UTLINE OF 
METAL STACK
0SUBSTRATE 0	 0WELL 0	 . #ONTACTS FROM
POLY TO STACK
XXXX
0OLYSILICON 
7F   UM X  FINGERS
,   UM
XSTACK   UM
YSTACK   UM
TOX   NM
,
X X X X X
X X X X X
7F
Figure 5.7: Microphotograph and ﬂoor plan of Square ISFET
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Figure 5.8: AMS 0.35μm CMOS ISFET pixel drain current (left) and transconductance
eﬃciency curve (right)
The ISFET was encapsulated and tested using on the same package that was used for
the tests performed on previous AMS ISFETs. This procedure is described in Appendix E.
Fig. 5.8 shows the ID-Vgs characteristics of the device for a pH 7 solution using an Ag/AgCl
reference electrode. The transconductance eﬃciency curve is shown on the right. The
ISFET behaves as expected from measurements on other ISFETs in the same technology.
It shows good linear range in the weak inversion region and has a gate voltage of 2 V at
ID=1 μA allowing operation using a 3.3 V supply. The transconductance eﬃciency peaks
at about 7.2 S/A which is almost identical to the rectangular equivalent ISFET of Fig. 4.24.
This observation tells us that surface device geometry does not play a role in the division
of the gate voltage, as long as the exposed area is the same.
5.4.2 Pixel design
The ISFET designed was interfaced to the I&F neuron described to form the ISFET pixel.
The neuron was adapted to interface onto an Address Event bus by modifying the output
stage in incorporate the request and acknowledge signals. The modiﬁed schematic is shown
in Appendix G. What changes in the mode of operation is that once the Neuron spikes a
!REQ is set on the AER bus which stays high until it is read and acknowledge signal, ACK
is returned which resets the neuron and allows further information to be transmitted. Pull
up transistors are added to prevent the bus from entering a meta-stable state.
The fabricated pixel ﬂoor plan and layout is shown in Fig. 5.9. The pixel dimension is
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80μm x100μm and is mainly dominated by the size of the ISFET.
5.4.3 Array design
A 3x11 pixel array of the pixels has been designed and fabricated to provide a proof of
principle for chemical imaging using ISFETs. The whole imager schematic can be found
in Appendix G. A 1-D 5bit AER bus was used to accommodate the 32 pixels with the
33rd used for characterisation purposes. The AER was designed from an existing Cadence
library1 [12]. The AER bus consists of a column encoder to assert the address of each pixel
when there is an event and an arbitration tree to select one of many requests, facilitated
through a binary tree hierarchy. Fig. 5.10 shows the fabricated array and ﬂoor plan of the
lay out of the blocks. The array size is 258μm x 2057μm and has been topologically planned
to accommodate a larger spatial area for the sample.
The ISFET designed gives us a 10nA current for pH7 at Vg=1.1V. For an increase
in acidiﬁcation we assume a unit decrease in pH (7-6). Without adaptation this requires
a maximum request rate of 45Khz and therefore the AER bandwidth must be at least
1.44x106events/sec (32x45Khz) which is achievable [13]. It is expected that the pixel mis-
match will be dominated by the threshold voltage variations of the ISFET devices, which
was shown in Chapter 4, and will ultimately deﬁne the dynamic range of the imager.
5.4.4 Adaptation
Adaptation for a single pixel was shown in section 5.3.2 which utilised the leakage current to
suppress spiking due to the overall buﬀer solution concentration and therefore sense small
changes in concentration. In order for the adaptation to be dynamic, the array needs to
be able to sense the buﬀer concentration it is in and set that to be the threshold current.
This will allow the array to be used in multiple buﬀered mediums without the need for
re-calibration each time.
Dynamic adaptation is possible by calculating a global average, Iavg, of all 33 pixels in
the array and using this at the threshold current, Ileak of each pixel. Then only ISFETs
which are sensing a local concentration greater than the global concentration of solution
will ﬁre. The average is calculated by mirroring out the sensor current from each pixel and
using a chain of current mirrors to divide down the current and sum (i.e a current-mode
1AER library provided by Dr. Philipp Haﬂiger, University of Oslo
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Figure 5.9: Microphotograph and ﬂoor plan of ISFET pixel
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Figure 5.10: Microphotograph and ﬂoor plan of Chemical Imager
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Figure 5.11: Simulated 16x16 ISFET pixel array with pH activity in the centre. Dynamic
power consumption is shown with and without adaptation
average), Appendix G Fig. G.2. The global concentration is expected to be slightly higher
than the buﬀer concentration so the threshold is relaxed slightly be setting the average
current to 90% of its value, Eq. 5.15.
Iavg = Ileak = 0.9
N∑
i=0
Iisensor
N
(5.15)
In order to show the eﬀects of adaptation a 16x16 array was simulated in Matlab with
acidiﬁcation taking place in the centre and random noise superimposed, see Fig. 5.11. The
mesh plots show the dynamic power consumption of the pixel array, calculated using Eq. 5.13
assuming 20pJ energy per spike. These results conﬁrm the following: a) the adaptation
mechanism only shows activity in the areas where there is elevated pH and suppresses the
surrounding pixels which would spike anyway due to the buﬀer concentration and b) the
adaptation reduces the dynamic power consumption from 375nW to 65nW. When using
adaptation in this fashion static operating frequency of the array is reduced down to 6Hz
which is due to leakage from devices. This is also apparent on the 3-D mesh plots from the
ﬂoor dynamic power being reduced from 200nW to 120pW.
The spatio-temporal eﬀects of the adaptation mechanism are can be seen in a simulation
of a 100x100 ISFET array, shown in Fig. 5.12. The ISFETs were biased to give 100nA at
pH 7 and random noise was superimposed. Shown is an increase in pH traversing the array
from left to right causing the sensor current to increase to 110nA. What we see is that
with the adaptation activated the baseline pH is removed compensating for the buﬀer and
the only current which can cause the neuron to spike is that of the traversing pH which
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peaks at about 7nA. Furthermore, we observe noise suppression in areas where there is a
baseline pH. This becomes apparent in the third snapshot when the pH bubble is leaving
the array, lowering the mean compensation value, Iavg, and therefore allowing the baseline
pH to cause some spiking.
5.4.5 Initial measured results
The fabricated array was encapsulated and preliminary measured results have been obtained
to prove its functionality. As the array has not been optimised for noise or power these
results serve just as a proof of principle. In order to extract events from the AER bus, a
USB AER monitor was used 2 with its Matlab libraries. All experiments were conducted
using a small drop of pH 7 buﬀer and a mini Ag/AgCl reference electrode with a 3.3 V
supply.
Fig. 5.13 shows the measured current-gate voltage sweeps of the reference pixel, IpH33,
the average of the 32 pixels, Iavg32, and the adaptation current, Iavg90, which is set to
90% of the global average. What we observe is the expected linearity of the weak inversion
ISFET but also we can see that the average of the 32 pixels is higher than that of the
reference pixel for a given gate voltage. This indicates threshold voltage mismatch in the
ISFETs of the array as reported in Chapter. 4, in which some ISFETs have a lower threshold
voltage than the reference yielding a higher drain current output for the given gate voltage.
Fig. 5.14 shows the spatial map acquired of the chemical image at pH 7 for a reference
electrode voltage, Vg=600mV. The number of events given in the frame are limited by the
USB AER interface to 16Kevents at a rate of about 50 Kevents/sec. No leakage current
was applied. The image gives us a fair indication of the chemical concentration above the
surface of the array with pH 7 giving on average about 500 events/pixel. Additionally it
can be observed that pixel 1 of the array gives signiﬁcantly more events than the rest of
the pixels (1300 events) indicating it is the one which has the lowest threshold voltage and
causes the increase in global average from the expected, as mentioned previously.
In order to reconstruct a reliable image, the threshold voltage mismatch of the ISFET
sensors need to be addressed. This variation due to trapped charge could be reduced by the
radiation of UV on the array as it was reported in [14]. This will also allow the adaptation
mechanism proposed to be implemented. All in all, these preliminary results show that the
2Data acquired using Simple Monitor USBXPress provided by Dr. Tobi Delbrck
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Figure 5.12: Simulated 100x100 ISFET pixel array biased at pH 7 = 100nA of drain current.
Shown is the uncompensated sensor current (left) and the sensor current compensated with
the mean of the array (right). A 10nA increase due to an increase in pH traverses the array
from left to right.
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Figure 5.13: Chemical Imager current output at pH 7. IpH33 is the reference pixel output,
Iavg32 is the average of the 32 pixels and Iavg90 is the adaptation current
acquisition of a chemical image is possible using ISFET devices and future development
should yield in a more advanced and robust intelligent chemical imager.
5.5 An acid base discriminator
This section presents an ISFET based I&F circuit which is capable of discriminating changes
in acidity or alkalinity of pH around a ﬁxed threshold, encoding both the duration and
intensity of this change in spike polarity encoded (SPE) signal for eﬃcient communication
[13]. Such a circuit is useful when qualitative changes in pH need to be monitored, such
as the discrete pH changes observed in DNA matching events used to detect mutations or
SNPs3[8] in a persons genome. These can be used to provide an indication of predisposition
to disease or outcome of therapeutic drug treatment.
The circuit schematic of the discriminator is shown in Fig. 5.15. The current from the
ISFET readout of Fig. 5.1, IpH is extracted using cascoded current mirrors M1-M4, which
is then inverted by the current mirror M17-M20 to form a negative copy. The same is done
for the leakage current, IpH , through current mirrors M5-M8 and M13-M16. The result is
a set of two currents, Iacid = Iph − Ileak and Ibase = Ileak − IpH . These currents are used as
the inputs to two separate neurons designed as in Fig. 5.2. The Neuron acid spikes when
there is an increase in acidity which causes Iacid to increase. Likewise the Neuron base only
3Single Nucleotide Polymorphism
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Figure 5.15: Acid Base discriminator schematic
spikes when there is an increase in alkalinity (i.e a decrease in acidity). The two neurons
share a common reset to ensure only one neuron spikes at any given time. The output
of each neuron is connected to a Set/Reset ﬂip ﬂop, which is set when the Neuron acid
is spiking and reset when Neuron base is set. This gives a digital pulse vonoﬀ which is
set high for the duration of that there is an increase in acidity and low for and increase
in alkalinity. This signal can then be used to determine the duration and polarity of the
increase or decrease. The outputs of the two neurons are then exclusive OR-ed (XOR)
with each other and with vonoﬀ to form a single polarity signal which temporally encodes
information about the amplitude of the signal as well as the polarity.
5.5.1 Simulation results
The circuit was designed and simulated in AMS 0.35μm. Transistor sizes of W/L=2μm/1μm
were used for the current mirrors with a supply voltage of 3.3 V. Fig. 5.16 shows the
simulation results of the system for a 10nA peak sinusoid on 100nA DC current simulating
an increase then decrease in IpH for a pH 7 at 100nA. What we can see is encoding to
the positive cycle by neuronacid and the negative cycle by neuronbase, with vonoﬀ giving
describing the polarity of the signal. The output voutA combines all three signals to give
an SPE output. Once transmitted the amplitude information can be reconstructed from
the spike timing and the polarity from the DC level acquired by low pass ﬁltering.
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Figure 5.16: Acid Base discriminator simulated results for 10 nA peak current at Iph(pH
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Figure 5.17: Increase in noise margin for a 1pA signal over 200 seconds
5.5.2 Integration
One of the advantages of encoding sensory information in the spike domain is that integra-
tion of the signal can be performed by counting the number of spikes in a ﬁxed time interval.
Integration in this this fashion allows for detection of small amplitude signals provided the
integration time is long enough. This eﬀectively lowers the noise ﬂoor of your channel due
to averaging of the signal.
Fig. 5.17 shows plots of the number of spikes from the I&F neuron presented over
a 200 second window due to leakage, fspike=2.3Hz, and for a 1pA signal, fspike=3.3Hz, at
IpH=Ileak=50pA. Assuming that the lowest signal4 is determined by the leakage through the
devices when they are oﬀ, we see a 1.43spike/sec increase in noise margin. This eﬀectively
tells us the longer you can aﬀord to count the spikes for, the smaller your signal of detection
can be. This is a very useful property when considering small amplitude chemical signals
which occur over a very long time scale. A ripple counter could be used to do so to give a
digital output which could then be further processed.
4Signal dependant noise such as ﬂicker and thermal noise which would cause jitter have not been modelled
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5.6 Summary
In this chapter the concept of neurally inspired chemical bionic systems was presented.
An ISFET sensor was combined with a standard I&F neuron to produce a chemical I&F
neuron. This allowed adaptation of ideas which have thus far been used in neuromorphic
engineering to produce large scale array based systems.
As a ﬁrst example an ISFET based chemical imager was presented made in unmodiﬁed
CMOS. This used a 3x11 array of chemical I&F neurons with an AER readout to encode
and transmit the chemical concentration of a sample on top of the die. Threshold voltage
mismatch of the individual ISFETs was found to be a major issue in reliably acquiring an
accurate image. An adaptation scheme was also proposed which allowed functionality to
the imager in any buﬀer solution and optimised the signal encoding by suppression of the
spiking due to the buﬀer pH. This was achieved by taking a global average of all pixels in
the array.
The second system presented was an pH based discriminator which used two neurons
to encode increases in acidity and alkalinity around a ﬁxed threshold. Combined with some
logic the system could be used to produce a SPE signal for eﬃcient communication as well
as take advantage of integrating the signal in the spike domain to increase the limits of
detection.
This work is the ﬁrst step in producing chemically ISFET based neuromorphic systems.
Once the issues concerning ISFET sensors in unmodiﬁed CMOS are addressed, this will lead
to monolithic implementations of chemical bionic systems adapted from various existing
neuromorphic processing systems.
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Chapter 6
Conclusion
This thesis introduced the concept of chemical bionics whereby the ISFET sensor is used as
a transducer to allow a chemical input for VLSI circuits to form novel bio-inspired chemically
dependant systems. This allowed for implementation of silicon metabolic cells in addition
to innovative chemical neuromorphic circuits. As a result, new prosthetic devices such
as the bio-inspired artiﬁcial pancreas and a novel spike based chemical imager, have been
made possible. Various challenges which exist with implementing the ISFET in a standard
CMOS technology have also been identiﬁed and methods of solution have been proposed to
allow for fully monolithic implementation. Furthermore, weak-inversion operation of CMOS
based ISFETs has been conﬁrmed, enabling low power chemical sensing.
6.1 Contributions
Chapter 2 introduces the concept of bio-inspired electronics and explained the motivations
of building systems based on biology. Neuromorphic VLSI was shown as a branch of bionics
in which the electrical behaviour of neurons was modelled to form networks which model
neural computations. The chemical nature of cells in the body was then described to show
that there is scope to make chemical bionic systems to mimic various organs. The ISFET has
then been shown as a potential device for a chemically gated ion channel. Action potentials
generated in neurons were also shown to be a combination of chemical and electrical eﬀects
which resulted in work towards the design of a H&H based chemical bionic neuron which
can be used to bridge this chemical activity to silicon VLSI circuits.
Chapter 3 identiﬁes the beta cell of the pancreas as an important metabolic cell for the
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control of blood glucose in type I diabetic patients. A silicon implementation of the beta cell
is then shown to match the bursting response of the biological beta cell to a glucose stimulus
above 5 mM. This implementation serves as the ﬁrst silicon metabolic cell implemented in
VLSI. This is then used to demonstrate a bio-inspired artiﬁcial pancreas using a linear
insulin infusion.
Chapter 4 introduced the ISFET as an input device for chemical bionic circuits. Imple-
mentation in unmodiﬁed CMOS has then been explored due to the advantages of monolithic
integration with MOSFETs, miniaturisation of the sensors, as well as minimum cost of fabri-
cation. Functional devices have been designed and fabricated in three separate technologies
to produce the ﬁrst technology comparison of ISFET devices. In addition to this, operation
in weak-inversion has been conﬁrmed, allowing for low power chemical sensing. Further-
more, the passivation capacitance has been observed to inﬂuence the device characteristics,
by changing the weak inversion slope. The problem of threshold voltage variation in devices
has also been shown to be a result the silicon nitride passivation of the CMOS process. A
uniﬁed model incorporating these eﬀects has also been proposed. This has described the
ISFET characteristics for operation in weak inversion. Finally, methods for compensation of
trapped charge have been shown by UV exposure and design of a novel PG-ISFET utilising
a programmable control gate to tune the device.
Chapter 5 has described an ISFET-based integrate and ﬁre neuron which can be incor-
porated in many existing neuromorphic circuits. Using this, a novel 3x11 ISFET chemical
imager has been designed and fabricated using AER to provide a spatio-temporal map of
the chemical concentration above the array of sensors. Utilising the explicit leakage current
of the I&F neuron, a method of adaptation has been shown to prevent spiking due to buﬀer
pH. Finally, a pH discriminator has been designed to encode increases in acidity and alka-
linity around a ﬁxed threshold and communicate eﬃciently using a spike polarity encoded
signal.
6.2 Recommendations for Future Work
Future developments based on material described in this thesis are proposed in the following
areas:
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6.2.1 A fully bio-inspired silicon pancreas
Artiﬁcial pancreas’ which have undergone clinical trials described in Chapter 3 have been
shown to cause episodes of hypoglycemia which can be equally harmful to diabetic patients.
During our investigations of the pancreas we have identiﬁed that the beta cell is responsible
for secreting insulin and controlling hyperglycemia and the alpha cell is responsible for
secreting glucagon to prevent hypoglycemia. The electrophysiology of the alpha cell is
similar to the beta cell in that it exhibits electrical behaviour, but for decreasing glucose
concentrations. Therefore a silicon alpha cell can be produced to work in conjunction with
the silicon beta cell to produce a true silicon pancreas. A conceptual system level diagram
is shown in Appendix H in which two pumps will be used on the patient, for insulin and
glucagon. This system also incorporates sensing other chemicals which are indicative of
diabetes such as ketones and fatty acids, to increase the eﬃciency of regulation.
The electrophysiological nature of these alpha and beta cells can be implemented in
silicon, and it is known that this couples to insulin/glucose release by exocytosis. The
system shown in Chapter 3 uses a linear spike to volume conversion for insulin release.
However, in order for the model to be a truly biological replica, the dynamics of exocytosis
also need to be modelled to give a more physiological insulin release.
It is also expected that if the system is not implanted, there will be several interface
issues, such as sensor delays, when the patient is put in the loop. These need to be investi-
gated, and the model updated to compensate for such cases.
6.2.2 Investigations of the ISFET
The ISFETs shown in Chapter 4 were developed on a fully unmodiﬁed CMOS process as
a result they suﬀered from reduced sensitivity, drift and large threshold voltage variation.
This was contributed mainly to the PECVD silicon nitride. Fabricating devices with an
opening in the passivation1 on top of the ISFET top metal could allow for silicon to be
deposited using LPCVD resulting in more stable devices.
The CMOS ISFET has been shown just as a pH sensor. Protocols for deposition of
various enzymes and ionophores need to investigated to make these ISFETs sensitive to
chemicals such as glucose, sodium and potassium. For the silicon beta cell presented in
1Could be achieved using a bond pad connected to the top metal layer of the ISFET which will leave
bare aluminium as the top metal
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Chapter 3, it would allow a truly monolithic implementation of a silicon metabolic cell. For
the chemical bionic neuron introduced in Chapter 2, it would allow detection of chemical
activity around the nerve bundle and a reconstruction the action potential in silicon.
6.2.3 Chemical imager using PG-ISFET
The array of ISFETs used for the chemical imager in Chapter 5 suﬀer from threshold
voltage variations, limiting the dynamic range of the system. The PG-ISFET was presented
in Chapter 4 as a solution to programming this threshold voltage. Therefore having the
PG-ISFET could allow for an auto-calibration phase which, using feedback could reduce
mismatch amongst the array. The spatio-temporal eﬀects of the chemical imager also need
to be demonstrated with the aid of microﬂuidics which would allow control of the chemicals
applied.
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Figure B.1: Chips fabricated during the course of this Thesis.
Appendix C
Chemical Voltages
C.1 The Nernst equation
In electronics we like dealing with voltages and currents and apply fundamental laws such
as Kirchoﬀ’s and Ohms to intuitively analyse and design our circuits. In order to relate to
biochemistry in this way we need to understand the fundamental physics which generate
electrochemical potentials which we can associate to electric voltages.
Potentiometry is a method of detection of ionic concentrations by using electrodes to
measure the potential diﬀerence between a sample solution and a solution of known con-
centration. The reason why there is a potential between the ions is due to diﬀusion being
balanced by an electric ﬁeld due to the ions.
Consider a membrane separating ions of two diﬀerent concentrations. What would
happen is the ions would begin to diﬀuse from the higher concentration to the lower setting
up a diﬀusion gradient. In doing so they would be opposed by the electric ﬁeld due to the
diﬀerence in ionic strengths on either side of the concentration gradient. When the diﬀusion
of the ions reaches an equilibrium with those drifting in the opposite direction due to the
electric ﬁeld, a stable potential is generated known as the Nernst potential.
E =
RT
nF
ln
(
ai,sample
ai,int
)
(C.1)
Equation C.1 describes the potential generated, where ai,sample is the activity of the
sample solution, ai,int is the activity of the reference solution, R is the universal gas constant
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Figure C.1: Electrode setup for measuring pH
(8.31432×103 N.m/kmol.K), T is the temperature in kelvins, F is the Faraday constant
(96485.3415 s.A/mol) and n is the number of electrons.
At this point it is important to point out the analogy which relates directly to the
thermal voltage according to Einstein’s relation:
RT
F
=
kT
q
= Vt (C.2)
C.2 pH sensitivity
For any chemical sensor it is important to understand the mechanisms which generate a
potential due to a change in concentration. Here we describe a simple potentiometric system
used to measure pH whose change in concentration is mapped to a potential described by
the nernst equation (C.1). pH is just a unit of measure of how acidic or alkaline a solution
is, represented by the natural logarithm of the hydrogen ion concentration (C.3). Its scale
is 1-14 where 1 is the most acidic and 14 is the most basic.
pH = −log([H+]) (C.3)
Fig. C.1 shows a simple two electrode system for measurement of pH. It is based on
the pH glass electrode which is used as the gold standard. What we have is a reference
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electrode and a working electrode immersed in a sample solution in which the pH may be
varied.
The reference electrode is used to give a stable known reference voltage so that any
changes in solution may be measured by the working electrode. The Ag/AgCl wire in
a solution of its salt, KCl, always regenerates the electrode and the excess KCl in the
electrode ensures that Cl− is always the dominant ion when the reference potential is
generated according to nernst (C.4). The liquid junction membrane prevents diﬀusion of
chloride ions into the sample solution.
Eref =
RT
nF
ln(aCl−) (C.4)
The working electrode is used to generated the variable potential based on changing
pH. The way it does this is again using a Pt or Ag/AgCl wire in contact with a solution
containing a known concentration of the ions to be sensed, [H+]ref . This is separated from
the sample solution by an ion selective membrane which buﬀers the ions of interest in a thin
surface layer of the membrane. The potential generated at this junction is given by (C.5).
EpH =
RT
nF
ln(
[H+]
[H+]ref
) (C.5)
So we now have the potentials generated by each electrode when in contact with the
solution. This completes the circuit and Kirchhoﬀ voltage law can now be applied to ﬁnd
what the sense voltage, V , will be. The potential which will be sensed by the two electrodes
is therefore the sum of the independent potentials around the loop:
V = Eref − RT
nF
ln(
[H+]
[H+]ref
) (C.6)
V = Eref +
RT
nF
ln([H+]ref )− RT
nF
ln[H+] (C.7)
Converting to pH by taking the natural logarithm and grouping constant terms:
V = Eref +
RT
nF
ln([H+]ref )− 2.303RT
nF
log([H+]) (C.8)
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V = Eref +
RT
nF
[H+]ref +
2.303RT
nF
pH (C.9)
The result of (C.9) is important as it tells us the maximum pH sensitivity as a result
of a pure Nernstian response. With an ideal stable potential reference we expect 59mV
(2.303*kT/q) per pH, (C.10), that is the benchmark sensitivity for all pH sensors.
dV
dpH
=
2.303RT
nF
= 2.303Vt = 59mV (C.10)
C.3 Determination of Vchem
Determination of non-pH dependant DC voltage included in Vchem was found by laser
trimming 1 oﬀ all the passivation from the ISFET of DIE 3 in the 0.25 μm CMOS technology.
The ISFET was radiated twice at maximum intensity of the UV lazer 2. Removal of the
passivation, results in removal of trapped charge as well as capacitive division. Therefore
any voltage shift from the standard MOSFET model is purely due to Vchem.
Fig. C.2 shows comparisons of the ID − VGS and transconductance eﬃciency curves for
the ISFET before and after the passivation was removed, as well as the MOSFET model
from which it was made.
What we can see is the expected shift in threshold voltage from about -10V to 500 mV
due to the removal of the trapped charge by the removal of the passivation. The removal
of the passivation is conﬁrmed by observing the transconductance eﬃciency cures which
shows n′ at about the same value as n after illumination, indicating similar capacitance.
Fig. C.3 shows the resulting voltage diﬀerence between the ISFET without passivation
and trapped charge and the MOSFET, indicating the a value of Vchem=-550mV.
C.4 Glucose ISFET preparation
Glucose oxidase is immobilised on the commercially-available Sentron ISFET surface by
the method of covalent immobilisation. Covalent binding of the enzyme to the surface
1Using the New Wave Research EzLase II semiconductor failure analysis laser system
2Setting 100 HI
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Figure C.3: Comparison of UMC 0.25μm ISFET with no passivation and MOSFET model.
The diﬀerence is due to Vchem
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of the electrode is generally the most irreversible immobilisation technique and therefore
potentially the most stable.
The attachment of the enzyme to ISFET surface involves a two step process:
1. Activating the surface by introducing a useful chemical reactivity to the otherwise
inert surface. This is achieved by doing silanisation using 2% 3-aminopropyltriethoxysilane
(0.2ml of 3-APTS:9.8ml of ethanol) from Sigma-Aldrich. The functionalise (amine) groups
were introduced during this process which allow coupling chemistry to take place with
proteins through the attendant amine grouping.
2. Cross-linking of the enzyme to the surface of the electrode (cross-linking is the
process chemically joining two or more molecules by a covalent binding). Cross linking
reagents contain reactive ends to speciﬁc functional groups (in this case amines) which are
present on the enzyme and the gate of ISFET. As a cross linker dimethyl adipimidate was
used. It consisted of imidoester groups which bind to the enzyme from one side and to the
amine groups on the other side.
The quantities used were as follows:
• Enzyme - 10-15mg of glucose oxidase (Fluka)
• Crosslinker - 1.226 mg of dimethyl adipimidate (Thermo Scientiﬁc)
• Buﬀer - 1ml PBS 10mM (phosphate buﬀer solution)
The ISFET was incubated in this solution at room temperature for 30 minutes.
Appendix D
CMOS ISFET Experiments
D.1 Device Characterisation
CMOS ISFETs used in this thesis were characterised using a Keithley 4200 SCS. ID-Vgs
sweeps of devices were obtained using the experimental setup in Fig. D.1. The drain source
voltage of the device was set to VDS=500mV for all measurements to ensure weak-inversion
saturation. The gate voltage was applied through a Ag/AgCl reference electrode. For triple
well NMOS devices the N-tub is biased at VDD to prevent latch up.
D.2 pH Sensitivity Experimental Setup
The pH sensitivity of all ISFET devices is evalutated using the source drain follower circuit
shown in Fig. D.2 connected to a Keithley 4200 SCS. A miniature Ag/AgCl reference
electrode is used which is grounded at all times. Bias currents of 100μA are used keeping
VDS ﬁxed at 510 mV. A change in pH is observed by tracking the source voltage of the
ISFET.
pH tests are carried out by having falcon tubes containing accurately measured pH
buﬀers and then immersing the device in for a ﬁxed period of 200 seconds. The instrumen-
tation is turned oﬀ to prevent potential damage of the device when changing buﬀers and
the ISFETs are washed with deionised water to prevent cross contamination.
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Figure D.1: Equipment set-up for electrical characterisation of ISFETs in a single pH buﬀer
solution.
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Figure D.2: ISFET readout circuit
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D.3 UMC 0.25μm pH Tests
Fig. D.3 shows the results of pH testing for the ISFET on test die 3. The device was
immersed in pH 4, 7 then 10. The graph has been modiﬁed to omit the jumps which occur
when the instrumentation is turned oﬀ and thus the timing of transitions should not be
taken into account. The ISFET source voltage changes are shown in Table. D.1, with an
average sensitivity of 36.6 mV/pH.
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Figure D.3: pH test of UMC 0.25μm ISFET
Table D.1: UMC 0.25μm ISFET source voltage for pH 4,7 and 10
pH 4 pH 7 pH 10
vs -398mV -493mV -617mV
ΔpH (mV/pH) 31.67 41.3
D.4 UMC 0.18μm pH Tests
Fig. D.4 shows the results of pH testing ISFET 3 of DIE 2. The ISFET was immersed in
pH solutions in the sequence 6, 7, 8, 7, 6, 7, 8 to show hysteresis eﬀects. The sharp rises
in source voltage are due to the turning oﬀ of the instrumentation to change pH solution.
Signiﬁcant drift is observed for the higher pH 8. This maybe due to the lower hydrogen ion
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Figure D.4: pH test of UMC 0.18μm ISFET
content trying to equilibrate with the insulator. The ISFET source voltage changes for the
ﬁrst three solution are emphasised on the bottom ﬁgure and are shown in Table. D.2, with
an average sensitivity of 33.16 mV/pH over all 7 pH steps.
Table D.2: UMC 18 ISFET source voltage for pH 6,7 and 8
pH 6 pH 7 pH 8 pH 7 pH 6 pH 7 pH 8
Vs -923.8mV -950.6mV -985.6mV -951mV -918mV -948mV -987mV
ΔpH (mV/pH) 26.8 32 35.6 33 30 39
D.5 AMS 0.35μm pH Tests
The AMS 0.35μm ISFET shared its source terminal with several other ISFET test structures
on the same die and therefore the readout in Fig. D.2 could not be used. Instead the ISFET
was biased at a Vg of 1.5V and the drain current was observed for a ﬁxed VDS of 500 mV.
The eﬀective change in gate voltage was then deduced using a look up table of the ID-Vgs
sweep of the device taken prior to the experiment. The results of the ISFET on die 1 are
shown in Fig. D.5 for pH steps of 6, 7, 8, 7, 6, 7, 8. The right ﬁgure shows the ﬁrst three
transitions with the eﬀective gate voltage points shown below. These results are summarised
in Table. D.3. The ISFET in this technology suﬀers from severe drift making diﬃcult to
determine an exact evaluation of pH sensitivity. A more indicative way to deduce the pH
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sensitivity is to observe the change in voltage at the change in pH as is shown in Fig. D.6.
The results of the transition points are shown in Table. D.4 giving an average sensitivity of
31.7 mV/pH.
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Figure D.5: pH test of AMS 0.35μm ISFET
Table D.3: AMS 0.35μm ISFET eﬀective gate source voltage for pH 6,7 and 8
pH 6 pH 7 pH 8
Vs 1.828V 1.808V 1.791V
ΔpH (mV/pH) 20 17
Table D.4: AMS 0.35μm ISFET eﬀective gate source voltages at pH transitions
pH change vgs ΔpH (mV/pH)
pH 6-7 1.837 - 1.799 39
pH 7-8 1.818 - 1.782 36
pH 8-7 1.806 - 1.831 -25
pH 7-6 1.863 - 1.890 -27
pH 6-7 1.920 - 1.875 45
pH 7-8 1.899 - 1.869 30
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Figure D.6: pH test of AMS 0.35μm ISFET
Appendix E
Encapsulation Procedures
E.1 SU-8 Encapsulation
The method used for SU-8 encapsulation on a 4-inch wafer-type 1 PCB, shown in Fig. E.1a.
The design facilitates eight sensor modules, each of which employ a die with ISFETs on one
side and a multi-purpose ribbon-connector at the other side, Fig. E.1b. The circumference
of the dipsticks are furrowed, allowing easy partitioning of the wafer once the encapsulation
process is completed. Additionally, potential electrostatic discharges (ESDs) that could
damage the devices during the process, are eliminated by application of the four ESD pads
depicted on the perimeter of the PCB which are connected to all devices.
The dies are interfaced on the PCB via Au wire-bonds as illustrated in Fig. E.1f. A
200μm thick SU-8 2100 layer was spun on the sample for 10 seconds with a relatively low
initial speed, to spread the viscus photoresist without damaging the bond-wires followed
by a 30 second spin at 500 rpm. The sample is then soft-baked in accordance with the
photoresists manual at T1 = 65◦C and T2 = 95◦C, with a reasonable ramp to avoid cracks
on the photoresist ﬁlm. Since SU-8 is a negative photoresist, the open-window above the
gates of the sensors was achieved by UV exposing the whole sample with the sensing area
masked oﬀ.
After exposing the sample, a hard-bake step is followed at T1 = 65◦C and T2 = 95◦C.
The specimen is then developed in EC solvent for 30 minutes. An isopropanol rinse usually
indicates if the developing is ﬁnalized while it dissolves the residual EC solvent from the
14-inch is used as a standard diameter for most clean room process due to the fact that silicon wafers are
made in such sizes
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wafer. In turn, the sample is thoroughly cleaned in de-ionized water. Finally, after the
encapsulation of the dies is completed, Fig. E.1c, the wafer can be easily partitioned into
individual modules.
E.2 Epoxy Encapsulation
Epoxy encapsulation was used for the ISFET dies of the UMC 0.18μm and AMS 0.35μm
technologies. The dies were glued onto fabricated printed circuit boards shown in Fig. E.2c
using an EPO-TEK H20E conductive epoxy and wirebonded using 25μm gold wire. The
dipsticks are then hand encapsulated using glob topping epoxy by EPO-TEK, type T7139.
The epoxy is carefully spread over the device using a toothpick until an opening remains
where the sensing surface is, Fig. E.2a,b. The epoxy is then cured in the oven at 120oC for
60 minutes.
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A	 B	
C	 D	
E	 F 	
Figure E.1: Encapsulation method of UMC 0.25μm ISFET dies using spin coated SU8. (a)
Circular 4 inch PCB made to house 8 dies and mount on the spinner. (b) Dies are glued to
pcb using a conductive epoxy, and wire bonded. Connectors are soldered to the pcb. (c,d,e)
SU-8 encapsulation with a window opened above dies using lithography. (f) Encapsulated
Wire bonds.
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A	 B	
C	
Figure E.2: Enacpsulation method of ISFET dies using epoxy. (a) AMS 0.35μm ISFET (b)
UMC 0.18μm ISFETs (c) Dipsticks made to mount/wirebond and encapsulate dies
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Figure F.1: PCB schematic for artiﬁcial pancreas demonstrator, BETA CELL and PO-
TENTIOSTAT
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Figure F.2: PCB schematic for artiﬁcial pancreas demonstrator, PUMPDRIVER
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Figure G.2: Pixel biasing and circuits used to create Iavg32 and Iavg90
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